
<html lang="en"     class="pb-page"  data-request-id="e76694c9-0a64-45ac-912c-ca4760c05119"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2012.55.issue-22;wgroup:string:ACHS website Group;article:article:10.1021/jm301276e;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Bicyclization and Tethering to Albumin Yields Long-Acting Peptide Antagonists" /></meta><meta name="dc.Creator" content="Alessandro  Angelini" /></meta><meta name="dc.Creator" content="Julia  Morales-Sanfrutos" /></meta><meta name="dc.Creator" content="Philippe  Diderich" /></meta><meta name="dc.Creator" content="Shiyu  Chen" /></meta><meta name="dc.Creator" content="Christian  Heinis" /></meta><meta name="dc.Description" content="Proteolytically stable peptide architectures are required for the development of long-acting peptide therapeutics. In this work, we found that a phage-selected bicyclic peptide antagonist exhibits ..." /></meta><meta name="Description" content="Proteolytically stable peptide architectures are required for the development of long-acting peptide therapeutics. In this work, we found that a phage-selected bicyclic peptide antagonist exhibits ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 5, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm301276e" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm301276e" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm301276e" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm301276e" /></link>
        
    
    

<title>Bicyclization and Tethering to Albumin Yields Long-Acting Peptide Antagonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm301276e" /></meta><meta property="og:title" content="Bicyclization and Tethering to Albumin Yields Long-Acting Peptide Antagonists" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0002.jpeg" /></meta><meta property="og:description" content="Proteolytically stable peptide architectures are required for the development of long-acting peptide therapeutics. In this work, we found that a phage-selected bicyclic peptide antagonist exhibits an unusually high stability in vivo and subsequently deciphered the underlying mechanisms of peptide stabilization. We found that the bicyclic peptide was significantly more stable than its constituent rings synthesized as two individual macrocycles. The two rings protect each other from proteolysis when linked together, conceivably by constraining the conformation and/or by mutually shielding regions prone to proteolysis. A second stabilization mechanism was found when the bicyclic peptide was linked to an albumin-binding peptide to prevent its rapid renal clearance. The bicyclic peptide conjugate not only circulated 50-fold longer (t1/2 = 24 h) but also became entirely resistant to proteolysis when tethered to the long-lived serum protein. The bicyclic peptide format overcomes a limitation faced by many peptide leads and appears to be suitable for the generation of long-acting peptide therapeutics." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm301276e"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm301276e">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm301276e&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm301276e&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm301276e&amp;href=/doi/10.1021/jm301276e" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 10187-10197</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm301273u" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm301278c" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Bicyclization and Tethering to Albumin Yields Long-Acting Peptide Antagonists</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alessandro++Angelini">Alessandro Angelini</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julia++Morales-Sanfrutos">Julia Morales-Sanfrutos</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philippe++Diderich">Philippe Diderich</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shiyu++Chen">Shiyu Chen</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Heinis">Christian Heinis</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Institute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland</span></div><div class="corresp-info"><strong>*</strong>Tel: +41(0)21 693 9350. E-mail: <a href="/cdn-cgi/l/email-protection#6a09021803191e030b0444020f030403192a0f1a0c06440902"><span class="__cf_email__" data-cfemail="85e6edf7ecf6f1ece4ebabede0ecebecf6c5e0f5e3e9abe6ed">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm301276e&amp;href=/doi/10.1021%2Fjm301276e" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 10187–10197</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 22, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 September 2012</li><li><span class="item_label"><b>Published</b> online</span>5 November 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 November 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm301276e" title="DOI URL">https://doi.org/10.1021/jm301276e</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10187%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAlessandro%2BAngelini%252C%2BJulia%2BMorales-Sanfrutos%252C%2BPhilippe%2BDiderich%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D22%26contentID%3Djm301276e%26title%3DBicyclization%2Band%2BTethering%2Bto%2BAlbumin%2BYields%2BLong-Acting%2BPeptide%2BAntagonists%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10197%26publicationDate%3DNovember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm301276e"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2402</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">37</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm301276e" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Bicyclization and Tethering to Albumin Yields Long-Acting Peptide Antagonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Alessandro&quot;,&quot;last_name&quot;:&quot;Angelini&quot;},{&quot;first_name&quot;:&quot;Julia&quot;,&quot;last_name&quot;:&quot;Morales-Sanfrutos&quot;},{&quot;first_name&quot;:&quot;Philippe&quot;,&quot;last_name&quot;:&quot;Diderich&quot;},{&quot;first_name&quot;:&quot;Shiyu&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Heinis&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;10187-10197&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm301276e&quot;},&quot;abstract&quot;:&quot;Proteolytically stable peptide architectures are required for the development of long-acting peptide therapeutics. In this work, we found that a phage-selected bicyclic peptide antagonist exhibits an unusually high stability in vivo and subsequently deciphered the underlying mechanisms of peptide stabilization. We found that the bicyclic peptide was significantly more stable than its constituent rings synthesized as two individual macrocycles. The two rings protect each other from proteolysis when linked together, conceivably by constraining the conformation and/or by mutually shielding regions prone to proteolysis. A second stabilization mechanism was found when the bicyclic peptide was linked to an albumin-binding peptide to prevent its rapid renal clearance. The bicyclic peptide conjugate not only circulated 50-fold longer (t1/2 = 24 h) but also became entirely resistant to proteolysis when tethered to the long-lived serum protein. The bicyclic peptide format overcomes a limitation faced by many peptide le&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301276e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301276e" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301276e&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301276e" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301276e&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301276e" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm301276e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301276e&amp;href=/doi/10.1021/jm301276e" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm301276e" /></input><a href="/doi/pdf/10.1021/jm301276e" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm301276e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm301276e%26sid%3Dliteratum%253Aachs%26pmid%3D23088498%26genre%3Darticle%26aulast%3DAngelini%26date%3D2012%26atitle%3DBicyclization%2Band%2BTethering%2Bto%2BAlbumin%2BYields%2BLong-Acting%2BPeptide%2BAntagonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D22%26spage%3D10187%26epage%3D10197%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291912" title="Fluorescence">Fluorescence</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290975" title="Biopolymers">Biopolymers</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jmcmar.2012.55.issue-22/production/jmcmar.2012.55.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/medium/jm-2012-01276e_0002.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301276e&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Proteolytically stable peptide architectures are required for the development of long-acting peptide therapeutics. In this work, we found that a phage-selected bicyclic peptide antagonist exhibits an unusually high stability in vivo and subsequently deciphered the underlying mechanisms of peptide stabilization. We found that the bicyclic peptide was significantly more stable than its constituent rings synthesized as two individual macrocycles. The two rings protect each other from proteolysis when linked together, conceivably by constraining the conformation and/or by mutually shielding regions prone to proteolysis. A second stabilization mechanism was found when the bicyclic peptide was linked to an albumin-binding peptide to prevent its rapid renal clearance. The bicyclic peptide conjugate not only circulated 50-fold longer (<i>t</i><sub>1/2</sub> = 24 h) but also became entirely resistant to proteolysis when tethered to the long-lived serum protein. The bicyclic peptide format overcomes a limitation faced by many peptide leads and appears to be suitable for the generation of long-acting peptide therapeutics.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66203" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66203" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Peptides possess a number of potential benefits as therapeutics, including high potency and target specificity as well as low toxicity. At the same time, they have limiting properties such as their generally low metabolic stability and rapid renal clearance. During systemic circulation, most peptides are degraded within minutes by peptidases in the blood, liver, and kidney.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Peptides that are not degraded by proteases are nevertheless rapidly eliminated by glomerular filtration in the kidney, typically with half-lives of less than an hour. In recent years, a number of strategies have been developed to counteract this latter mechanism of peptide elimination.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> These strategies, including linkage of the peptides to large polymers (e.g., PEG) or fusion to long-lived serum proteins such as albumin or the Fc antibody fragment of IgG, have extended peptide elimination half-lives to the order of days. To benefit from such prolonged circulation times, the peptides need to be proteolytically stable to exert their activity throughout their time in circulation. This is exemplified by a recent work in which the monocyclic natriuretic peptide was linked to an antibody Fc fragment but could not fully benefit from the long circulation time of the Fc (<i>t</i><sub>1/2</sub> of around 2 days in mice) because the peptide was proteolytically degraded.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The requirement for higher metabolic stability should therefore be taken into account in the development of peptide agonists or antagonists designed to circulate for an extended time in the body.</div><div class="NLM_p">Proteolytic stability depends mainly on the amino acid sequence and peptide format. While linear peptides are typically degraded within minutes in systemic circulation, cyclic structures tend to be more stable. This is because the peptide ends of cyclic structures are not accessible to exopeptidases and the backbones of cyclized peptides are less flexible, preventing an optimal fit to the active sites of endopeptidases.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In fact, many natural peptides are cyclic<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and have presumably evolved to confer binding and stability advantages over their ancestral linear peptides. Examples are the peptide hormones oxytocin, somatostatin, and atrial natriuretic peptide, which have longer half-lives than their linear counterparts.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a> Stabilization through cyclization is even more pronounced for multicyclic peptides. Many natural peptides and small proteins are cyclized by two or more disulfide bridges and show enhanced stability due to a significantly reduced sensitivity to proteolytic cleavage. One remarkable family of multicyclic peptides, the cystine knot proteins, contains three disulfide bridges organized in a knotted structure.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> An example is conotoxin ω-MVIIA, a cystine knot isolated from marine cone snail venom, which is clinically used for its analgesic activity.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In cyclotides, a subfamily of cystine knot proteins, the backbone is additionally cyclized head-to-tail, enhancing topological complexity and stability. The prototype of this subfamily, kalata B1, was not digested even after incubation with high protease concentrations.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Cyclic peptides enriched for biological activities and evolved for higher stability have been extracted from diverse natural sources. For example, a library rich in multicyclic peptides (termed Melusine) was generated by fractionation of more than 1200 animal venoms and is provided by Atheris/Bachem.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><div class="NLM_p">De novo-generated peptide ligands are typically developed based on cyclic structures to exploit their inherently higher stability. Large random libraries of disulfide-cyclized peptides are screened by phage display or other display techniques to isolate binders to numerous targets. More recently, a method based on phage display was developed to generate and screen random bicyclic peptide libraries.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Bicyclic peptides are obtained by chemically linking linear peptides of the format Cys-(Xaa)<sub><i>n</i></sub>-Cys-(Xaa)<i><sub>n</sub></i>-Cys (the number of amino acids “<i>n</i>” is typically between 3 and 6) via the three cysteine residues to tris-(bromomethyl)benzene (TBMB).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> We have applied this approach for the isolation of bicyclic peptide binders to different targets including the urokinase-type plasminogen activator (uPA),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> a serine protease implicated in tumor growth and invasion.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The most potent bicyclic peptide inhibitor <b>1</b> (UK18; H-A<u class="uu">C</u>SRYEVD<u class="uu">C</u>RGRGSA<u class="uu">C</u>G-NH<sub>2</sub>; the underlined cysteines are linked to TBMB) blocked human uPA with a <i>K</i><sub>i</sub> of 53 nM and was highly specific. Crystallization of the complex revealed that the bicyclic peptide forms a large interaction surface with uPA (>700 Å<sup>2</sup>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p last">In this work, we aimed at assessing the proteolytic stability of the in vitro-evolved bicyclic peptide inhibitor of uPA and at understanding whether the in vitro-evolved bicyclic peptides are more stable than other peptide formats. Toward this end, we synthesized a range of linear and monocyclic analogues of the bicyclic peptide <b>1</b> and compared their stabilities in blood plasma ex vivo. These experiments revealed an unexpected stabilization mechanism of bicyclic peptides. In the second part of this work, we linked the bicyclic peptide to an albumin-binding tag to enable a longer circulation time, which would be required for the inhibition of uPA for extended time periods. This longer exposure of the bicyclic peptide to serum proteases allowed us to test its stability in vivo for multiple days. Tethering to albumin further increased the stability of the peptide through yet another mechanism and yielded an antagonist that was completely stable in vivo for multiple days.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32313" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32313" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Plasma Stability of Linear, Monocyclic, and Bicyclic Peptide Formats</h3><div class="NLM_p">The stability of bicyclic peptide <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A, left) was assessed by incubating the peptide in mouse plasma at a concentration of 50 μM for 24 and 48 h at 37 °C and analyzing the resulting species by chromatography and mass spectrometry (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B, left). After 24 h, three new species with minor modifications were observed in addition to the intact bicyclic peptide (Figures S1A and S2A in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). After 48 h, a significant quantity of intact bicyclic peptide was still present, whereas the fraction of proteolyzed peptide had slightly increased (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>D, left). In a second experiment, the monocyclic peptide <b>2</b> (monocyclic UK18) having only one macrocyclic ring generated by connecting the two terminal cysteines of an analogous peptide (H-A<u class="uu">C</u>SRYEVDSRGRGSA<u class="uu">C</u>G-NH<sub>2</sub>)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> with <i>m</i>-di(bromomethyl)benzene (DBMB) was treated equivalently (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A, middle). In contrast to the bicyclic structure, the monocyclic peptide was rapidly degraded (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B, middle). The detectable degradation products were found to be linearized peptides, while around 60% of the peptide was digested into smaller fragments that could not be detected by HPLC (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>C,D, middle, and Figures S1B and S2B in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Not surprisingly, the linear peptide <b>3</b> with a sequence similar to <b>1</b> (all three cysteines are replaced by serines: H-ASSRYEVDSRGRGSASG-NH<sub>2</sub>) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A, right)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> was rapidly hydrolyzed as well (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B–D, right, and Figures S1C and S2C in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). In none of the peptide formats was oxidation of the thioether bonds or modification of amino acid side chains observed.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/medium/jm-2012-01276e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Stability of different peptide formats. (A) Schematic drawing of bicyclic peptide <b>1</b>, monocylic peptide <b>2</b>, and linear peptide <b>3</b>. (B) Chromatographic analysis of peptides incubated in mouse plasma for 0, 24, and 48 h at a concentration of 50 μM and 37 °C. Samples were analyzed by reversed-phase chromatography (RP-HPLC) using a C8 column and absorption measured at a wavelength of 220 nm. (C) Masses of peptides detected by ESI mass spectrometry in the indicated peaks of the RP-HPLC chromatograms. The peptides and peptide fragments that potentially correspond to the masses are schematically depicted. (D) The relative amounts of peptide and peptide fragments were quantified by integrating the peak area in the RP-HPLC chromatograms and are represented in a bar diagram. The relative amount of intact or marginally modified peptide is shown in black, and that of massively degraded peptide is shown in white.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301276e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Proteolytic Stability of the Two Individual Rings of a Bicyclic Peptide</h3><div class="NLM_p">Intrigued by the high stability of the bicyclic peptide format, we investigated the mechanism of stabilization. One plausible explanation is that the smaller macrocyclic rings in the bicyclic peptide structure (rings of eight amino acids) are more conformationally constrained than the large ring of the monocyclic peptide format (ring of 15 amino acids) and are therefore less susceptible to proteases. To compare peptides of equal ring size, we synthesized the two peptide rings of <b>1</b> individually (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). The N-terminal ring <b>4</b> (H-A<u class="uu">C</u>SRYEVD<u class="uu">C</u>-NH<sub>2</sub>) (Figures S3A and S3B in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) and the C-terminal ring <b>5</b> (H-<u class="uu">C</u>RGRGSA<u class="uu">C</u>G-NH<sub>2</sub>) (Figures S3C and S3D in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) were cyclized with DBMB and exposed to mouse plasma. After only 24 h of incubation, both of the peptides could not be detected anymore, and the observed degradation products were heavily modified (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Mass spectrometric analysis indicated that the N-terminal ring <b>4</b> had lost the exocyclic alanine and peptide fragments within the ring (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C, left, and Figures S3E and S4A in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). In the C-terminal peptide ring <b>5</b>, all amino acids of the peptide loop were excised (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C, right, and Figures S3F and S4B in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/medium/jm-2012-01276e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Stability of the two individual peptide rings of <b>1</b>. (A) Schematic drawing of the N- and C-terminal peptide rings <b>4</b> and <b>5</b>. (B) Chromatographic analysis of peptides incubated in mouse plasma for 0, 24, and 48 h at a concentration of 50 μM and 37 °C. Samples were analyzed by reversed-phase chromatography (RP-HPLC) using a C8 column and absorption measured at a wavelength of 220 nm. (C) Masses of peptides detected by ESI mass spectrometry in the indicated peaks of the RP-HPLC chromatograms. The peptides and peptide fragments that potentially correspond to the masses are schematically depicted. (D) The relative amounts of the intact monocyclic peptides and degradation products were quantified by integrating the peak area in the RP-HPLC chromatograms and are represented in a bar diagram. The relative amount of intact cyclic peptide is shown in black, and the different degradation products are shown in gray and white.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301276e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Half-Life and Metabolic Stability of Bicyclic Peptide <b>1</b> in Vivo</h3><div class="NLM_p">The elimination half-life (<i>t</i><sub>1/2</sub>) and metabolic stability of <b>1</b> were assessed in mice. To facilitate detection and quantification in plasma samples, <b>1</b> was synthesized with a fluorescent tag (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). Because the C-terminal end of <b>1</b> was freely accessible in the uPA/<b>1</b> complex as previously determined by X-ray crystallography,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> fluorescein was linked to this end of the molecule. A linear peptide <b>6</b> based on <b>1</b> but extended at the C terminus with a Gly-Ser-Gly linker and <span class="smallcaps smallerCapital">l</span>-propargylglycline was synthesized, cyclized with TBMB (yielding <b>7</b>), and linked to fluorescein-azide by cycloaddition (Figures S5 and S6 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). This fluorescein-labeled bicyclic peptide <b>8</b> (UK18-fluorescein) efficiently inhibited uPA (<i>K</i><sub>i</sub> = 82 nM), indicating that the linker and fluorescent tag did not significantly affect binding to the protease (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Two hundred microliters of 50 μM <b>8</b> (corresponding to 1.25 mg/kg) was injected intravenously into mice. The concentration of conjugate was quantified at different time points by two complementary assays. Analysis of the samples by reversed-phase ultrafast liquid chromatography (UFLC) gave <i>t</i><sub>1/2</sub> α and <i>t</i><sub>1/2</sub> β values of 2.9 and 30 min, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A and Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The UFLC analysis showed a single fluorescent species in the plasma samples eluting with the same retention time as <b>8</b>. In a different assay based on ELISA, <b>8</b> was captured by immobilized uPA and detected with an antifluorescein antibody conjugate. This assay gave essentially the same <i>t</i><sub>1/2</sub> α and <i>t</i><sub>1/2</sub> β values of 2.9 and 29 min, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B and Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Elution of <b>8</b> as a single peak in the reversed-phase liquid chromatography and binding to uPA in the ELISA assay suggested that most, if not all, of the bicyclic peptide remained intact during the first hour of circulation. Because of the relatively short half-life of the bicyclic peptide, its stability could not be assessed over a longer time period.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/medium/jm-2012-01276e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0007.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Schematic drawing of <b>8</b> (A) and <b>13</b> (B). Key chemical structures such as the mesitylene linker in the bicyclic peptide, the disulfide bridge in the albumin binding peptide <b>9</b>, the triazole linker, and the fluorescein (highlighted in green) are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301276e&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/medium/jm-2012-01276e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0006.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Pharmacokinetic parameters of <b>8</b> and <b>13</b> in mice. Compounds <b>8</b> and <b>13</b> were applied intravenously (200 μL of 50 μM; around 25 μg of <b>8</b> and 50 μg of <b>13</b>), blood samples were taken at the indicated time points, and the concentration of conjugate was measured by reversed-phase UFLC (A) and ELISA (B). The indicated values are averages of at least two mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301276e&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition of Human uPA by <b>1</b>, <b>8</b>, and <b>13</b><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="4" align="center">Inhibitory Activity</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char="±"><i>K</i><sub>i</sub> ± SE (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±"><b>1</b></th><th class="colsep0 rowsep0" align="center"><b>8</b></th><th class="colsep0 rowsep0" align="center"><b>13</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">casein</td><td class="colsep0 rowsep0" align="char" char="±">52 ± 2</td><td class="colsep0 rowsep0" align="left">82 ± 2</td><td class="colsep0 rowsep0" align="left">17 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">casein/hSA</td><td class="colsep0 rowsep0" align="char" char="±">60 ± 1</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">48 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">casein/mSA</td><td class="colsep0 rowsep0" align="char" char="±">54 ± 3</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">132 ± 9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bSA</td><td class="colsep0 rowsep0" align="char" char="±">53 ± 4</td><td class="colsep0 rowsep0" align="left">86 ± 4</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ovA</td><td class="colsep0 rowsep0" align="char" char="±">56 ± 5</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Inhibitory activities (<i>K</i><sub>i</sub>) were determined at 25 °C and physiological pH (7.4) using a chromogenic substrate (H-Glu-Gly-Arg-pNA). The inhibition was tested in the presence of 0.1% (w/v) casein or 0.1% (w/v) casein and either 1.5 μM hSA or 1.5 μM mSA. Additionally, the inhibition was tested in the presence of 0.1% (w/v) ovA or 0.1% (w/v) bSA. The indicated values are means of at least three measurements. SE, standard error.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pharmacokinetic Parameters of <b>8</b> and <b>13</b> in Mice<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="5" align="center">Pharmacokinetic Parameters</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><b>8</b></th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><b>13</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">UFLC</th><th class="colsep0 rowsep0" align="center" char=".">ELISA</th><th class="colsep0 rowsep0" align="center" char=".">UFLC</th><th class="colsep0 rowsep0" align="center" char=".">ELISA</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μM)</td><td class="colsep0 rowsep0" align="char" char=".">3.98</td><td class="colsep0 rowsep0" align="char" char=".">3.67</td><td class="colsep0 rowsep0" align="char" char=".">5.34</td><td class="colsep0 rowsep0" align="char" char=".">5.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> α (min)</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">268</td><td class="colsep0 rowsep0" align="char" char=".">229</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> β (min)</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">1440</td><td class="colsep0 rowsep0" align="char" char=".">1620</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–2days</sub>(h μg/mL)</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char=".">964</td><td class="colsep0 rowsep0" align="char" char=".">772</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/h)</td><td class="colsep0 rowsep0" align="char" char=".">8.78</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.089</td><td class="colsep0 rowsep0" align="char" char=".">0.113</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>d</sub> (mL)</td><td class="colsep0 rowsep0" align="char" char=".">6.33</td><td class="colsep0 rowsep0" align="char" char=".">6.97</td><td class="colsep0 rowsep0" align="char" char=".">3.09</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Compounds <b>8</b> and <b>13</b> were applied intravenously (1.25 mg/kg <b>8</b> and 2.5 mg/kg <b>13</b>), and their concentrations in blood plasma samples were measured by reversed-phase UFLC and ELISA. The maximal concentration (<i>C</i><sub>max</sub>) in plasma was measured 5 (for <b>8</b>) and 30 min (for <b>13</b>) after injection.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Extending the Plasma Circulation Time of Bicyclic Peptide <b>1</b></h3><div class="NLM_p">We were interested in extending the circulation time of <b>1</b> to facilitate future testing of its inhibitory effect on tumor growth in mice. At the same time, a longer half-life would allow measurement of its metabolic stability in vivo over a longer time. The bicyclic peptide <b>1</b> was therefore conjugated to the albumin-binding peptide <b>9</b> (SA21; Ac-RLIEDI<u class="uu">C</u>LPRWG<u class="uu">C</u>LWEDD-NH<sub>2</sub>; disulfide-cyclized via the underlined cysteine residues), which had been isolated by phage affinity selection against albumin.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Previously, conjugation of an antibody Fab fragment to a similar albumin-binding peptide (SA06, H-QRLMEDI<u class="uu">C</u>LPRWG<u class="uu">C</u>LWEDDF-NH<sub>2</sub>) extended its elimination half-life from 1.28 to 19.7 h in mice and from 5.9 to 68.5 h in rabbits.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> In another work, linkage to a related albumin-binding peptide (SA20, Ac-QRLIEDI<u class="uu">C</u>LPRWG<u class="uu">C</u>LWEDDF-NH<sub>2</sub>) prolonged the elimination half-life of growth hormone and prolactin in mice from 0.49 and 0.84 h to 1.94 and 4.78 h, respectively.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> We generated the conjugate <b>13</b> (UK18-SA21; Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B) by linking derivatives of the bicyclic peptide <b>1</b> and the monocyclic albumin-binding peptide <b>9</b> by cycloaddition (Figure S5 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). The alkyne-functionalized bicyclic peptide <b>7</b> was obtained as described above (Figures S5 and S6 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). The albumin binding peptide derivative <b>12</b> was obtained by synthesizing the 18-amino acid peptide <b>9</b> (RLIEDI<u class="uu">C</u>LPRWG<u class="uu">C</u>LWEDD) with an N-terminal azido-functionalized Lys-Gly linker (<b>10</b>), oxidative cyclization (<b>11</b>), and conjugation with NHS-functionalized fluorescein (Figures S5 and S7 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). In this synthetic strategy, the fluorophore was placed in between <b>1</b> and <b>9</b> in the conjugate to prevent its loss by N- or C-terminal degradation and to allow tracing of potential fluorescent degradation products (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B).</div><div class="NLM_p">The binding of <b>13</b> to albumin was assessed by fluorescence polarization. Compound <b>13</b> bound to mouse serum albumin (mSA) and human serum albumin (hSA) with <i>K</i><sub>D</sub> values of 14 and 354 nM, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A,B and Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Albumin-binding peptide <b>12</b> alone (tagged with fluorescein) bound to mSA and hSA with <i>K</i><sub>D</sub> values of 24 and 321 nM, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and Figure S8 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Fluorescence polarization also allowed measurement of the affinity (<i>K</i><sub>D</sub>) of <b>13</b> for human uPA, which was found to be 68 nM (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C and Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/medium/jm-2012-01276e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Binding and inhibitory activity of <b>13</b>. Binding of <b>13</b> to hSA (A), mSA (B), and human uPA (C) was determined by fluorescence polarization. (D) Inhibition of human uPA in the presence of casein only (0.1% w/v) or casein (0.1% w/v) and 1.5 μM hSA or 1.5 μM mSA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301276e&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Binding Properties of <b>11</b> (Albumin-Binding Peptide <b>9</b> Tagged with Fluorescein) and <b>13</b><a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="3" align="center">Binding Affinity</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center"><i>K</i><sub>D</sub> ± SE (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>11</b></th><th class="colsep0 rowsep0" align="center" char="±"><b>13</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hSA</td><td class="colsep0 rowsep0" align="left">321 ± 27</td><td class="colsep0 rowsep0" align="char" char="±">354 ± 19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mSA</td><td class="colsep0 rowsep0" align="left">24 ± 6</td><td class="colsep0 rowsep0" align="char" char="±">14 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">huPA</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char="±">68 ± 15</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">The binding affinity for hSA, mSA, and human uPA was determined by fluorescence polarization (FP) at 25 °C and physiological pH (7.4). The indicated values are means of at least three measurements. SE, standard error.</p></div></div></div><div class="NLM_p">The inhibitory activities of <b>1</b> and conjugates thereof were quantified in activity assays with human uPA and a chromogenic substrate. Compound <b>13</b> inhibited uPA more potently (<i>K</i><sub>i</sub> = 17 nM) than either nonconjugated bicyclic peptide <b>1</b> (<i>K</i><sub>i</sub> = 53 nM) or <b>8</b> (<i>K</i><sub>i</sub> = 82 nM) (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>D and Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The addition of hSA to the assay increased the <i>K</i><sub>i</sub> of <b>13</b> to 48 nM (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>D and Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), while that of nonconjugated <b>1</b> did not change significantly upon hSA addition (<i>K</i><sub>i</sub> = 60 nM) (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). In the presence of mSA, <b>13</b> and <b>1</b> inhibited human uPA with <i>K</i><sub>i</sub> values of 132 and 54 nM, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>D and Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p last">The pharmacokinetic properties of <b>13</b> were assessed in mice by intravenous injection (200 μL of a 50 μM solution; corresponding to 2.5 mg/kg) and determination of the concentrations with two different methods. Measurements of the conjugate concentrations by reversed-phase UFLC and fluorescence detection gave <i>t</i><sub>1/2</sub> α and <i>t</i><sub>1/2</sub> β half-lives of 4.5 and 24 h, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A and Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In the chromatographic analysis, only one fluorescent species was observed, suggesting that <b>13</b> remained intact. Quantification of the concentrations by sandwich ELISA gave <i>t</i><sub>1/2</sub> α and <i>t</i><sub>1/2</sub> β half-lives of 3.8 and 27 h, respectively. In this sandwich ELISA, only conjugate with functional bicyclic peptide was detected (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B and Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The route of elimination of <b>13</b> was not investigated, but we expect that most of the conjugate is cleared by the kidney.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Metabolic Stability of Conjugate <b>13</b> in Plasma ex Vivo and in Vivo</h3><div class="NLM_p">The stability of <b>13</b> in plasma was assessed by incubation in mouse plasma ex vivo for 24 and 48 h at 37 °C, followed by chromatographic and mass spectrometric analysis. For mass spectrometric analysis, the peptide conjugate was first dissociated from albumin by denaturation with 0.1% TFA and successively separated from other serum proteins by reversed-phase liquid chromatography. For direct comparison, the stability of <b>8</b> was tested in parallel. Compound <b>13</b> eluted in HPLC as a single peak, and mass spectrometric analysis showed a single mass corresponding to the intact conjugate (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A and Figure S9 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). In contrast, <b>8</b> was eluted in two or three peaks, and mass spectrometric analysis showed a similar extent and pattern of proteolysis as found previously for nontagged bicyclic peptide <b>1</b> (Figure S10 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/medium/jm-2012-01276e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Stability of bicyclic peptide ex vivo and in vivo. (A) Compound <b>13</b> incubated in mouse plasma ex vivo was analyzed by reversed-phase chromatography (RP-HPLC) using a C8 column, and absorption was measured at a wavelength of 220 nm. Compound <b>13</b> (indicated with “a”) eluted immediately prior to a broad peak of multiple plasma components (see also Figure S9 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). (B) Compound <b>13</b> injected into the tail vein of mice, and blood samples were taken after the indicated time points and analyzed by reversed-phase UFLC using a C8 column and fluorescence detection (excitation at 490 nm and emission at 525 nm). Fluorescence monitoring required a buffer system with neutral pH resulting in a broad and asymmetric peak for <b>13</b>. Components of plasma did not show fluorescence (first chromatogram). (C) Mass spectra of peaks eluting at between 10 and 11 min in the UFLC chromatogram shown in B. The detected mass corresponded to intact <b>13</b> (<i>M</i><sub>r</sub> = 5097 Da).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301276e&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The ELISA assay applied in the pharmacokinetic study suggested that <b>13</b> remained functional while in circulation for multiple days, but this assay could not exclude minor modifications such as partial proteolysis or oxidation. We therefore analyzed the mass of <b>13</b> in blood samples taken 0, 24, and 48 h postinjection. The fluorescently labeled species were isolated from the mouse plasma samples by reversed-phase UFLC and analyzed by mass spectrometry. A single peak was observed in all three samples, and mass spectrometric analysis showed a single species with a molecular mass of 5097 Da, which corresponded to the intact conjugate (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B,C).</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34778" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34778" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In our first set of experiments, we found that an in vitro-evolved bicyclic peptide antagonist possesses high proteolytic stability and is significantly more stable than its monocyclic analogue. Similar observations have been made previously for naturally evolved bicyclic peptides such as sunflower trypsin inhibitor (SFTI-1), a 14-amino acid head-to-tail cyclized peptide with a disulfide bridge that divides the peptide into 29- and 23-membered rings (GR<u class="uu">C</u>TKSIPPI<u class="uu">C</u>FPD).<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> Reduction of the Cys3–Cys11 disulfide bond in SFTI-1 was described to lower the stability significantly.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> At this stage, we assumed that the increased stability of the bicyclic peptides SFTI-1 and <b>1</b> resulted primarily from the smaller size of the macrocyclic rings (two 8-aa vs 15-aa in <b>1</b> and 7- or 9-aa vs 14-aa in SFTI-1) and the consequent lower conformational flexibility of the peptide backbones.</div><div class="NLM_p">A second set of experiments showed that the bicyclic peptide <b>1</b> is significantly more stable than its two individually synthesized rings. This finding indicated that the bicyclic peptide is not solely stabilized by the increased constraint imposed by the smaller macrocyclic rings and suggested additional stabilization mechanisms. We hypothesize two mechanisms that could explain this stabilization effect. First, the two connected rings may have a lower conformational flexibility due to steric exclusion or noncovalent interactions between the rings, which results in a higher proteolytic stability. Second, one ring may simply shield a region of the second ring from proteolytic attack and vice versa. It is likely that these two mechanisms apply to other bicyclic peptides. In fact, Albericio and co-workers have recently generated bicyclic architectures termed “siamese depsipeptides” by connecting two units of the depsipeptide sansalvamide A by a short linker.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Functional characterization of the bicyclic structures suggested a higher conformational constraint, but the effect of bicyclization on the structures' proteolytic stability was not tested.</div><div class="NLM_p">Chromatographic and mass spectrometric analysis of peptide degradation products yielded information on the extent of proteolysis and hinted at the relevant cleavage sites as well as degradation pathways. The bicyclic peptide was first nicked in one ring, and several amino acids of the opened ring were subsequently degraded. On the basis of the molecular masses, the first cleavage takes place between Arg12 and Gly13. Overall, a significant portion of the bicyclic peptide remained fully intact, and the three degradation products observed after 48 h of incubation in plasma were cleaved at only one of the two rings. In contrast, the monocyclic and linear peptide analogues of <b>1</b> were cleaved at multiple sites, resulting in a rapid degradation. Mass spectrometric analysis of the fragments indicated that monocyclic and linear <b>1</b> were cleaved at the same preferred sites, after arginine residues in the positions 4 (Arg4), 10 (Arg10), and 12 (Arg12). In the bicyclic peptide, cleavage after Arg4 in the first ring was not observed, and cleavage after Arg10 was slow. In the bicyclic format, these two sites are close to the branching mesitylene group, and access of proteases may be sterically hindered.</div><div class="NLM_p">Conjugation of <b>1</b> to the albumin-binding peptide <b>9</b> improved its inhibitory activity by 3-fold, resulting in a <i>K</i><sub>i</sub> of 17 nM. The tighter binding most likely resulted from additional interactions formed between <b>9</b> and uPA. In the presence of hSA, the improvement was abrogated, resulting in a <i>K</i><sub>i</sub> of 48 nM, which is close to that of nonconjugated <b>1</b> (53 nM). Conjugation of peptides to proteins such as albumin or Fc, or to polymers such as PEG, often reduces their potency by large factors.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> We were pleased to see that <b>1</b> tethered via <b>9</b> to albumin retained its activity.</div><div class="NLM_p">The elimination half-life of <b>13</b> was around 50-fold longer than that of <b>1</b>. As compared to other peptides or proteins that were tethered via similar peptides to albumin, the elimination half-life of 24 h was surprisingly long. For example, antibody Fab fragment specific for tissue factor fused to SA06 exhibited a half-life of 10.4 h upon intravenous administration to mice.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Another Fab fragment specific for Her2 was fused to SA06 and had a half-life of 19.7 h when injected intravenously in mice.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The conjugates SA20-hGH and SA20-prolactin applied intraperitoneally to mice had much shorter elimination half-lives of 1.9 and 4.8 h, respectively.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> These shorter half-lives may have resulted from weaker binding of the conjugates to mSA or from lower metabolic stability. Compound <b>13</b> was entirely resistant to proteolysis in mouse plasma ex vivo. Noncovalent tethering of the bicyclic peptide to the surface of albumin appears to shield it from serum proteases. Similar effects were previously described for PEGylated peptides<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> or peptides that were covalently conjugated to serum albumin.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30">(27-30)</a> The clinically approved insulin and GLP-1 tagged with albumin-binding fatty acids demonstrate high stability in vivo and likely also benefit from the same effect.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a></div><div class="NLM_p">The long half-life of <b>13</b> allowed us to further evaluate the stability of the bicyclic peptide in the circulation, where the peptide is additionally exposed to membrane-anchored proteases. Conjugate <b>13</b> purified from blood samples taken 2 days postinjection was entirely intact. This result was supported by the finding that reversed-phase UFLC chromatographic analysis of the blood samples showed a single species and that the conjugate was able to bind uPA in a sandwich ELISA even after circulating for 2 days in mice. Low proteolytic stability has hindered the development of long-acting therapeutic peptides. For example, the glucagon-like peptide and variants thereof that show improved stability are proteolytically degraded by dipeptidyl dipeptidase 4. The albumin-tethered bicyclic peptide <b>13</b> clearly overcomes this limitation and paves the way for the development of peptide therapeutics with longer lasting effects.</div><div class="NLM_p last">In summary, we found that an in vitro-evolved bicyclic peptide inhibitor tethered to an albumin-binding peptide is stable for multiple days in vivo. The high stability is likely based on multiple mechanisms, including conformational constraints and shielding effects mediated by the neighboring peptide rings and by albumin. This peptide format overcomes a limitation faced by many in vitro-evolved peptide leads and promises to be suitable for the generation of long-acting peptide therapeutics.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72024" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72024" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Materials</h3><div class="NLM_p last">Fmoc-protected amino acids, Fmoc-rink amide AM resin (0.26 mmol/g resin), <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA), and <i>O</i>-benzotriazole-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyl-uronium-hexafluoro-phosphate (HBTU) were purchased from Iris Biotech GmbH (Marktredwitz, Germany). Trifluoroacetic acid (TFA), TBMB, <i>m</i>-di(bromomehyl)benzene (DBMB), <span class="smallcaps smallerCapital">l</span>-ascorbic acid sodium salt, tris((1-benzyl-1<i>H</i>-1,2,3-triazol-4-yl)methyl) amine (TBTA), copper(II) sulfate-pentahydrate (CuSO<sub>4</sub>·H<sub>2</sub>O), tris(2-carboxyethyl)phosphine (TCEP), and 5(6)-carboxyfluorescein <i>N</i>-hydroxysuccinimide ester were purchased from Sigma-Aldrich (Steinheim, Germany). 1,2-Ethanedithiol (EDT), thioanisole, and piperidine were obtained from Fluka (Buchs, Switzerland). Phenol was purchased from Acros Organics (Geel, Belgium), 5(6)-carboxyfluorescein azide was from Matabion, 5-azido-pentanoic acid was from Bachem (Bachem, Switzerland), and (<i>S</i>)-<i>N</i>-Fmoc-propargylglycine was from Shanghai Plus Bio-Sci&Tech (Shanghai, China). All reagents were used as received without further purification. hSA, mSA, bovine serum albumin (bSA), ovalbumin (ovA), and casein were purchased from Sigma-Aldrich. Human uPA was either purchased from Molecular Innovations (Novi, MI) or recombinantly produced and purified in house as previously described.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Peptide Synthesis</h3><div class="NLM_p last">Peptides were synthesized on the Advanced ChemTech 348Ω peptide synthesizer (Aapptec, Louisville, United States) by standard Fmoc solid-phase chemistry on a Rink Amide AM resin (0.03 mmol scale) as described previously.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The coupling was carried out twice for each amino acid (6 equiv, 0.4 M, in DMF) using HBTU (5.5 equiv, 0.4 M, in DMF) and DIPEA (9 equiv, 1.2 M in DMF). Fmoc groups were removed using a 20% v/v solution of piperidine in DMF. The final peptides were deprotected and cleaved from the resin by treatment with TFA/thioanisole/H<sub>2</sub>O/phenol/EDT (90/2.5/2.5/2.5/2.5 v/v, 4 mL) for 3 h at room temperature. The resin was removed by filtration under vacuum, and the peptides were precipitated with cold diethyl ether (40 mL). The precipitated peptides were washed with cold diethyl ether (20 mL × 2). Finally, the peptides were dissolved in H<sub>2</sub>O:MeCN (5:2) and lyophilized. Peptides to be cyclized by alkylation were directly treated with TBMB or DBMB without purification (see cyclization protocol below). The linear peptide <b>3</b> and the derivatives of <b>9</b> were purified by semipreparative reversed-phase HPLC (PrepLC 4000-Waters system, XBridge BEH300 Prep C18 column, 9.4 mm × 250 mm, Waters) using a flow rate of 6 mL/min and a linear gradient of 10–50% v/v solvent B over 30 min (A, 0.1% v/v TFA and 99.9% v/v H<sub>2</sub>O; B, 94.9% v/v MeCN, 5% v/v H<sub>2</sub>O, and 0.1% v/v TFA). Fractions containing the desired peptide were lyophilized.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemical Cyclization</h3><div class="NLM_p">Peptides were cyclized with TBMB as follows. To a solution of crude peptide (8 mL, 0.625 mM peptide) in aqueous buffer (20 mM NH<sub>4</sub>HCO<sub>3</sub>, pH 8.0), TBMB was added (2 mL, 5 mM in MeCN). The final reagent and solvent concentrations in the reaction mixture were 0.5 mM crude peptide, 1 mM TBMB, 80% v/v aqueous buffer, and 20% v/v MeCN. The reaction mixture was incubated at 30 °C in a water bath for 1 h and then lyophilized. TBMB-modified peptide <b>1</b> was purified by semipreparative reversed-phase HPLC as described above. TBMB-modified <b>7</b> was purified by size exclusion chromatography using a Superdex Peptide 10/300 GL column (GE Healthcare) and solvent C (30% v/v MeCN, 69.9% v/v H<sub>2</sub>O, and 0.1% v/v TFA) on an AKTApurifier system (GE Healthcare). Fractions containing the desired peptide were pooled together and lyophilized.</div><div class="NLM_p">Peptides were cyclized with DBMB as follows. To a solution of crude peptide (5 mL, 1 mM) in aqueous buffer (20 mM NH<sub>4</sub>HCO<sub>3</sub>, pH 8.5), DBMB in MeCN (5 mL, 2 mM) was added. The final reagent and solvent concentrations in the reaction mixture were 0.5 mM crude peptide, 1 mM DBMB, 50% v/v aqueous buffer, and 50% v/v MeCN. The reaction mixture was incubated at 37 °C in a water bath for 1 h and then lyophilized. DBMB-modified peptides <b>2</b>, <b>4</b>, and <b>6</b> were purified by semipreparative reversed-phase HPLC as described above and lyophilized.</div><div class="NLM_p last">Peptides were cyclized by disulfide-bridge formation as follows. Air was bubbled for 3 h through a filter-sterilized oxidizing solution of 95% v/v 20 mM NH<sub>4</sub>HCO<sub>3</sub> buffer, pH 8.0, and 5% v/v DMSO. The peptide <b>10</b> (azido-KG-SA21) (12.7 mg) was dissolved in 20 mL of the oxidizing solution and kept at room temperature for 3 days. After lyophilization, disulfide-cyclized peptide <b>11</b> was purified by semipreparative reversed-phase HPLC as described above and the product lyophilized.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Labeling of Peptides with Fluorophores</h3><div class="NLM_p">Fluorescein was conjugated to <b>7 (</b>bicyclic peptide-GSG-alkyne) as follows (to obtain peptide <b>8</b>). In a 1.5 mL eppendorf tube, CuSO<sub>4</sub>·H<sub>2</sub>O (100 μL of a 20 mM solution in H<sub>2</sub>O mQ) was mixed with TBTA (100 μL of a 20 mM solution in DMSO) and sodium ascorbate (200 μL of a 50 mM solution in H<sub>2</sub>O mQ). To the resulting catalytic mixture, a solution of <b>7</b> (1.7 mM) and 5(6)-carboxyfluorescein azide (2 mM) in DMSO (0.6 mL) was added. The final reagent and solvent concentrations in the reaction mixture were 1 mM of peptide, 1.2 mM of 5(6)-carboxyfluorescein azide, 2 mM CuSO<sub>4</sub>·H<sub>2</sub>O, 2 mM TBTA, 10 mM sodium ascorbate, 30% v/v H<sub>2</sub>O, and 70% v/v DMSO. The click-chemistry reaction was allowed to proceed at room temperature overnight. The crude reaction was purified by semipreparative reversed-phase HPLC as described above and lyophilized. The mass of <b>8</b> was confirmed by ESI-MS (2658.55 Da).</div><div class="NLM_p last">Fluorescein was conjugated to <b>11</b> (disulfide-cyclized azido-KG-SA21 peptide) as follows (to obtain peptide <b>12</b>). To a solution of <b>11</b> (2 mM, 1 equiv) and 5(6)-carboxylfluorescein <i>N</i>-hydroxysuccinimide ester (6 mM, 3 equiv) in dry DMSO (0.5 mL), 12.5 μL of DIPEA was added. The reaction mixture was kept at room temperature for 1 h and then purified by semipreparative reversed-phase HPLC as described above. Fractions containing the desired peptide were lyophilized.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Linking Bicyclic Peptide and Albumin-Binding Peptide by Azide–Alkyne Cycloaddition to Obtain Conjugate <b>13</b></h3><div class="NLM_p last">In a 1.5 mL eppendorf tube, CuSO<sub>4</sub>·H<sub>2</sub>O (100 μL of a 20 mM solution in H<sub>2</sub>O mQ) was mixed with TBTA (100 μL of 20 mM solution in DMSO) and sodium ascorbate (200 μL of a 50 mM solution in H<sub>2</sub>O mQ). To the resulting catalytic mixture, a solution of the alkyne-functionalized peptide <b>7</b> (2 mM) and <b>12</b> (1.7 mM) in DMSO (0.6 mL) was added. The final reagent and solvent concentrations in the reaction mixture were 1 mM <b>12</b>, 1.2 mM <b>7</b>, 2 mM CuSO<sub>4</sub>·H<sub>2</sub>O, 2 mM TBTA, 10 mM sodium ascorbate, 30% v/v pure H<sub>2</sub>O mQ, and 70% v/v DMSO. The reaction was allowed to proceed at room temperature overnight. The crude reaction was purified by semipreparative reversed-phase HPLC as described above, and fractions containing the desired peptide were lyophilized. The mass of <b>13</b> was confirmed by ESI-MS (5058.19 Da).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chromatographic and Mass Spectrometric Analysis of Peptides and Peptide Conjugates</h3><div class="NLM_p last">The purity of peptides and peptide conjugates was assessed by analytical reversed-phase HPLC (Waters HPLC equipped with Waters 2487 dual λ absorbance detector and with both Waters 600 pump and controller, Waters) using a Vydac C18 (218TP) column (4.6 mm × 250 mm) (Grace & Co.). At a flow rate of 1 mL/min, a linear gradient was applied with a mobile phase composed of eluant A (0.1% v/v TFA solution, 99.9% v/v H<sub>2</sub>O) and eluant B (99.9% v/v MeCN and 0.1% v/v TFA). The purity of all peptides or peptide conjugates was >95%. For mass spectrometric analysis, the samples were mixed with 30% v/v MeCN, 70% v/v H<sub>2</sub>O, and 0.1% v/v formic acid. The molecular mass of RP-HPLC purified peptides was determined by electrospray ionization mass spectrometry (ESI-MS) performed on a quadrupole time-of-flight mass spectrometer (Q-TOF) Ultima API (Waters, Millford, MA) operated with the standard ESI source in positive mode or by MALDI-TOF performed on an Axima-CFR plus MALDI-TOF mass spectrometer (Axima-CFR plus, Kratos Shimadzu Biotech, Manchester, United Kingdom). α-Cyano-4-hydroxycinnamic acid (α-CHCA) dissolved in 50% v/v MeCN, 49.9% v/v H<sub>2</sub>O, and 0.1% v/v TFA was used as a matrix.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Measuring Binding Affinities by Fluorescence Polarization</h3><div class="NLM_p last">Proteins were serially diluted (3/2 fold) in phosphate buffer (10 mM Na<sub>2</sub>HPO<sub>4</sub>, pH 7.4, and 150 mM NaCl). Serially diluted proteins and fluorescent compounds (peptides and fluorescein also diluted in phosphate buffer) were mixed 1:1 (v/v). Seventy-five microliters of each mixture was transferred into a well of a black 96-well half area microplate (Corning, Corning, NY) and incubated at room temperature for 30 min. The fluorescence polarization of each solution was measured in a multiwell plate reader (Envision 2103, PerkinElmer, Waltham, MA) using an excitation filter at 480 nm and an emission filter at 535 nm. The dissociation constants (<i>K</i><sub>D</sub>) were determined by nonlinear regression analyses of <i>A</i> versus [P]<sub>T</sub> using eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a><a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a><span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/jm-2012-01276e_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span>where <i>A</i> is the experimental fluorescence anisotropy. <i>A</i><sub>f</sub> and <i>A</i><sub>b</sub> are the fluorescence anisotropy for the free and the fully bound fluorescent ligand, respectively. [L]<sub>T</sub> and [P]<sub>T</sub> represent the total fluorescent ligand and protein concentration, respectively. <i>K</i><sub>D</sub> is the dissociation constant for the binding equilibrium. Values were determined using OriginPro 8G software (OriginLab Corporation), and graphs were made with GraphPad Prism 5.01 software (GraphPad software).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Determination of Inhibitory Activities</h3><div class="NLM_p last">Inhibition of human uPA by the different peptide conjugates was measured by incubating different concentrations of each peptide (2-fold dilutions, ranging from 8 μM to 1.95 nM) with 1.5 nM human uPA (UPA-LMW, from human urine, 33 kDa). The enzymatic assays were performed at 25 °C in 150 μL volume of buffer containing 10 mM Tris-Cl, pH 7.4, 150 mM NaCl, 10 mM MgCl<sub>2</sub>, 1 mM CaCl<sub>2</sub>, 0.01% v/v Triton-X100, and 5% v/v DMSO and using the chromogenic substrate H-Glu-Gly-Arg-pNA (50 μM; Bachem, Bubendorf, Switzerland). The inhibition assay was performed in the presence of 0.1% (w/v) casein alone or 0.1% (w/v) casein with either 1.5 μM hSA or 1.5 μM mSA. Additionally, the inhibition was tested in the presence of 0.1% (w/v) ovA or 0.1% (w/v) bSA. The initial velocities were monitored as changes in absorbance at 405 nm during 1 h on a microtiter plate reader Spectra MAX 340 (Spectramax absorption plate reader, Molecular Devices, Sunnyvale, CA). Apparent equilibrium constants <i>K</i><sub>i</sub><sup>app</sup> values were determined by nonlinear regression analyses of <i>V</i><sub>i</sub>/<i>V</i><sub>0</sub> versus [I]<sub>0</sub> using eq <a class="ref internalNav" href="#eq2" aria-label="2">2</a><span class="NLM_disp-formula" id="eq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/jm-2012-01276e_m002.gif" alt="" /></img><span class="labelSpan">(2)</span></span>where <i>V</i><sub>i</sub> and <i>V</i><sub>o</sub> are the reaction velocities in the presence and absence of peptide inhibitor, respectively. [E]<sub>0</sub> and [I]<sub>0</sub> represent the total enzyme and peptide inhibitor concentration, respectively. <i>K</i><sub>i</sub><sup>app</sup> is the apparent inhibition constant in the presence of chromogenic substrate. The final <i>K</i><sub>i</sub> was subsequently determined by correcting for the competitive effect of the substrate [S]<sub>0</sub> using eq <a class="ref internalNav" href="#eq3" aria-label="3">3</a><span class="NLM_disp-formula" id="eq3"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/jm-2012-01276e_m003.gif" alt="" /></img><span class="labelSpan">(3)</span></span>where the kinetic constant <i>K</i><sub>m</sub> is the <i>K</i><sub>m</sub> for the hydrolysis of H-Glu-Gly-Arg-pNA catalyzed by huPA, which has been determined by standard Michaelis–Menten equations as described previously.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Values were determined using OriginPro 8G software (OriginLab Corporation), and graphs were made with GraphPad Prism 5.01 software (GraphPad software, Inc.).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Pharmacokinetic Studies</h3><div class="NLM_p last">All animal studies were carried out according to Swiss regulations under a project license granted by the Service de la consommation et des affaires vétérinaires vaudois. Female BALB/c mice (Charles River, France) aged 7–9 weeks were intravenously injected with 200 μL (50 μM in PBS) of <b>8</b> (2–3 mice per time point) or <b>13</b> (2–3 mice per time point). Blood samples were collected (5, 10, 20, 40, 80, 160, and 320 min after infection of <b>8</b> and 0.5, 1, 2, 4, 8, 16, 24, 32, and 48 h after injection of <b>13</b>) into EDTA-treated tubes and kept on ice. Cells were removed from plasma by centrifugation at 2000<i>g</i> for 15 min at 4 °C. The supernatants (plasma) were transferred to new tubes and centrifuged again at 6000<i>g</i> for 15 min at 4 °C. Plasma samples were aliquoted in small volumes (5–20 μL) and kept at −80 °C until further analysis. Analysis by UFLC was performed as follows. Plasma samples were diluted in ammonium acetate buffer (50 mM, pH 7.5) and analyzed on a Shimadzu UFLC system (UFLCXR) equipped with a fluorescence detector (RF-20A XS, excitation-490 nm, emission-525 nm) and a Vydac C8 (208TP) column (4.6 mm × 250 mm) (Grace & Co.). The linear gradient elution was 0–100% v/v solvent B over 15 min at a flow rate of 1 mL/min (A: ammonium acetate buffer, 50 mM, pH 7.5; B: 100% v/v MeCN). Analysis by ELISA was performed as follows: high capacity binding polystyrene 96-microtiter plates (Nunc-Immuno plate, Denmark) were coated with 5 μg/mL (100 μL/well) of active recombinant human uPA in PBS, pH 7.4, overnight at 4 °C. Wells containing immobilized human uPA were washed twice with PBST (PBS containing 0.05% v/v Tween-20, 350 μL/well) and twice with PBS (350 μL/well). This washing procedure was repeated after each incubation period. The microtiter plates were blocked with 350 μL/well of PBST with 1% w/v casein for 1 h at room temperature. Standard and plasma samples were diluted in PBS buffer containing TCEP (2 mM) and incubated in a thermocycler (Eppendorf-Mastercycler, Hamburg, Germany) at 42 °C for 30 min. Serial dilutions (100 μL/well) of the reduced standards (ranging from 60 to 0.7 nM) and plasma samples were added to the microtiter plate coated with human uPA and incubated at room temperature for 1.5 h. Biotinylated goat polyclonal antifluorescein antibody (Abcam, Cambridge, United States) was used for detection of both <b>13</b> and <b>8</b> in plasma. Primary antifluorescein antibody, diluted 1:50.000 (100 μL/well) in PBST with 1% w/v casein, was added and incubated at room temperature for 1 h. After washing, Neutravidin coupled to Horse Radish Peroxidase (Invitrogen, Paisley, United Kingdom, 1 mg/mL) diluted 1:2000 (100 μL/well) in PBST with 1% w/v casein was added and incubated at room temperature for 30 min. Plates were developed by adding 100 μL/well of 1-Step Ultra TMB-ELISA (Thermo scientific, Rockford, IL) substrate solution. The enzyme reaction was stopped after 30 min by adding 100 μL/well of 2 M sulfuric acid. Signal intensities were measured at 450 nm in a microtiter plate reader Spectra MAX 340 (Molecular Devices). Values were calculated with GraphPad Prism 5.01 software (GraphPad software). The concentrations versus time data were analyzed using a two-compartment model. The volume of distribution (<i>V</i><sub>d</sub>) was calculated by dividing the applied quantity of <b>8</b> (25 μg) and <b>13</b> (50 μg) by the extrapolated plasma concentration at time 0 (back-extrapolated from the slope of the elimination phase). The clearance (CL) was calculated by multiplying the elimination rate [ln(2)/<i>t</i><sub>1/2</sub> β] with the volume of distribution (<i>V</i><sub>d</sub>).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Plasma Stability Assays</h3><div class="NLM_p last">Peptide (12.5 μL of 1 mM in 100% v/v filter-sterilized H<sub>2</sub>O) was added to 237.5 μL of mouse plasma (final peptide concentration was 50 μM in 250 μL final volume). and the mixture was incubated at 37 °C on a thermo block (Eppendorf-Mastercycler). After 0, 24, and 48 h, 50 μL samples were taken, mixed with 50 μL of filter-sterilized H<sub>2</sub>O containing 0.1% v/v TFA, and kept at −20 °C until analysis. The samples (100 μL each) were characterized by analytical reversed-phase high-performance liquid chromatography (RP-HPLC) on an Agilent HPLC system (1260 Infinity) equipped with an autocollector and a Vydac C8 (208TP) column (4.6 mm × 250 mm) (Grace & Co.). The linear gradient elution was 0–100% v/v solvent B over 35 min at a flow rate of 1 mL/min (A: 95% v/v H<sub>2</sub>O, 5% v/v MeCN, and 0.1% v/v TFA; B: 95% v/v MeCN, 5% v/v H<sub>2</sub>O, and 0.1% v/v TFA). Fractions containing peptide were lyophilized, resuspended in an aqueous 30% v/v MeCN (0.1% v/v formic acid), and analyzed by using either ESI-MS or MALDI-TOF technique.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24"><a href="/doi/suppl/10.1021/jm301276e">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14038" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14038" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Supplementary figures showing the synthesis strategies of the peptide conjugates and figures showing experimental data from the peptide binding, inhibition, and stability assays. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm301276e/suppl_file/jm301276e_si_001.pdf">jm301276e_si_001.pdf (2.26 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm301276e" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82028" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82028" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Heinis</span> - <span class="hlFld-Affiliation affiliation">Institute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e4878c968d97908d858aca8c818d8a8d97a481948288ca878c"><span class="__cf_email__" data-cfemail="fa99928893898e939b94d4929f93949389ba9f8a9c96d49992">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessandro Angelini</span> - <span class="hlFld-Affiliation affiliation">Institute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julia Morales-Sanfrutos</span> - <span class="hlFld-Affiliation affiliation">Institute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philippe Diderich</span> - <span class="hlFld-Affiliation affiliation">Institute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shiyu Chen</span> - <span class="hlFld-Affiliation affiliation">Institute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Alessandro Angelini and Julia Morales-Sanfrutos have contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1888e2209-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15372" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15372" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Laure Menin and Luca Fornelli for their help with mass spectrometry experiments and analysis. We gratefully acknowledge Alice Tzeng for critical reading of this manuscript. Furthermore, we are grateful to Luc Reymond, Moser Simone, Prof. Kai Johnsson, and all of the group members for helpful discussions and technical assistance. The financial contributions from the Swiss National Science Foundation (SNSF Professorship PP00P3_123524/1 to C.H.), the National Competence Center for Biomolecular Imaging (NCCBI; Ph.D. fellowship to P.D.), and the Ministerio de Educacion del Gobierno de Espana (postdoc fellowship to J.M.S.) are gratefully acknowledged.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i29" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i29"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i30" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i30"> Abbreviations Used</h2><tr><td class="NLM_term">TBMB</td><td class="NLM_def"><p class="first last">tris-(bromomethyl)benzene</p></td></tr><tr><td class="NLM_term">TCEP</td><td class="NLM_def"><p class="first last">tris(2-carboxyethyl)phosphine</p></td></tr><tr><td class="NLM_term">uPA</td><td class="NLM_def"><p class="first last">urokinase-type plasminogen activator</p></td></tr><tr><td class="NLM_term">bSA</td><td class="NLM_def"><p class="first last">bovine serum albumin</p></td></tr><tr><td class="NLM_term">hSA</td><td class="NLM_def"><p class="first last">human serum albumin</p></td></tr><tr><td class="NLM_term">mSA</td><td class="NLM_def"><p class="first last">mouse serum albumin</p></td></tr><tr><td class="NLM_term">ovA</td><td class="NLM_def"><p class="first last">ovalbumin</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01171" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01171" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 33 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Werle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernkop-Schnurch, A.</span><span> </span><span class="NLM_article-title">Strategies to improve plasma half life time of peptide and protein drugs</span> <span class="citation_source-journal">Amino Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1007%2Fs00726-005-0289-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=16622600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD28Xls1egsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2006&pages=351-367&author=M.+Werleauthor=A.+Bernkop-Schnurch&title=Strategies+to+improve+plasma+half+life+time+of+peptide+and+protein+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies to improve plasma half life time of peptide and protein drugs</span></div><div class="casAuthors">Werle, M.; Bernkop-Schnuerch, A.</div><div class="citationInfo"><span class="NLM_cas:title">Amino Acids</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">351-367</span>CODEN:
                <span class="NLM_cas:coden">AACIE6</span>;
        ISSN:<span class="NLM_cas:issn">0939-4451</span>.
    
            (<span class="NLM_cas:orgname">Springer Wien</span>)
        </div><div class="casAbstract">A review.  Due to the obvious advantages of long-acting peptide and protein drugs, strategies to prolong blood plasma half life time of such compds. are highly on demand.  Short plasma half life times are commonly due to fast renal clearance as well as to enzymic degrdn. occurring during systemic circulation.  Modifications of the peptide/protein can lead to prolonged plasma half life times.  By shortening the overall amino acid amt. of somatostatin and replacing L-analog amino acids with D-amino acids, plasma half life time of the derivate octreotide was 1.5 h in comparison to only few minutes of somatostatin.  A PEG2,40K conjugate of INF-α-2b exhibited a 330-fold prolonged plasma half life time compared to the native protein.  It was the aim of this review to provide an overview of possible strategies to prolong plasma half life time such as modification of N- and C-terminus or PEGylation as well as methods to evaluate the effectiveness of drug modifications.  Furthermore, fundamental data about most important proteolytic enzymes of human blood, liver, and kidney as well as their cleavage specificity and inhibitors for them are provided to predict enzymic cleavage of peptide and protein drugs during systemic circulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovVKc2VODC97Vg90H21EOLACvtfcHk0lgZQOJygMrUyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xls1egsrw%253D&md5=2e286c53028f38cfe33deef26bb160d0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs00726-005-0289-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-005-0289-3%26sid%3Dliteratum%253Aachs%26aulast%3DWerle%26aufirst%3DM.%26aulast%3DBernkop-Schnurch%26aufirst%3DA.%26atitle%3DStrategies%2520to%2520improve%2520plasma%2520half%2520life%2520time%2520of%2520peptide%2520and%2520protein%2520drugs%26jtitle%3DAmino%2520Acids%26date%3D2006%26volume%3D30%26spage%3D351%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Pollaro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diderich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angelini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellotto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinis, C.</span><span> </span><span class="NLM_article-title">Measuring net protease activities in biological samples using selective peptidic inhibitors</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">427</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2012&pages=18-20&author=L.+Pollaroauthor=P.+Diderichauthor=A.+Angeliniauthor=S.+Bellottoauthor=H.+Wegnerauthor=C.+Heinis&title=Measuring+net+protease+activities+in+biological+samples+using+selective+peptidic+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPollaro%26aufirst%3DL.%26aulast%3DDiderich%26aufirst%3DP.%26aulast%3DAngelini%26aufirst%3DA.%26aulast%3DBellotto%26aufirst%3DS.%26aulast%3DWegner%26aufirst%3DH.%26aulast%3DHeinis%26aufirst%3DC.%26atitle%3DMeasuring%2520net%2520protease%2520activities%2520in%2520biological%2520samples%2520using%2520selective%2520peptidic%2520inhibitors%26jtitle%3DAnal.%2520Biochem.%26date%3D2012%26volume%3D427%26spage%3D18%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Kontermann, R. E.</span><span> </span><span class="NLM_article-title">Strategies for extended serum half-life of protein therapeutics</span> <span class="citation_source-journal">Curr. Opin. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">868</span><span class="NLM_x">–</span> <span class="NLM_lpage">876</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1016%2Fj.copbio.2011.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=21862310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOhtLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=868-876&author=R.+E.+Kontermann&title=Strategies+for+extended+serum+half-life+of+protein+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for extended serum half-life of protein therapeutics</span></div><div class="casAuthors">Kontermann, Roland E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">868-876</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  With a growing no. of protein therapeutics being developed, many of them exhibiting a short plasma half-life, half-life extension strategies find increasing attention by the biotech and pharmaceutical industry.  Extension of the half-life can help to reduce the no. of applications and to lower doses, thus are beneficial for therapeutic but also economic reasons.  Here, a comprehensive overview of currently developed half-life extension strategies is provided including those aiming at increasing the hydrodynamic vol. of a protein drug but also those implementing recycling processes mediated by the neonatal Fc receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq31zlJXgPlCrVg90H21EOLACvtfcHk0lgZQOJygMrUyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOhtLfK&md5=bfc4ed0a2ac98e447b1e7be799f02d32</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.copbio.2011.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.copbio.2011.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DKontermann%26aufirst%3DR.%2BE.%26atitle%3DStrategies%2520for%2520extended%2520serum%2520half-life%2520of%2520protein%2520therapeutics%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D2011%26volume%3D22%26spage%3D868%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Mezo, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reidy, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amari, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoehn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitonti, A. J.</span><span> </span><span class="NLM_article-title">Atrial natriuretic peptide-Fc, ANP-Fc, fusion proteins: semisynthesis, in vitro activity and pharmacokinetics in rats</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc200592c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVKrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=518-526&author=A.+R.+Mezoauthor=K.+A.+McDonnellauthor=S.+C.+Lowauthor=J.+Songauthor=T.+J.+Reidyauthor=Q.+Luauthor=J.+V.+Amariauthor=T.+Hoehnauthor=R.+T.+Petersauthor=J.+Dumontauthor=A.+J.+Bitonti&title=Atrial+natriuretic+peptide-Fc%2C+ANP-Fc%2C+fusion+proteins%3A+semisynthesis%2C+in+vitro+activity+and+pharmacokinetics+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Atrial Natriuretic Peptide-Fc, ANP-Fc, Fusion Proteins: Semisynthesis, In Vitro Activity and Pharmacokinetics in Rats</span></div><div class="casAuthors">Mezo, Adam R.; McDonnell, Kevin A.; Low, Susan C.; Song, Jeff; Reidy, Tom J.; Lu, Qi; Amari, John V.; Hoehn, Todd; Peters, Robert T.; Dumont, Jennifer; Bitonti, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">518-526</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Atrial natriuretic peptide (ANP) may be a useful mol. for the treatment of cardiovascular diseases due to its potent natriuretic effects.  In an effort to prolong the short in vivo half-life of ANP, fusions of the peptide to the Fc domain of IgG were generated using a semisynthetic methodol.  Synthetic ANP peptides were synthesized with thioesters at either the N- or C-termini of the peptide and subsequently linked to the N-terminus of recombinantly expressed Fc using native chem. ligation.  The linker length between the ANP and Fc moieties was varied among 2, 11, or 16 amino acids.  In addn., either one ("monomeric") or two ("dimeric") ANP peptides were linked to Fc to study whether this modification had an effect on in vitro activity and/or in vivo half-life.  The various constructs were studied for in vitro activity using a cell-based cGMP assay.  The ANP-Fc fusion constructs were between 16- and ∼375-fold weaker than unconjugated ANP in this assay, and a trend was obsd. where the most potent conjugates were those with longer linkers and in the dimeric configuration.  The pharmacokinetics of several constructs were assessed in rats, and the half-life of the ANP-Fc's were found to be approx. 2 orders of magnitude longer than that of the unconjugated peptide.  There was no significant difference in terminal half-life between the monomeric and dimeric constructs (2.8-5.5 h), but a trend was obsd. where the Cmax of the monomeric constructs was approx. 3-fold higher than that of the dimeric constructs, although the origin of this effect is not understood.  These novel ANP-Fc fusion constructs hold promise for future therapeutic application in the treatment of cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokycZW1pNZmLVg90H21EOLACvtfcHk0lgZQOJygMrUyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVKrsrs%253D&md5=dceffc220228072aab6469cc5a4bbaa2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fbc200592c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc200592c%26sid%3Dliteratum%253Aachs%26aulast%3DMezo%26aufirst%3DA.%2BR.%26aulast%3DMcDonnell%26aufirst%3DK.%2BA.%26aulast%3DLow%26aufirst%3DS.%2BC.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DReidy%26aufirst%3DT.%2BJ.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DAmari%26aufirst%3DJ.%2BV.%26aulast%3DHoehn%26aufirst%3DT.%26aulast%3DPeters%26aufirst%3DR.%2BT.%26aulast%3DDumont%26aufirst%3DJ.%26aulast%3DBitonti%26aufirst%3DA.%2BJ.%26atitle%3DAtrial%2520natriuretic%2520peptide-Fc%252C%2520ANP-Fc%252C%2520fusion%2520proteins%253A%2520semisynthesis%252C%2520in%2520vitro%2520activity%2520and%2520pharmacokinetics%2520in%2520rats%26jtitle%3DBioconjugate%2520Chem.%26date%3D2012%26volume%3D23%26spage%3D518%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Tyndall, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, D. P.</span><span> </span><span class="NLM_article-title">Proteases universally recognize beta strands in their active sites</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">999</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr040669e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=973-999&author=J.+D.+Tyndallauthor=T.+Nallauthor=D.+P.+Fairlie&title=Proteases+universally+recognize+beta+strands+in+their+active+sites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Proteases universally recognize beta strands in their active sites</span></div><div class="casAuthors">Tyndall, Joel D. A.; Nall, Tessa; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">973-999</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Proteases account for a significant proportion (∼2%) of the human genome with >550 defined members and a further ∼100 predicted human proteases.  Proteases also represent 1-5% of the genomes of infectious organisms such as bacteria, parasites, and viruses.  They are categorized by the nature of their active site catalytic residue(s) as metallo (34%), serine (30%), cysteine (26%), aspartic (4%), and the less characterized threonine (5%).  Mammalian proteases, of which ∼20% are membrane-bound, are aberrantly expressed or underregulated during many disease conditions, suggesting that inhibitors of specific proteases might be able to control irregular mammalian physiol.  Alternatively, since there are now >50 human proteases where one or more genetic mutations have been found to lead to hereditary diseases, gene therapy may be a useful approach when it eventually becomes technol. feasible.  The goal of protease inhibitor design is to develop potent inhibitors of the offending or mammalian protease but with accompanying selectivity to avoid inhibiting very similar host proteases required for normal host physiol.  This review summarizes an anal. of >1500 3-dimensional crystal (x-ray) and soln. (NMR) structures from the Protein Data Bank of substrates, products, and inhibitors bound in the active sites of all 5 protease classes.  Most of the active sites, with few exceptions, have been found to recognize peptidic and non-peptidic ligands in an extended β-strand conformation.  Such conformational selection of ligands explains the resistance of folded/structured regions of proteins to proteolytic degrdn., the susceptibility of denatured proteins to processing, and the higher affinity of conformationally constrained 'extended' inhibitors/substrates for proteases.  On the basis of the results presented by the authors, one would predict that the use of various approaches to fix an extended β-strand ligand conformation should produce high-affinity inhibitors even for proteases of unknown structure, provided that the substrate specificity and protease type is known.  This inference should be extremely valuable, particularly when the structure of a protease is not known and inhibitor design has to be based solely on substrate preferences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8uFIrmHewBrVg90H21EOLACvtfcHk0lhGdXo8Ajqu6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqtLo%253D&md5=67da540a9c260f7c80d9a2f7128dfc15</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fcr040669e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr040669e%26sid%3Dliteratum%253Aachs%26aulast%3DTyndall%26aufirst%3DJ.%2BD.%26aulast%3DNall%26aufirst%3DT.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DProteases%2520universally%2520recognize%2520beta%2520strands%2520in%2520their%2520active%2520sites%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D105%26spage%3D973%26epage%3D999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Trabi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craik, D. J.</span><span> </span><span class="NLM_article-title">Circular proteins—No end in sight</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=132-138&author=M.+Trabiauthor=D.+J.+Craik&title=Circular+proteins%E2%80%94No+end+in+sight"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrabi%26aufirst%3DM.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26atitle%3DCircular%2520proteins%25E2%2580%2594No%2520end%2520in%2520sight%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2002%26volume%3D27%26spage%3D132%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Muttenthaler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Araujo, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dekan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alewood, P. F.</span><span> </span><span class="NLM_article-title">Modulating oxytocin activity and plasma stability by disulfide bond engineering</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8585</span><span class="NLM_x">–</span> <span class="NLM_lpage">8596</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100989w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8585-8596&author=M.+Muttenthalerauthor=A.+Anderssonauthor=A.+D.+de+Araujoauthor=Z.+Dekanauthor=R.+J.+Lewisauthor=P.+F.+Alewood&title=Modulating+oxytocin+activity+and+plasma+stability+by+disulfide+bond+engineering"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm100989w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100989w%26sid%3Dliteratum%253Aachs%26aulast%3DMuttenthaler%26aufirst%3DM.%26aulast%3DAndersson%26aufirst%3DA.%26aulast%3Dde%2BAraujo%26aufirst%3DA.%2BD.%26aulast%3DDekan%26aufirst%3DZ.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26aulast%3DAlewood%26aufirst%3DP.%2BF.%26atitle%3DModulating%2520oxytocin%2520activity%2520and%2520plasma%2520stability%2520by%2520disulfide%2520bond%2520engineering%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8585%26epage%3D8596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Reissmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imhof, D.</span><span> </span><span class="NLM_article-title">Development of conformationally restricted analogues of bradykinin and somatostatin using constrained amino acids and different types of cyclization</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2823</span><span class="NLM_x">–</span> <span class="NLM_lpage">2844</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.2174%2F0929867043364135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=15544478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosVynuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=2823-2844&author=S.+Reissmannauthor=D.+Imhof&title=Development+of+conformationally+restricted+analogues+of+bradykinin+and+somatostatin+using+constrained+amino+acids+and+different+types+of+cyclization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Development of conformationally restricted analogs of bradykinin and somatostatin using constrained amino acids and different types of cyclization</span></div><div class="casAuthors">Reissmann, Siegmund; Imhof, Diana</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2823-2844</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The structure-based design of peptide drugs requires the knowledge of the bioactive conformation.  Studies on this receptor-bound 3D structure require linear or cyclic analogs with strongly reduced flexibility, but high biol. activity, since only analogs with retained potency have preserved the bioactive conformation.  Constrained amino acids contg. double bonds or bulky substituents at the Nα-, Cα- and Cβ-atom as well as at the arom. ring atom were successfully applied to obtain potent and stable analogs of bradykinin and somatostatin, which due to their restricted conformation were suitable objects for conformational studies.  Besides the generation of constrained cyclic analogs with improved biol. and pharmacol. properties, cyclic peptides were used as convenient models for the study of turn formations.  Cyclization of the linear peptide bradykinin was performed by linking the N-terminus and the C-terminus, and in both bradykinin and somatostatin by cyclization using the amino acid side chains and by backbone cyclization.  The later requires the introduction of Nα-functionalized amino acids for ring closure which can be performed either through incorporation of Nα-functionalized amino acids or dipeptide building units.  Conformational anal. of a cyclic bradykinin analog by means of NMR-studies together with mol. dynamics simulation led to a quasicyclic 3D structure with two turns and together with other 3D structures provided a pharmacophore model of bradykinin antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov42oSt19vsbVg90H21EOLACvtfcHk0lhGdXo8Ajqu6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosVynuro%253D&md5=b662d8ac59b1ebf58b0b1ce6ab36461c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F0929867043364135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043364135%26sid%3Dliteratum%253Aachs%26aulast%3DReissmann%26aufirst%3DS.%26aulast%3DImhof%26aufirst%3DD.%26atitle%3DDevelopment%2520of%2520conformationally%2520restricted%2520analogues%2520of%2520bradykinin%2520and%2520somatostatin%2520using%2520constrained%2520amino%2520acids%2520and%2520different%2520types%2520of%2520cyclization%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D2823%26epage%3D2844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Bovy, P. R.</span><span> </span><span class="NLM_article-title">Structure activity in the atrial natriuretic peptide (ANP) family</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1002%2Fmed.2610100105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=2136927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADyaK3cXptFynsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1990&pages=115-142&author=P.+R.+Bovy&title=Structure+activity+in+the+atrial+natriuretic+peptide+%28ANP%29+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structure activity in the atrial natriuretic peptide (ANP) family</span></div><div class="casAuthors">Bovy, Philippe R.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-42</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    </div><div class="casAbstract">A review, with 121 refs., on the structure and synthesis of atriopeptin analogs with lengths ranging between 30 and <10 amino acid residues; the identification of the min. mol. size and bioactive conformation; and the contribution of each amino acid side chain to receptor recognition and activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ48wu9_DHm7Vg90H21EOLACvtfcHk0lgWhGEHoWaLYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXptFynsA%253D%253D&md5=a6a7ad279abe2aa7c31c43c8b286c330</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fmed.2610100105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.2610100105%26sid%3Dliteratum%253Aachs%26aulast%3DBovy%26aufirst%3DP.%2BR.%26atitle%3DStructure%2520activity%2520in%2520the%2520atrial%2520natriuretic%2520peptide%2520%2528ANP%2529%2520family%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1990%26volume%3D10%26spage%3D115%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Daly, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craik, D. J.</span><span> </span><span class="NLM_article-title">Bioactive cystine knot proteins</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1016%2Fj.cbpa.2011.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=21362584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntV2luro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=362-368&author=N.+L.+Dalyauthor=D.+J.+Craik&title=Bioactive+cystine+knot+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactive cystine knot proteins</span></div><div class="casAuthors">Daly, Norelle L.; Craik, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">362-368</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The cystine knot is a structural motif that confers exceptional stability on proteins.  Here we provide an update on the topol. of the cystine knot and the combinatorial diversity of proteins that contain it.  We describe recent chem. biol. studies that have utilized this structural motif for the development of potential therapeutic or diagnostic agents.  The cystine knot appears to have evolved in fungi, plants and animals as a stable and adaptable framework for the display of a wide variety of bioactive peptide sequences, but is amenable to chem. or recombinant synthesis and thus has a wide range of applications in chem., biol. and medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof-bZHYTT2rbVg90H21EOLACvtfcHk0lgWhGEHoWaLYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntV2luro%253D&md5=36ab9a8c7b875eccbb9f023b15139a1f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2011.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2011.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DN.%2BL.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26atitle%3DBioactive%2520cystine%2520knot%2520proteins%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D15%26spage%3D362%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Miljanich, G. P.</span><span> </span><span class="NLM_article-title">Ziconotide: Neuronal calcium channel blocker for treating severe chronic pain</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">3029</span><span class="NLM_x">–</span> <span class="NLM_lpage">3040</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.2174%2F0929867043363884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=15578997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpvV2is7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=3029-3040&author=G.+P.+Miljanich&title=Ziconotide%3A+Neuronal+calcium+channel+blocker+for+treating+severe+chronic+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Ziconotide: Neuronal calcium channel blocker for treating severe chronic pain</span></div><div class="casAuthors">Miljanich, G. P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3029-3040</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Ziconotide (PRIALT) is a neuroactive peptide in the final stages of clin. development as a novel non-opioid treatment for severe chronic pain.  It is the synthetic equiv. of ω-MVIIA, a component of the venom of the marine snail, Conus magus.  The mechanism of action underlying ziconotide's therapeutic profile derives from its potent and selective blockade of neuronal N-type voltage-sensitive calcium channels (N-VSCCs).  Direct blockade of N-VSCCs inhibits the activity of a subset of neurons, including pain-sensing primary nociceptors.  This mechanism of action distinguishes ziconotide from all other analgesics, including opioid analgesics.  In fact, ziconotide is potently anti-nociceptive in animal models of pain in which morphine exhibits poor anti-nociceptive activity.  Moreover, in contrast to opiates, tolerance to ziconotide is not obsd.  Clin. studies of ziconotide in more than 2,000 patients reveal important correlations to ziconotide's non-clin. pharmacol.  For example, ziconotide provides significant pain relief to severe chronic pain sufferers who have failed to obtain relief from opiate therapy and no evidence of tolerance to ziconotide is seen in these patients.  Contingent on regulatory approval, ziconotide will be the 1st in a new class of neurol. drugs: the N-type calcium channel blockers, or NCCBs.  Its novel mechanism of action as a non-opioid analgesic suggests ziconotide has the potential to play a valuable role in treatment regimens for severe chronic pain.  If approved for clin. use, ziconotide will further validate the neuroactive venom peptides as a source of new and useful medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobm9vmoUd5-7Vg90H21EOLACvtfcHk0lgWhGEHoWaLYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpvV2is7c%253D&md5=d9fac93922cac758ea913b50da48a330</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F0929867043363884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043363884%26sid%3Dliteratum%253Aachs%26aulast%3DMiljanich%26aufirst%3DG.%2BP.%26atitle%3DZiconotide%253A%2520Neuronal%2520calcium%2520channel%2520blocker%2520for%2520treating%2520severe%2520chronic%2520pain%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D3029%26epage%3D3040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Colgrave, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craik, D. J.</span><span> </span><span class="NLM_article-title">Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: The importance of the cyclic cystine knot</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">5965</span><span class="NLM_x">–</span> <span class="NLM_lpage">5975</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi049711q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsFGgsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=5965-5975&author=M.+L.+Colgraveauthor=D.+J.+Craik&title=Thermal%2C+chemical%2C+and+enzymatic+stability+of+the+cyclotide+kalata+B1%3A+The+importance+of+the+cyclic+cystine+knot"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Thermal, Chemical, and Enzymatic Stability of the Cyclotide Kalata B1: The Importance of the Cyclic Cystine Knot</span></div><div class="casAuthors">Colgrave, Michelle L.; Craik, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5965-5975</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cyclotides constitute a recently discovered family of plant-derived peptides that have the unusual features of a head-to-tail cyclized backbone and a cystine knot core.  These features are thought to contribute to their exceptional stability, as qual. obsd. during expts. aimed at sequencing and characterizing early members of the family.  However, to date there has been no quant. study of the thermal, chem., or enzymic stability of the cyclotides.  In this study, the authors demonstrate the stability of the prototypic cyclotide kalata B1 to the chaotropic agents 6 M guanidine hydrochloride (GdHCl) and 8 M urea, to temps. approaching boiling, to acid, and following incubation with a range of proteases, conditions under which most proteins readily unfold.  NMR spectroscopy was used to demonstrate the thermal stability, while fluorescence and CD were used to monitor the chem. stability.  Several variants of kalata B1 were also examd., including kalata B2, which has five amino acid substitutions from B1, two acyclic permutants in which the backbone was broken but the cystine knot was retained, and a two-disulfide bond mutant.  Together, these allowed detns. of the relative roles of the cystine knot and the circular backbone on the stability of the cyclotides.  Addn. of a denaturant to kalata B1 or an acyclic permutant did not cause unfolding, but the two-disulfide deriv. was less stable, despite having a similar three-dimensional structure.  It appears that the cystine knot is more important than the circular backbone in the chem. stability of the cyclotides.  Furthermore, the cystine knot of the cyclotides is more stable than those in similar-sized mols., judging by a comparison with the conotoxin PVIIA.  There was no evidence for enzymic digestion of native kalata B1 as monitored by LC-MS, but the reduced form was susceptible to proteolysis by trypsin, endoproteinase Glu-C, and thermolysin.  Fluorescence spectra of kalata B1 in the presence of dithiothreitol, a reducing agent, showed a marked increase in intensity thought to be due to removal of the quenching effect on the Trp residue by the neighboring Cys-5-Cys-17 disulfide bond.  In general, the reduced peptides were significantly more susceptible to chem. or enzymic breakdown than the oxidized species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI1We2BSc3QLVg90H21EOLACvtfcHk0lgWhGEHoWaLYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsFGgsL4%253D&md5=4d42bc872644a74d75610fe84846ece1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fbi049711q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi049711q%26sid%3Dliteratum%253Aachs%26aulast%3DColgrave%26aufirst%3DM.%2BL.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26atitle%3DThermal%252C%2520chemical%252C%2520and%2520enzymatic%2520stability%2520of%2520the%2520cyclotide%2520kalata%2520B1%253A%2520The%2520importance%2520of%2520the%2520cyclic%2520cystine%2520knot%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D5965%26epage%3D5975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span>Melusine. <a href="http://www.melusine.com" class="extLink">www.melusine.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Melusine.+www.melusine.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Heinis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutherford, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, G.</span><span> </span><span class="NLM_article-title">Phage-encoded combinatorial chemical libraries based on bicyclic peptides</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">502</span><span class="NLM_x">–</span> <span class="NLM_lpage">507</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1038%2Fnchembio.184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=19483697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1altbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=502-507&author=C.+Heinisauthor=T.+Rutherfordauthor=S.+Freundauthor=G.+Winter&title=Phage-encoded+combinatorial+chemical+libraries+based+on+bicyclic+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Phage-encoded combinatorial chemical libraries based on bicyclic peptides</span></div><div class="casAuthors">Heinis, Christian; Rutherford, Trevor; Freund, Stephan; Winter, Greg</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">502-507</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Here we describe a phage strategy for the selection of ligands based on bicyclic or linear peptides attached covalently to an org. core.  We designed peptide repertoires with three reactive cysteine residues, each spaced apart by several random amino acid residues, and we fused the repertoires to the phage gene-3-protein.  Conjugation with tris-(bromomethyl)benzene via the reactive cysteines generated repertoires of peptide conjugates with two peptide loops anchored to a mesitylene core.  Iterative affinity selections yielded several enzyme inhibitors; after further mutagenesis and selection, we were able to chem. synthesize a lead inhibitor (PK15; Ki = 1.5 nM) specific to human plasma kallikrein that efficiently interrupted the intrinsic coagulation pathway in human plasma tested ex vivo.  This approach offers a powerful means of generating and selecting bicyclic macrocycles (or if cleaved, linear derivs. thereof) as ligands poised at the interface of small-mol. drugs and biologics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZhJRZyldisLVg90H21EOLACvtfcHk0lgpWidwuicB6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1altbs%253D&md5=0634460f77b185fbcf85309c6dbf93e3</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.184%26sid%3Dliteratum%253Aachs%26aulast%3DHeinis%26aufirst%3DC.%26aulast%3DRutherford%26aufirst%3DT.%26aulast%3DFreund%26aufirst%3DS.%26aulast%3DWinter%26aufirst%3DG.%26atitle%3DPhage-encoded%2520combinatorial%2520chemical%2520libraries%2520based%2520on%2520bicyclic%2520peptides%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D502%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Timmerman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beld, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puijk, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meloen, R. H.</span><span> </span><span class="NLM_article-title">Rapid and quantitative cyclization of multiple peptide loops onto synthetic scaffolds for structural mimicry of protein surfaces</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">824</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1002%2Fcbic.200400374" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=15812852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksFajsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=821-824&author=P.+Timmermanauthor=J.+Beldauthor=W.+C.+Puijkauthor=R.+H.+Meloen&title=Rapid+and+quantitative+cyclization+of+multiple+peptide+loops+onto+synthetic+scaffolds+for+structural+mimicry+of+protein+surfaces"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid and quantitative cyclization of multiple peptide loops onto synthetic scaffolds for structural mimicry of protein surfaces</span></div><div class="casAuthors">Timmerman, Peter; Beld, Joris; Puijk, Wouter C.; Meloen, Rob H.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">821-824</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">This work describes cyclization reaction of cysteine-contg. linear peptides onto bromomethylated arom. scaffolds without requiring side-chain protections.  The reaction is extremely fast and clean and runs to completion in less than 15 min at room temp.  The cyclic peptides are good mimics of protein surfaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfSQnHmkXl_LVg90H21EOLACvtfcHk0lgpWidwuicB6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksFajsL0%253D&md5=52a1d3bb0bc8a483a683cdb900525c0f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200400374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200400374%26sid%3Dliteratum%253Aachs%26aulast%3DTimmerman%26aufirst%3DP.%26aulast%3DBeld%26aufirst%3DJ.%26aulast%3DPuijk%26aufirst%3DW.%2BC.%26aulast%3DMeloen%26aufirst%3DR.%2BH.%26atitle%3DRapid%2520and%2520quantitative%2520cyclization%2520of%2520multiple%2520peptide%2520loops%2520onto%2520synthetic%2520scaffolds%2520for%2520structural%2520mimicry%2520of%2520protein%2520surfaces%26jtitle%3DChemBioChem%26date%3D2005%26volume%3D6%26spage%3D821%26epage%3D824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Angelini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cendron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Touati, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanotti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinis, C.</span><span> </span><span class="NLM_article-title">Bicyclic peptide inhibitor reveals large contact interface with a protease target</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb200478t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslGit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=817-821&author=A.+Angeliniauthor=L.+Cendronauthor=S.+Chenauthor=J.+Touatiauthor=G.+Winterauthor=G.+Zanottiauthor=C.+Heinis&title=Bicyclic+peptide+inhibitor+reveals+large+contact+interface+with+a+protease+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Bicyclic Peptide Inhibitor Reveals Large Contact Interface with a Protease Target</span></div><div class="casAuthors">Angelini, Alessandro; Cendron, Laura; Chen, Shiyu; Touati, Jeremy; Winter, Greg; Zanotti, Giuseppe; Heinis, Christian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">817-821</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">From a large combinatorial library of chem. constrained bicyclic peptides we isolated a selective and potent (Ki = 53 nM) inhibitor of human urokinase-type plasminogen activator (uPA) and crystd. the complex.  This revealed an extended structure of the peptide with both peptide loops engaging the target to form a large interaction surface of 701 Å2 with multiple hydrogen bonds and complementary charge interactions, explaining the high affinity and specificity of the inhibitor.  The interface resembles that between two proteins and suggests that these constrained peptides have the potential to act as small protein mimics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_mNSBCb03BLVg90H21EOLACvtfcHk0lgpWidwuicB6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslGit74%253D&md5=00ecceafcb4d3403d9c5c2a1c93032a5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fcb200478t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb200478t%26sid%3Dliteratum%253Aachs%26aulast%3DAngelini%26aufirst%3DA.%26aulast%3DCendron%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DTouati%26aufirst%3DJ.%26aulast%3DWinter%26aufirst%3DG.%26aulast%3DZanotti%26aufirst%3DG.%26aulast%3DHeinis%26aufirst%3DC.%26atitle%3DBicyclic%2520peptide%2520inhibitor%2520reveals%2520large%2520contact%2520interface%2520with%2520a%2520protease%2520target%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2012%26volume%3D7%26spage%3D817%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Andreasen, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egelund, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, H. H.</span><span> </span><span class="NLM_article-title">The plasminogen activation system in tumor growth, invasion, and metastasis</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1007%2Fs000180050497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=10949579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslOrsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=25-40&author=P.+A.+Andreasenauthor=R.+Egelundauthor=H.+H.+Petersen&title=The+plasminogen+activation+system+in+tumor+growth%2C+invasion%2C+and+metastasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The plasminogen activation system in tumor growth, invasion, and metastasis</span></div><div class="casAuthors">Andreasen, P. A.; Egelund, R.; Petersen, H. H.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-40</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review with 197 refs.  Generation of the serine proteinase plasmin from the extracellular zymogen plasminogen can be catalyzed by either of two other serine proteinases, the tissue-type and tissue-type plasminogen activators (uPA and tPA).  The plasminogen activation system also includes the serpins PAI-1 and PAI-2, and the uPA receptor (uPAR).  Many findings, gathered over several decades, strongly suggest an important and causal role for uPA-catalyzed plasmin generation in cancer cell invasion through the extracellular matrix.  Recent evidence suggests that the uPA system is also involved in cancer cell-directed tissue remodeling.  Moreover, the system also supports cell migration and invasion by plasmin-independent mechanisms, including multiple interactions between uPA, uPAR, PAI-1, extracellular matrix proteins, integrins, endocytosis receptors, and growth factors.  These interactions seem to allow temporal and spatial reorganizations of the system during cell migration and a selective degrdn. of extracellular matrix proteins during invasion.  The increased knowledge about the plasminogen activation system may allow utilization of its components as targets for anti-invasive therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU5ANtYZtQgbVg90H21EOLACvtfcHk0lgLOeHstc7POA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslOrsrk%253D&md5=6760b4d8aabe089ac9a2fe4587b08103</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs000180050497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs000180050497%26sid%3Dliteratum%253Aachs%26aulast%3DAndreasen%26aufirst%3DP.%2BA.%26aulast%3DEgelund%26aufirst%3DR.%26aulast%3DPetersen%26aufirst%3DH.%2BH.%26atitle%3DThe%2520plasminogen%2520activation%2520system%2520in%2520tumor%2520growth%252C%2520invasion%252C%2520and%2520metastasis%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2000%26volume%3D57%26spage%3D25%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Dennis, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadkhodayan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchhofer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damico, L. A.</span><span> </span><span class="NLM_article-title">Albumin binding as a general strategy for improving the pharmacokinetics of proteins</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">35035</span><span class="NLM_x">–</span> <span class="NLM_lpage">35043</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1074%2Fjbc.M205854200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=12119302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD38Xnt1Wgsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=35035-35043&author=M.+S.+Dennisauthor=M.+Zhangauthor=Y.+G.+Mengauthor=M.+Kadkhodayanauthor=D.+Kirchhoferauthor=D.+Combsauthor=L.+A.+Damico&title=Albumin+binding+as+a+general+strategy+for+improving+the+pharmacokinetics+of+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Albumin Binding as a General Strategy for Improving the Pharmacokinetics of Proteins</span></div><div class="casAuthors">Dennis, Mark S.; Zhang, Min; Meng, Y. Gloria; Kadkhodayan, Miryam; Kirchhofer, Daniel; Combs, Dan; Damico, Lisa A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">35035-35043</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Plasma protein binding can be an effective means of improving the pharmacokinetic properties of otherwise short lived mols.  Using peptide phage display, we identified a series of peptides having the core sequence DICLPRWGCLW that specifically bind serum albumin from multiple species with high affinity.  These peptides bind to albumin with 1:1 stoichiometry at a site distinct from known small mol. binding sites.  Using surface plasmon resonance, the dissocn. equil. const. of peptide SA21 (Ac-RLIEDICLPRWGCLWEDD-NH2) was detd. to be 266 ± 8, 320 ± 22, and 467 ± 47 nm for rat, rabbit, and human albumin, resp.  SA21 has an unusually long half-life of 2.3 h when injected by i.v. bolus into rabbits.  A related sequence, fused to the anti-tissue factor Fab of D3H44 (Presta, L., Sims, P., Meng, Y. G., Moran, P., Bullens, S., Bunting, S., Schoenfeld, J., Lowe, D., Lai, J., Rancatore, P., Iverson, M., Lim, A., Chisholm, V., Kelley, R. F., Riederer, M., and Kirchhofer, D. (2001) Thromb. Haemost. 85, 379-389), enabled the Fab to bind albumin with similar affinity to that of SA21 while retaining the ability of the Fab to bind tissue factor.  This interaction with albumin resulted in reduced in vivo clearance of 25- and 58-fold in mice and rabbits, resp., when compared with the wild-type D3H44 Fab.  The half-life was extended 37-fold to 32.4 h in rabbits and 26-fold to 10.4 h in mice, achieving 25-43% of the albumin half-life in these animals.  These half-lives exceed those of a Fab'2 and are comparable with those seen for polyethylene glycol-conjugated Fab mols., immunoadhesins, and albumin fusions, suggesting a novel and generic method for improving the pharmacokinetic properties of rapidly cleared proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLFW2XIwkgXbVg90H21EOLACvtfcHk0lgLOeHstc7POA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xnt1Wgsbk%253D&md5=f026054505bc103514fca23f1070bd0d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M205854200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M205854200%26sid%3Dliteratum%253Aachs%26aulast%3DDennis%26aufirst%3DM.%2BS.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DMeng%26aufirst%3DY.%2BG.%26aulast%3DKadkhodayan%26aufirst%3DM.%26aulast%3DKirchhofer%26aufirst%3DD.%26aulast%3DCombs%26aufirst%3DD.%26aulast%3DDamico%26aufirst%3DL.%2BA.%26atitle%3DAlbumin%2520binding%2520as%2520a%2520general%2520strategy%2520for%2520improving%2520the%2520pharmacokinetics%2520of%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D35035%26epage%3D35043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Nguyen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyes, A. E.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damico, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, M. S.</span><span> </span><span class="NLM_article-title">The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin</span> <span class="citation_source-journal">Protein Eng., Des. Sel.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1093%2Fprotein%2Fgzl011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=16621915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmt1Wktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2006&pages=291-297&author=A.+Nguyenauthor=A.+E.+Reyesauthor=M.+Zhangauthor=P.+McDonaldauthor=W.+L.+Wongauthor=L.+A.+Damicoauthor=M.+S.+Dennis&title=The+pharmacokinetics+of+an+albumin-binding+Fab+%28AB.Fab%29+can+be+modulated+as+a+function+of+affinity+for+albumin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin</span></div><div class="casAuthors">Nguyen, Allen; Reyes, Arthur E., II; Zhang, Min; McDonald, Paul; Wong, Wai Lee T.; Damico, Lisa A.; Dennis, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Engineering, Design & Selection</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">291-297</span>CODEN:
                <span class="NLM_cas:coden">PEDSBR</span>;
        ISSN:<span class="NLM_cas:issn">1741-0126</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">An AB.Fab (albumin-binding Fab) consists of a Fab and a phage-derived albumin-binding peptide.  This mol. is capable of binding both antigen and albumin simultaneously.  Using a Fab derived from Herceptin we generated a panel of AB.Fab variants with wide-ranging affinities for albumin.  An assay that measured AB.Fab binding to albumin in soln. was developed to most accurately reflect the binding affinity for albumin in vivo.  Affinity varied depending upon the species of albumin tested.  For rat and rabbit albumin, affinities ranged from 0.04 to 2.5 μM.  Reduced affinity for albumin correlated with a reduced half-life and higher clearance rates in both species; the beta half-life ranged 6-fold while clearance ranged over 50-fold in rats and 20-fold in rabbits.  To est. the pharmacokinetic properties of an AB.Fab in humans, AB.Fab variants with similar affinities for rat and rabbit albumin were selected.  Using their pharmacokinetic parameters and the principles of allometric scaling for albumin, we est. an approx. beta half-life for an AB.Fab with 0.5 μM affinity for albumin of up to 4 days in humans with a clearance of 76 mL/h.  These variants demonstrate the ability to modulate the clearance of a Fab fragment in vivo and help to establish guidelines for pharmacokinetic engineering of mols. through albumin binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9SJ16IWdf77Vg90H21EOLACvtfcHk0lgLOeHstc7POA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmt1Wktb8%253D&md5=a783bc53292c684b3daefc72fd633734</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fprotein%2Fgzl011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fprotein%252Fgzl011%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DA.%26aulast%3DReyes%26aufirst%3DA.%2BE.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DMcDonald%26aufirst%3DP.%26aulast%3DWong%26aufirst%3DW.%2BL.%26aulast%3DDamico%26aufirst%3DL.%2BA.%26aulast%3DDennis%26aufirst%3DM.%2BS.%26atitle%3DThe%2520pharmacokinetics%2520of%2520an%2520albumin-binding%2520Fab%2520%2528AB.Fab%2529%2520can%2520be%2520modulated%2520as%2520a%2520function%2520of%2520affinity%2520for%2520albumin%26jtitle%3DProtein%2520Eng.%252C%2520Des.%2520Sel.%26date%3D2006%26volume%3D19%26spage%3D291%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Langenheim, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. Y.</span><span> </span><span class="NLM_article-title">Improving the pharmacokinetics/pharmacodynamics of prolactin, GH, and their antagonists by fusion to a synthetic albumin-binding peptide</span> <span class="citation_source-journal">J. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">203</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1677%2FJOE-09-0211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=19770179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWhurrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2009&pages=375-387&author=J.+F.+Langenheimauthor=W.+Y.+Chen&title=Improving+the+pharmacokinetics%2Fpharmacodynamics+of+prolactin%2C+GH%2C+and+their+antagonists+by+fusion+to+a+synthetic+albumin-binding+peptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the pharmacokinetics/pharmacodynamics of prolactin, GH, and their antagonists by fusion to a synthetic albumin-binding peptide</span></div><div class="casAuthors">Langenheim, John F.; Chen, Wen Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endocrinology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">375-387</span>CODEN:
                <span class="NLM_cas:coden">JOENAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-0795</span>.
    
            (<span class="NLM_cas:orgname">Society for Endocrinology</span>)
        </div><div class="casAbstract">To prolong the circulation half-life of human prolactin (hPRL), human GH (hGH), and their competitive antagonists, hPRL-G129R and hGH-G120R, we examd. the effects of fusing a serum albumin-binding peptide (SA20) to their amino- or carboxyl-terminus.  Fusion of the SA20 peptide to the amino-terminus of the ligands was less detrimental upon their ability to induce or inhibit signal transduction and cell proliferation in vitro than fusion to the carboxyl-terminus.  Pharmacokinetic (PK) studies in mice revealed that the half-life of SA20-hPRL and SA20-hGH was prolonged and their clearance was reduced in comparison with hPRL and hGH.  Pharmacodynamic (PD) studies in 8-wk-old female mice revealed that lobuloalveolar development in mammary glands was greater in all three groups (daily, every 2 days, or every third day over a 12-day period) of mice treated with SA20-hPRL (4 mg/kg) compared with hPRL (3·59 mg/kg).  Similarly, daily administration (i.p.) of SA20-hGH (8 mg/kg) or hGH (7·15 mg/kg) to 23-day-old female mice over a 40-day period revealed the superiority of SA20-hGH over hGH as measured by wt. gain, body length, and lobuloalveolar development in the mammary glands.  These findings indicate that SA20 modification of hPRL, hGH, and their resp. antagonists improves their PK/PD properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3eGLuNdKoQ7Vg90H21EOLACvtfcHk0lgA5NM9Mh6Gmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWhurrN&md5=371d7be39ed671d3ec7cd25d03ab62fc</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1677%2FJOE-09-0211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252FJOE-09-0211%26sid%3Dliteratum%253Aachs%26aulast%3DLangenheim%26aufirst%3DJ.%2BF.%26aulast%3DChen%26aufirst%3DW.%2BY.%26atitle%3DImproving%2520the%2520pharmacokinetics%252Fpharmacodynamics%2520of%2520prolactin%252C%2520GH%252C%2520and%2520their%2520antagonists%2520by%2520fusion%2520to%2520a%2520synthetic%2520albumin-binding%2520peptide%26jtitle%3DJ.%2520Endocrinol.%26date%3D2009%26volume%3D203%26spage%3D375%26epage%3D387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Korsinczky, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirra, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craik, D. J.</span><span> </span><span class="NLM_article-title">Sunflower trypsin inhibitor-1</span> <span class="citation_source-journal">Curr. Protein Pept. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.2174%2F1389203043379594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=15544530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFGjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=351-364&author=M.+L.+Korsinczkyauthor=H.+J.+Schirraauthor=D.+J.+Craik&title=Sunflower+trypsin+inhibitor-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Sunflower trypsin inhibitor-1</span></div><div class="casAuthors">Korsinczky, Michael L. J.; Schirra, Horst Joachim; Craik, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Protein and Peptide Science</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">351-364</span>CODEN:
                <span class="NLM_cas:coden">CPPSCM</span>;
        ISSN:<span class="NLM_cas:issn">1389-2037</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  SFTI-1 is a bicyclic 14 amino acid peptide that was originally isolated from the seeds of the sunflower Helianthus annuus.  It is a potent inhibitor of trypsin, with a sub-nanomolar Ki value and is homologous to the active site region of the well-known family of serine protease inhibitors known as the Bowman-Birk trypsin inhibitors.  It has a cyclic backbone that is cross-braced by a single disulfide bridge and a network of hydrogen bonds that result in a well-defined structure.  SFTI-1 is amenable to chem. synthesis, allowing for the creation of synthetic variants.  Alterations to the structure such as linearizing the backbone or removing the disulfide bridge do not reduce the potency of SFTI-1 significantly, and minimizing the peptide to as few as nine residues results in only a small decrease in reactivity.  The creation of linear variants of SFTI-1 also provides a tool for investigating putative linear precursor peptides.  The mechanism of biosynthesis of SFTI-1 is not yet known but it seems likely that it is a gene-coded product that has arisen from a precursor protein that may be evolutionarily related to classic Bowman-Birk inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPPRnSe76NqbVg90H21EOLACvtfcHk0lgA5NM9Mh6Gmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFGjtbc%253D&md5=b2344eaaa52a5ebb807593168a2737ac</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F1389203043379594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389203043379594%26sid%3Dliteratum%253Aachs%26aulast%3DKorsinczky%26aufirst%3DM.%2BL.%26aulast%3DSchirra%26aufirst%3DH.%2BJ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26atitle%3DSunflower%2520trypsin%2520inhibitor-1%26jtitle%3DCurr.%2520Protein%2520Pept.%2520Sci.%26date%3D2004%26volume%3D5%26spage%3D351%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Luckett, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konarev, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewry, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, R. L.</span><span> </span><span class="NLM_article-title">High-resolution structure of a potent, cyclic proteinase inhibitor from sunflower seeds</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1006%2Fjmbi.1999.2891" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=10390350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADyaK1MXktFehsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=1999&pages=525-533&author=S.+Luckettauthor=R.+S.+Garciaauthor=J.+J.+Barkerauthor=A.+V.+Konarevauthor=P.+R.+Shewryauthor=A.+R.+Clarkeauthor=R.+L.+Brady&title=High-resolution+structure+of+a+potent%2C+cyclic+proteinase+inhibitor+from+sunflower+seeds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">High-Resolution Structure of a Potent, Cyclic Proteinase Inhibitor from Sunflower Seeds</span></div><div class="casAuthors">Luckett, S.; Garcia, R. Santiago; Barker, J. J.; Konarev, Al. V.; Shewry, P. R.; Clarke, A. R.; Brady, R. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">525-533</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Proteinaceous serine proteinase inhibitors are widespread throughout the plant kingdom where they play an important role in protection against pests and pathogens.  Here, we describe the isolation and characterization of a novel 14 amino acid residue cyclic peptide from sunflower seeds, which is a potent inhibitor of trypsin (Ki=100 pM).  The crystal structure of this peptide in complex with bovine β-trypsin shows both sequence and conformational similarity with the trypsin-reactive loop of the Bowman-Birk family of serine proteinase inhibitors.  This inhibitor, however, is unique in being monofunctional, cyclic and far shorter (14 amino acid residues) than inhibitors belonging to this family (typically 60-70 amino acid residues).  The high potency of this peptide is likely to arise from the considerable structural rigidity achieved through its cyclic nature which is further stabilized by a single internal disulfide bond.  This study helps delineate the minimal unit required for effective peptide inhibitors of serine proteinases, and will assist in the further design of inhibitors to this widespread class of enzymes.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqflG8_cLIMOLVg90H21EOLACvtfcHk0lgA5NM9Mh6Gmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktFehsb0%253D&md5=2f3b198effcf0085d4337c2a47a2826d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1999.2891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1999.2891%26sid%3Dliteratum%253Aachs%26aulast%3DLuckett%26aufirst%3DS.%26aulast%3DGarcia%26aufirst%3DR.%2BS.%26aulast%3DBarker%26aufirst%3DJ.%2BJ.%26aulast%3DKonarev%26aufirst%3DA.%2BV.%26aulast%3DShewry%26aufirst%3DP.%2BR.%26aulast%3DClarke%26aufirst%3DA.%2BR.%26aulast%3DBrady%26aufirst%3DR.%2BL.%26atitle%3DHigh-resolution%2520structure%2520of%2520a%2520potent%252C%2520cyclic%2520proteinase%2520inhibitor%2520from%2520sunflower%2520seeds%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1999%26volume%3D290%26spage%3D525%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Colgrave, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korsinczky, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craik, D. J.</span><span> </span><span class="NLM_article-title">Sunflower trypsin inhibitor-1, proteolytic studies on a trypsin inhibitor peptide and its analogs</span> <span class="citation_source-journal">Biopolymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2010&pages=665-672&author=M.+L.+Colgraveauthor=M.+J.+Korsinczkyauthor=R.+J.+Clarkauthor=F.+Foleyauthor=D.+J.+Craik&title=Sunflower+trypsin+inhibitor-1%2C+proteolytic+studies+on+a+trypsin+inhibitor+peptide+and+its+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColgrave%26aufirst%3DM.%2BL.%26aulast%3DKorsinczky%26aufirst%3DM.%2BJ.%26aulast%3DClark%26aufirst%3DR.%2BJ.%26aulast%3DFoley%26aufirst%3DF.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26atitle%3DSunflower%2520trypsin%2520inhibitor-1%252C%2520proteolytic%2520studies%2520on%2520a%2520trypsin%2520inhibitor%2520peptide%2520and%2520its%2520analogs%26jtitle%3DBiopolymers%26date%3D2010%26volume%3D94%26spage%3D665%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Ruiz-Rodriguez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spengler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albericio, F.</span><span> </span><span class="NLM_article-title">Siamese depsipeptides: constrained bicyclic architectures</span> <span class="citation_source-journal">Angew. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">8564</span><span class="NLM_x">–</span> <span class="NLM_lpage">8567</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=8564-8567&author=J.+Ruiz-Rodriguezauthor=J.+Spenglerauthor=F.+Albericio&title=Siamese+depsipeptides%3A+constrained+bicyclic+architectures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuiz-Rodriguez%26aufirst%3DJ.%26aulast%3DSpengler%26aufirst%3DJ.%26aulast%3DAlbericio%26aufirst%3DF.%26atitle%3DSiamese%2520depsipeptides%253A%2520constrained%2520bicyclic%2520architectures%26jtitle%3DAngew.%2520Chem.%26date%3D2009%26volume%3D48%26spage%3D8564%26epage%3D8567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Harris, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chess, R. B.</span><span> </span><span class="NLM_article-title">Effect of pegylation on pharmaceuticals</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1038%2Fnrd1033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=12612647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFKrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=214-221&author=J.+M.+Harrisauthor=R.+B.+Chess&title=Effect+of+pegylation+on+pharmaceuticals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of PEGylation on pharmaceuticals</span></div><div class="casAuthors">Harris, J. Milton; Chess, Robert B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">214-221</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein and peptide drugs hold great promise as therapeutic agents.  However, many are degraded by proteolytic enzymes, can be rapidly cleared by the kidneys, generate neutralizing antibodies and have a short circulating half-life.  PEGylation, the process by which polyethylene glycol chains are attached to protein and peptide drugs, can overcome these and other shortcomings.  By increasing the mol. mass of proteins and peptides and shielding them from proteolytic enzymes, PEGylation improves pharmacokinetics.  This article will review how PEGylation can result in drugs that are often more effective and safer, and which show improved patient convenience and compliance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLhPAuz8WjMLVg90H21EOLACvtfcHk0lick7KwBHkHpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFKrtLs%253D&md5=d6bb387e746740b10e088e1f55af37db</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrd1033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1033%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DJ.%2BM.%26aulast%3DChess%26aufirst%3DR.%2BB.%26atitle%3DEffect%2520of%2520pegylation%2520on%2520pharmaceuticals%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D214%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Dennis, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarland, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogasawara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwall, R.</span><span> </span><span class="NLM_article-title">Imaging tumors with an albumin-binding Fab, a novel tumor-targeting agent</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=254-261&author=M.+S.+Dennisauthor=H.+Jinauthor=D.+Duggerauthor=R.+Yangauthor=L.+McFarlandauthor=A.+Ogasawaraauthor=S.+Williamsauthor=M.+J.+Coleauthor=S.+Rossauthor=R.+Schwall&title=Imaging+tumors+with+an+albumin-binding+Fab%2C+a+novel+tumor-targeting+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDennis%26aufirst%3DM.%2BS.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DDugger%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DMcFarland%26aufirst%3DL.%26aulast%3DOgasawara%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DS.%26aulast%3DCole%26aufirst%3DM.%2BJ.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DSchwall%26aufirst%3DR.%26atitle%3DImaging%2520tumors%2520with%2520an%2520albumin-binding%2520Fab%252C%2520a%2520novel%2520tumor-targeting%2520agent%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D254%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Holmes, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibaudeau, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">L'Archeveque, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milner, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezrin, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridon, D. P.</span><span> </span><span class="NLM_article-title">Site specific 1:1 opioid:albumin conjugate with in vitro activity and long in vivo duration</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc0000233" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt1GktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2000&pages=439-444&author=D.+L.+Holmesauthor=K.+Thibaudeauauthor=B.+L%27Archevequeauthor=P.+G.+Milnerauthor=A.+M.+Ezrinauthor=D.+P.+Bridon&title=Site+specific+1%3A1+opioid%3Aalbumin+conjugate+with+in+vitro+activity+and+long+in+vivo+duration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Site specific 1:1 opioid:albumin conjugate with in vitro activity and long in vivo duration</span></div><div class="casAuthors">Holmes, Darren L.; Thibaudeau, Karen; L'Archeveque, Benoit; Milner, Peter G.; Ezrin, Alan M.; Bridon, Dominique P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">439-444</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A site-specific 1:1 dynorphin A-(1-13)-NH2 deriv. conjugated specifically to Cys 34 on human serum albumin (CCI-1035) was shown to be an opioid receptor agonist in vitro and to be a long lasting antinociceptive agent when administered i.v. to mice as assessed by an acetic acid writhing assay.  When 10 μmol/kg of CCI-1035 was administered to mice, rapid antinociception was obsd. within 5 min following i.v. bolus injection and was sustained beyond 8 h.  Antinociceptive activity was absent in a heat induced pain model using a mouse tail-flick assay.  This finding represents the first report of a 1:1 albumin opioid conjugate retaining potent in vivo activity equal to or greater than dynorphin A, accompanied by a dramatic extension in duration of action.  This novel site-specific bioconjugation technol. produces an agent that may be useful for peripheral pain therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIp8OKpfc78LVg90H21EOLACvtfcHk0lick7KwBHkHpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt1GktLY%253D&md5=f5ca43125a08038376a65ace5c91e828</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fbc0000233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc0000233%26sid%3Dliteratum%253Aachs%26aulast%3DHolmes%26aufirst%3DD.%2BL.%26aulast%3DThibaudeau%26aufirst%3DK.%26aulast%3DL%2527Archeveque%26aufirst%3DB.%26aulast%3DMilner%26aufirst%3DP.%2BG.%26aulast%3DEzrin%26aufirst%3DA.%2BM.%26aulast%3DBridon%26aufirst%3DD.%2BP.%26atitle%3DSite%2520specific%25201%253A1%2520opioid%253Aalbumin%2520conjugate%2520with%2520in%2520vitro%2520activity%2520and%2520long%2520in%2520vivo%2520duration%26jtitle%3DBioconjugate%2520Chem.%26date%3D2000%26volume%3D11%26spage%3D439%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Leger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benquet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quraishi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Wyk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridon, D.</span><span> </span><span class="NLM_article-title">Kringle 5 peptide-albumin conjugates with anti-migratory activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">845</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=841-845&author=R.+Legerauthor=C.+Benquetauthor=X.+Huangauthor=O.+Quraishiauthor=P.+van+Wykauthor=D.+Bridon&title=Kringle+5+peptide-albumin+conjugates+with+anti-migratory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeger%26aufirst%3DR.%26aulast%3DBenquet%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DQuraishi%26aufirst%3DO.%26aulast%3Dvan%2BWyk%26aufirst%3DP.%26aulast%3DBridon%26aufirst%3DD.%26atitle%3DKringle%25205%2520peptide-albumin%2520conjugates%2520with%2520anti-migratory%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D841%26epage%3D845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Leger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robitaille, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quraishi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denholm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benquet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Wyk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellerin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet-Gagnon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridon, D.</span><span> </span><span class="NLM_article-title">Synthesis and in vitro analysis of atrial natriuretic peptide-albumin conjugates</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3571</span><span class="NLM_x">–</span> <span class="NLM_lpage">3575</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3571-3575&author=R.+Legerauthor=M.+Robitailleauthor=O.+Quraishiauthor=E.+Denholmauthor=C.+Benquetauthor=J.+Caretteauthor=P.+van+Wykauthor=I.+Pellerinauthor=N.+Bousquet-Gagnonauthor=J.+P.+Castaigneauthor=D.+Bridon&title=Synthesis+and+in+vitro+analysis+of+atrial+natriuretic+peptide-albumin+conjugates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeger%26aufirst%3DR.%26aulast%3DRobitaille%26aufirst%3DM.%26aulast%3DQuraishi%26aufirst%3DO.%26aulast%3DDenholm%26aufirst%3DE.%26aulast%3DBenquet%26aufirst%3DC.%26aulast%3DCarette%26aufirst%3DJ.%26aulast%3Dvan%2BWyk%26aufirst%3DP.%26aulast%3DPellerin%26aufirst%3DI.%26aulast%3DBousquet-Gagnon%26aufirst%3DN.%26aulast%3DCastaigne%26aufirst%3DJ.%2BP.%26aulast%3DBridon%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520analysis%2520of%2520atrial%2520natriuretic%2520peptide-albumin%2520conjugates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3571%26epage%3D3575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Leger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibaudeau, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robitaille, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quraishi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Wyk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet-Gagnon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridon, D. P.</span><span> </span><span class="NLM_article-title">Identification of CJC-1131-albumin bioconjugate as a stable and bioactive GLP-1(7–36) analog</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4395</span><span class="NLM_x">–</span> <span class="NLM_lpage">4398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4395-4398&author=R.+Legerauthor=K.+Thibaudeauauthor=M.+Robitailleauthor=O.+Quraishiauthor=P.+van+Wykauthor=N.+Bousquet-Gagnonauthor=J.+Caretteauthor=J.+P.+Castaigneauthor=D.+P.+Bridon&title=Identification+of+CJC-1131-albumin+bioconjugate+as+a+stable+and+bioactive+GLP-1%287%E2%80%9336%29+analog"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeger%26aufirst%3DR.%26aulast%3DThibaudeau%26aufirst%3DK.%26aulast%3DRobitaille%26aufirst%3DM.%26aulast%3DQuraishi%26aufirst%3DO.%26aulast%3Dvan%2BWyk%26aufirst%3DP.%26aulast%3DBousquet-Gagnon%26aufirst%3DN.%26aulast%3DCarette%26aufirst%3DJ.%26aulast%3DCastaigne%26aufirst%3DJ.%2BP.%26aulast%3DBridon%26aufirst%3DD.%2BP.%26atitle%3DIdentification%2520of%2520CJC-1131-albumin%2520bioconjugate%2520as%2520a%2520stable%2520and%2520bioactive%2520GLP-1%25287%25E2%2580%259336%2529%2520analog%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4395%26epage%3D4398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Knudsen, L. B.</span><span> </span><span class="NLM_article-title">Glucagon-like peptide-1: the basis of a new class of treatment for type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4128</span><span class="NLM_x">–</span> <span class="NLM_lpage">4134</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030630m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4128-4134&author=L.+B.+Knudsen&title=Glucagon-like+peptide-1%3A+the+basis+of+a+new+class+of+treatment+for+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm030630m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030630m%26sid%3Dliteratum%253Aachs%26aulast%3DKnudsen%26aufirst%3DL.%2BB.%26atitle%3DGlucagon-like%2520peptide-1%253A%2520the%2520basis%2520of%2520a%2520new%2520class%2520of%2520treatment%2520for%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4128%26epage%3D4134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Knudsen, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huusfeldt, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, F. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thogersen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agerso, H.</span><span> </span><span class="NLM_article-title">Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1664</span><span class="NLM_x">–</span> <span class="NLM_lpage">1669</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9909645" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVKksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1664-1669&author=L.+B.+Knudsenauthor=P.+F.+Nielsenauthor=P.+O.+Huusfeldtauthor=N.+L.+Johansenauthor=K.+Madsenauthor=F.+Z.+Pedersenauthor=H.+Thogersenauthor=M.+Wilkenauthor=H.+Agerso&title=Potent+derivatives+of+glucagon-like+peptide-1+with+pharmacokinetic+properties+suitable+for+once+daily+administration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration</span></div><div class="casAuthors">Knudsen, Lotte B.; Nielsen, Per F.; Huusfeldt, Per O.; Johansen, Nils L.; Madsen, Kjeld; Pedersen, Freddy Z.; Thogersen, Henning; Wilken, Michael; Agerso, Henrik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1664-1669</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of very potent derivs. of the 30-amino acid peptide hormone glucagon-like peptide-1 (GLP-1) is described.  The compds. were all derivatized with fatty acids in order to protract their action by facilitating binding to serum albumin. GLP-1 had a potency (EC50) of 55 pM for the cloned human GLP-1 receptor.  Many of the compds. had similar or even higher potencies, despite quite large substituents.  All compds. derivatized with fatty acids equal to or longer than 12 carbon atoms were very protracted compared to GLP-1 and thus seem suitable for once daily administration to type 2 diabetic patients.  A structure-activity relationship was obtained. GLP-1 could be derivatized with linear fatty acids up to the length of 16 carbon atoms, sometimes longer, almost anywhere in the C-terminal part without considerable loss of potency.  Derivatization with two fatty acid substituents led to a considerable loss of potency.  A structure-activity relationship on derivatization of specific amino acids generally was obtained.  It was found that the longer the fatty acid, the more potency was lost.  Simultaneous modification of the N-terminus (in order to obtain better metabolic stability) interfered with fatty acid derivatization and led to loss of potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_iyZt3E6tG7Vg90H21EOLACvtfcHk0lij9jm0NfwhNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVKksLg%253D&md5=d050c27dd6aea795191798254e2bf080</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm9909645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9909645%26sid%3Dliteratum%253Aachs%26aulast%3DKnudsen%26aufirst%3DL.%2BB.%26aulast%3DNielsen%26aufirst%3DP.%2BF.%26aulast%3DHuusfeldt%26aufirst%3DP.%2BO.%26aulast%3DJohansen%26aufirst%3DN.%2BL.%26aulast%3DMadsen%26aufirst%3DK.%26aulast%3DPedersen%26aufirst%3DF.%2BZ.%26aulast%3DThogersen%26aufirst%3DH.%26aulast%3DWilken%26aufirst%3DM.%26aulast%3DAgerso%26aufirst%3DH.%26atitle%3DPotent%2520derivatives%2520of%2520glucagon-like%2520peptide-1%2520with%2520pharmacokinetic%2520properties%2520suitable%2520for%2520once%2520daily%2520administration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1664%26epage%3D1669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Roehrl, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G.</span><span> </span><span class="NLM_article-title">A general framework for development and data analysis of competitive high-throughput screens for small-molecule inhibitors of protein-protein interactions by fluorescence polarization</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">16056</span><span class="NLM_x">–</span> <span class="NLM_lpage">16066</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi048233g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=16056-16066&author=M.+H.+Roehrlauthor=J.+Y.+Wangauthor=G.+Wagner&title=A+general+framework+for+development+and+data+analysis+of+competitive+high-throughput+screens+for+small-molecule+inhibitors+of+protein-protein+interactions+by+fluorescence+polarization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fbi048233g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi048233g%26sid%3Dliteratum%253Aachs%26aulast%3DRoehrl%26aufirst%3DM.%2BH.%26aulast%3DWang%26aufirst%3DJ.%2BY.%26aulast%3DWagner%26aufirst%3DG.%26atitle%3DA%2520general%2520framework%2520for%2520development%2520and%2520data%2520analysis%2520of%2520competitive%2520high-throughput%2520screens%2520for%2520small-molecule%2520inhibitors%2520of%2520protein-protein%2520interactions%2520by%2520fluorescence%2520polarization%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D16056%26epage%3D16066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 37 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Mengzhe Wang, Hui Wang, Crystal Q. Niu, Tao Zhang, Zhanhong Wu, <span class="NLM_string-name hlFld-ContribAuthor">Zibo Li</span>. </span><span class="cited-content_cbyCitation_article-title">Tetrazine-TCO Ligation: A Potential Simple Approach to Improve Tumor Uptake through Enhanced Blood Circulation. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2020,</strong> <em>31 </em>
                                    (7)
                                     , 1795-1803. <a href="https://doi.org/10.1021/acs.bioconjchem.0c00264" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.0c00264</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.0c00264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.0c00264%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DTetrazine-TCO%252BLigation%25253A%252BA%252BPotential%252BSimple%252BApproach%252Bto%252BImprove%252BTumor%252BUptake%252Bthrough%252BEnhanced%252BBlood%252BCirculation%26aulast%3DWang%26aufirst%3DMengzhe%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29042020%26date%3D03062020%26date%3D19062020%26date%3D03062020%26volume%3D31%26issue%3D7%26spage%3D1795%26epage%3D1803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Drew L. Sellers, James-Kevin Y. Tan, Julio Marco B. Pineda, David J. Peeler, Veronica L. Porubsky, Brynn R. Olden, Stephen J. Salipante, <span class="NLM_string-name hlFld-ContribAuthor">Suzie H. Pun</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Ligands Deliver Model Drug Cargo into the Central Nervous System along Autonomic Neurons. </span><span class="cited-content_cbyCitation_journal-name">ACS Nano</span><span> <strong>2019,</strong> <em>13 </em>
                                    (10)
                                     , 10961-10971. <a href="https://doi.org/10.1021/acsnano.9b01515" title="DOI URL">https://doi.org/10.1021/acsnano.9b01515</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsnano.9b01515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsnano.9b01515%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Nano%26atitle%3DTargeting%252BLigands%252BDeliver%252BModel%252BDrug%252BCargo%252Binto%252Bthe%252BCentral%252BNervous%252BSystem%252Balong%252BAutonomic%252BNeurons%26aulast%3DSellers%26aufirst%3DDrew%2BL.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D23022019%26date%3D17092019%26date%3D07102019%26volume%3D13%26issue%3D10%26spage%3D10961%26epage%3D10971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Alexander
A. Vinogradov, Yizhen Yin, <span class="NLM_string-name hlFld-ContribAuthor">Hiroaki Suga</span>. </span><span class="cited-content_cbyCitation_article-title">Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining Challenges. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (10)
                                     , 4167-4181. <a href="https://doi.org/10.1021/jacs.8b13178" title="DOI URL">https://doi.org/10.1021/jacs.8b13178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.8b13178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.8b13178%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DMacrocyclic%252BPeptides%252Bas%252BDrug%252BCandidates%25253A%252BRecent%252BProgress%252Band%252BRemaining%252BChallenges%26aulast%3DVinogradov%26aufirst%3DAlexander%2BA.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D10122018%26date%3D27022019%26date%3D15022019%26volume%3D141%26issue%3D10%26spage%3D4167%26epage%3D4181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaycie  Deyle</span>, <span class="hlFld-ContribAuthor ">Xu-Dong  Kong</span>, and <span class="hlFld-ContribAuthor ">Christian  Heinis</span>  . </span><span class="cited-content_cbyCitation_article-title">Phage Selection of Cyclic Peptides for Application in Research and Drug Development. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2017,</strong> <em>50 </em>
                                    (8)
                                     , 1866-1874. <a href="https://doi.org/10.1021/acs.accounts.7b00184" title="DOI URL">https://doi.org/10.1021/acs.accounts.7b00184</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.accounts.7b00184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.accounts.7b00184%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DPhage%252BSelection%252Bof%252BCyclic%252BPeptides%252Bfor%252BApplication%252Bin%252BResearch%252Band%252BDrug%252BDevelopment%26aulast%3DDeyle%26aufirst%3DKaycie%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D13042017%26date%3D18072017%26date%3D15082017%26volume%3D50%26issue%3D8%26spage%3D1866%26epage%3D1874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philipp M.  Cromm</span>, <span class="hlFld-ContribAuthor ">Jochen  Spiegel</span>, <span class="hlFld-ContribAuthor ">Philipp  Küchler</span>, <span class="hlFld-ContribAuthor ">Laura  Dietrich</span>, <span class="hlFld-ContribAuthor ">Julia  Kriegesmann</span>, <span class="hlFld-ContribAuthor ">Mathias  Wendt</span>, <span class="hlFld-ContribAuthor ">Roger S.  Goody</span>, <span class="hlFld-ContribAuthor ">Herbert  Waldmann</span>, and <span class="hlFld-ContribAuthor ">Tom N.  Grossmann</span>  . </span><span class="cited-content_cbyCitation_article-title">Protease-Resistant and Cell-Permeable Double-Stapled Peptides Targeting the Rab8a GTPase. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2016,</strong> <em>11 </em>
                                    (8)
                                     , 2375-2382. <a href="https://doi.org/10.1021/acschembio.6b00386" title="DOI URL">https://doi.org/10.1021/acschembio.6b00386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.6b00386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.6b00386%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DProtease-Resistant%252Band%252BCell-Permeable%252BDouble-Stapled%252BPeptides%252BTargeting%252Bthe%252BRab8a%252BGTPase%26aulast%3DCromm%26aufirst%3DPhilipp%2BM.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D04052016%26date%3D23062016%26date%3D11072016%26date%3D19082016%26date%3D23062016%26volume%3D11%26issue%3D8%26spage%3D2375%26epage%3D2382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vanessa  Baeriswyl</span>, <span class="hlFld-ContribAuthor ">Sara  Calzavarini</span>, <span class="hlFld-ContribAuthor ">Shiyu  Chen</span>, <span class="hlFld-ContribAuthor ">Alessandro  Zorzi</span>, <span class="hlFld-ContribAuthor ">Luca  Bologna</span>, <span class="hlFld-ContribAuthor ">Anne  Angelillo-Scherrer</span>, and <span class="hlFld-ContribAuthor ">Christian  Heinis</span>  . </span><span class="cited-content_cbyCitation_article-title">A Synthetic Factor XIIa Inhibitor Blocks Selectively Intrinsic Coagulation Initiation. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2015,</strong> <em>10 </em>
                                    (8)
                                     , 1861-1870. <a href="https://doi.org/10.1021/acschembio.5b00103" title="DOI URL">https://doi.org/10.1021/acschembio.5b00103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.5b00103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.5b00103%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DA%252BSynthetic%252BFactor%252BXIIa%252BInhibitor%252BBlocks%252BSelectively%252BIntrinsic%252BCoagulation%252BInitiation%26aulast%3DBaeriswyl%26aufirst%3DVanessa%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D17022015%26date%3D07052015%26date%3D19052015%26date%3D21082015%26volume%3D10%26issue%3D8%26spage%3D1861%26epage%3D1870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shiyu  Chen</span>, <span class="hlFld-ContribAuthor ">Inmaculada  Rentero Rebollo</span>, <span class="hlFld-ContribAuthor ">Sergey A.  Buth</span>, <span class="hlFld-ContribAuthor ">Julia  Morales-Sanfrutos</span>, <span class="hlFld-ContribAuthor ">Jeremy  Touati</span>, <span class="hlFld-ContribAuthor ">Petr G.  Leiman</span>, and <span class="hlFld-ContribAuthor ">Christian  Heinis</span>  . </span><span class="cited-content_cbyCitation_article-title">Bicyclic Peptide Ligands Pulled out of Cysteine-Rich Peptide Libraries. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2013,</strong> <em>135 </em>
                                    (17)
                                     , 6562-6569. <a href="https://doi.org/10.1021/ja400461h" title="DOI URL">https://doi.org/10.1021/ja400461h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja400461h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja400461h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DBicyclic%252BPeptide%252BLigands%252BPulled%252Bout%252Bof%252BCysteine-Rich%252BPeptide%252BLibraries%26aulast%3DChen%26aufirst%3DShiyu%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D24012013%26date%3D17042013%26date%3D01052013%26date%3D05042013%26volume%3D135%26issue%3D17%26spage%3D6562%26epage%3D6569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takahiro  Ishizawa</span>, <span class="hlFld-ContribAuthor ">Takashi  Kawakami</span>, <span class="hlFld-ContribAuthor ">Patrick C.  Reid</span>, and <span class="hlFld-ContribAuthor ">Hiroshi  Murakami</span>  . </span><span class="cited-content_cbyCitation_article-title">TRAP Display: A High-Speed Selection Method for the Generation of Functional Polypeptides. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2013,</strong> <em>135 </em>
                                    (14)
                                     , 5433-5440. <a href="https://doi.org/10.1021/ja312579u" title="DOI URL">https://doi.org/10.1021/ja312579u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja312579u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja312579u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DTRAP%252BDisplay%25253A%252BA%252BHigh-Speed%252BSelection%252BMethod%252Bfor%252Bthe%252BGeneration%252Bof%252BFunctional%252BPolypeptides%26aulast%3DIshizawa%26aufirst%3DTakahiro%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D25122012%26date%3D29032013%26date%3D10042013%26date%3D18032013%26volume%3D135%26issue%3D14%26spage%3D5433%26epage%3D5440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Outlook. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 213-222. <a href="https://doi.org/10.1002/9783527343430.ch8" title="DOI URL">https://doi.org/10.1002/9783527343430.ch8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527343430.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527343430.ch8%26sid%3Dliteratum%253Aachs%26atitle%3DOutlook%26date%3D2021%26date%3D2021%26spage%3D213%26epage%3D222%26pub%3DWiley%26atitle%3DCyclized%252BHelical%252BPeptides%26aulast%3DLi%26aufirst%3DZigang%26date%3D2021%26date%3D2021%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zachary R.  Crook</span>, <span class="hlFld-ContribAuthor ">Natalie W.  Nairn</span>, <span class="hlFld-ContribAuthor ">James M.  Olson</span>. </span><span class="cited-content_cbyCitation_article-title">Miniproteins as a Powerful Modality in Drug Development. </span><span class="cited-content_cbyCitation_journal-name">Trends in Biochemical Sciences</span><span> <strong>2020,</strong> <em>45 </em>
                                    (4)
                                     , 332-346. <a href="https://doi.org/10.1016/j.tibs.2019.12.008" title="DOI URL">https://doi.org/10.1016/j.tibs.2019.12.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tibs.2019.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tibs.2019.12.008%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Biochemical%2520Sciences%26atitle%3DMiniproteins%252Bas%252Ba%252BPowerful%252BModality%252Bin%252BDrug%252BDevelopment%26aulast%3DCrook%26aufirst%3DZachary%2BR.%26date%3D2020%26volume%3D45%26issue%3D4%26spage%3D332%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongzhuo  Huang</span>, <span class="hlFld-ContribAuthor ">Jianqing  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Introduction to biomimetic therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Biomaterials Science</span><span> <strong>2020,</strong> <em>8 </em>
                                    (4)
                                     , 1017-1019. <a href="https://doi.org/10.1039/D0BM90007A" title="DOI URL">https://doi.org/10.1039/D0BM90007A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0BM90007A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0BM90007A%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomaterials%2520Science%26atitle%3DIntroduction%252Bto%252Bbiomimetic%252Btherapeutics%26aulast%3DHuang%26aufirst%3DYongzhuo%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D4%26spage%3D1017%26epage%3D1019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Advaita  Ganguly</span>, <span class="hlFld-ContribAuthor ">Kumakshi  Sharma</span>, <span class="hlFld-ContribAuthor ">Kaustav  Majumder</span>. </span><span class="cited-content_cbyCitation_article-title">Peptides as biopolymers—past, present, and future. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 87-104. <a href="https://doi.org/10.1016/B978-0-12-816897-4.00004-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-816897-4.00004-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816897-4.00004-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816897-4.00004-7%26sid%3Dliteratum%253Aachs%26atitle%3DPeptides%252Bas%252Bbiopolymers%2525E2%252580%252594past%25252C%252Bpresent%25252C%252Band%252Bfuture%26aulast%3DGanguly%26aufirst%3DAdvaita%26date%3D2020%26spage%3D87%26epage%3D104%26pub%3DElsevier%26atitle%3DBiopolymer-Based%252BFormulations%26date%3D2020%26volume%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mochamad Zakki  Fahmi</span>, <span class="hlFld-ContribAuthor ">Denika Liyan Nor  Wibowo</span>, <span class="hlFld-ContribAuthor ">Satya Candra Wibawa  Sakti</span>, <span class="hlFld-ContribAuthor ">Hwei Voon  Lee</span>, <span class="hlFld-ContribAuthor ">Isnaeni</span>. </span><span class="cited-content_cbyCitation_article-title">Human serum albumin capsulated hydrophobic carbon nanodots as staining agent on HeLa tumor cell. </span><span class="cited-content_cbyCitation_journal-name">Materials Chemistry and Physics</span><span> <strong>2020,</strong> <em>239 </em>, 122266. <a href="https://doi.org/10.1016/j.matchemphys.2019.122266" title="DOI URL">https://doi.org/10.1016/j.matchemphys.2019.122266</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.matchemphys.2019.122266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.matchemphys.2019.122266%26sid%3Dliteratum%253Aachs%26jtitle%3DMaterials%2520Chemistry%2520and%2520Physics%26atitle%3DHuman%252Bserum%252Balbumin%252Bcapsulated%252Bhydrophobic%252Bcarbon%252Bnanodots%252Bas%252Bstaining%252Bagent%252Bon%252BHeLa%252Btumor%252Bcell%26aulast%3DFahmi%26aufirst%3DMochamad%2BZakki%26date%3D2020%26volume%3D239%26spage%3D122266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Zorzi</span>, <span class="hlFld-ContribAuthor ">Sara  Linciano</span>, <span class="hlFld-ContribAuthor ">Alessandro  Angelini</span>. </span><span class="cited-content_cbyCitation_article-title">Non-covalent albumin-binding ligands for extending the circulating half-life of small biotherapeutics. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2019,</strong> <em>10 </em>
                                    (7)
                                     , 1068-1081. <a href="https://doi.org/10.1039/C9MD00018F" title="DOI URL">https://doi.org/10.1039/C9MD00018F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00018F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00018F%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DNon-covalent%252Balbumin-binding%252Bligands%252Bfor%252Bextending%252Bthe%252Bcirculating%252Bhalf-life%252Bof%252Bsmall%252Bbiotherapeutics%26aulast%3DZorzi%26aufirst%3DAlessandro%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D7%26spage%3D1068%26epage%3D1081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vanessa P.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Loganathan  Palanikumar</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Kennel</span>, <span class="hlFld-ContribAuthor ">Daiane S.  Alves</span>, <span class="hlFld-ContribAuthor ">Yujie  Ye</span>, <span class="hlFld-ContribAuthor ">Jonathan S.  Wall</span>, <span class="hlFld-ContribAuthor ">Mazin  Magzoub</span>, <span class="hlFld-ContribAuthor ">Francisco N.  Barrera</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic insights into the pH-dependent membrane peptide ATRAM. </span><span class="cited-content_cbyCitation_journal-name">Journal of Controlled Release</span><span> <strong>2019,</strong> <em>298 </em>, 142-153. <a href="https://doi.org/10.1016/j.jconrel.2019.02.010" title="DOI URL">https://doi.org/10.1016/j.jconrel.2019.02.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jconrel.2019.02.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jconrel.2019.02.010%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Controlled%2520Release%26atitle%3DMechanistic%252Binsights%252Binto%252Bthe%252BpH-dependent%252Bmembrane%252Bpeptide%252BATRAM%26aulast%3DNguyen%26aufirst%3DVanessa%2BP.%26date%3D2019%26volume%3D298%26spage%3D142%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhavesh  Khatri</span>, <span class="hlFld-ContribAuthor ">Venkateswara Rao  Nuthakki</span>, <span class="hlFld-ContribAuthor ">Jayanta  Chatterjee</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies to Enhance Metabolic Stabilities. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 17-40. <a href="https://doi.org/10.1007/978-1-4939-9504-2_2" title="DOI URL">https://doi.org/10.1007/978-1-4939-9504-2_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-9504-2_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-9504-2_2%26sid%3Dliteratum%253Aachs%26atitle%3DStrategies%252Bto%252BEnhance%252BMetabolic%252BStabilities%26aulast%3DKhatri%26aufirst%3DBhavesh%26date%3D2019%26date%3D2019%26spage%3D17%26epage%3D40%26pub%3DSpringer%2520New%2520York%26atitle%3DCyclic%252BPeptide%252BDesign%26aulast%3DGoetz%26aufirst%3DGilles%26date%3D2019%26volume%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siddhartha  Roy</span>, <span class="hlFld-ContribAuthor ">Piya  Ghosh</span>, <span class="hlFld-ContribAuthor ">Israr  Ahmed</span>, <span class="hlFld-ContribAuthor ">Madhumita  Chakraborty</span>, <span class="hlFld-ContribAuthor ">Gitashri  Naiya</span>, <span class="hlFld-ContribAuthor ">Basusree  Ghosh</span>. </span><span class="cited-content_cbyCitation_article-title">Constrained α-Helical Peptides as Inhibitors of Protein-Protein and Protein-DNA Interactions. </span><span class="cited-content_cbyCitation_journal-name">Biomedicines</span><span> <strong>2018,</strong> <em>6 </em>
                                    (4)
                                     , 118. <a href="https://doi.org/10.3390/biomedicines6040118" title="DOI URL">https://doi.org/10.3390/biomedicines6040118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biomedicines6040118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiomedicines6040118%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicines%26atitle%3DConstrained%252B%2525CE%2525B1-Helical%252BPeptides%252Bas%252BInhibitors%252Bof%252BProtein-Protein%252Band%252BProtein-DNA%252BInteractions%26aulast%3DRoy%26aufirst%3DSiddhartha%26date%3D2018%26date%3D2018%26volume%3D6%26issue%3D4%26spage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rhiannon  Beard</span>, <span class="hlFld-ContribAuthor ">Andy  Stucki</span>, <span class="hlFld-ContribAuthor ">Muriel  Schmitt</span>, <span class="hlFld-ContribAuthor ">Gabrielle  Py</span>, <span class="hlFld-ContribAuthor ">Christophe  Grundschober</span>, <span class="hlFld-ContribAuthor ">Antony D.  Gee</span>, <span class="hlFld-ContribAuthor ">Edward W.  Tate</span>. </span><span class="cited-content_cbyCitation_article-title">Building bridges for highly selective, potent and stable oxytocin and vasopressin analogs. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (11)
                                     , 3039-3045. <a href="https://doi.org/10.1016/j.bmc.2018.03.019" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.03.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.03.019%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DBuilding%252Bbridges%252Bfor%252Bhighly%252Bselective%25252C%252Bpotent%252Band%252Bstable%252Boxytocin%252Band%252Bvasopressin%252Banalogs%26aulast%3DBeard%26aufirst%3DRhiannon%26date%3D2018%26volume%3D26%26issue%3D11%26spage%3D3039%26epage%3D3045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P. A.  Slominskiĭ</span>, <span class="hlFld-ContribAuthor ">M. I.  Shadrina</span>. </span><span class="cited-content_cbyCitation_article-title">Peptide pharmaceuticals: opportunities, prospects and limitations. </span><span class="cited-content_cbyCitation_journal-name">Molecular Genetics Microbiology and Virology (Russian version)</span><span> <strong>2018,</strong> <em>36 </em>
                                    (1)
                                     , 8. <a href="https://doi.org/10.18821/0208-0613-2018-36-1-8-14" title="DOI URL">https://doi.org/10.18821/0208-0613-2018-36-1-8-14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18821/0208-0613-2018-36-1-8-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18821%2F0208-0613-2018-36-1-8-14%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Genetics%2520Microbiology%2520and%2520Virology%2520%2528Russian%2520version%2529%26atitle%3DPeptide%252Bpharmaceuticals%25253A%252Bopportunities%25252C%252Bprospects%252Band%252Blimitations%26aulast%3DSlominski%25C4%25AD%26aufirst%3DP.%2BA.%26date%3D2018%26volume%3D36%26issue%3D1%26spage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P. A.  Slominsky</span>, <span class="hlFld-ContribAuthor ">M. I.  Shadrina</span>. </span><span class="cited-content_cbyCitation_article-title">Peptide Pharmaceuticals: Opportunities, Prospects, and Limitations. </span><span class="cited-content_cbyCitation_journal-name">Molecular Genetics, Microbiology and Virology</span><span> <strong>2018,</strong> <em>33 </em>
                                    (1)
                                     , 8-14. <a href="https://doi.org/10.3103/S0891416818010123" title="DOI URL">https://doi.org/10.3103/S0891416818010123</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3103/S0891416818010123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3103%2FS0891416818010123%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Genetics%252C%2520Microbiology%2520and%2520Virology%26atitle%3DPeptide%252BPharmaceuticals%25253A%252BOpportunities%25252C%252BProspects%25252C%252Band%252BLimitations%26aulast%3DSlominsky%26aufirst%3DP.%2BA.%26date%3D2018%26date%3D2018%26volume%3D33%26issue%3D1%26spage%3D8%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Zorzi</span>, <span class="hlFld-ContribAuthor ">Simon J.  Middendorp</span>, <span class="hlFld-ContribAuthor ">Jonas  Wilbs</span>, <span class="hlFld-ContribAuthor ">Kaycie  Deyle</span>, <span class="hlFld-ContribAuthor ">Christian  Heinis</span>. </span><span class="cited-content_cbyCitation_article-title">Acylated heptapeptide binds albumin with high affinity and application as tag furnishes long-acting peptides. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2017,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/ncomms16092" title="DOI URL">https://doi.org/10.1038/ncomms16092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/ncomms16092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fncomms16092%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DAcylated%252Bheptapeptide%252Bbinds%252Balbumin%252Bwith%252Bhigh%252Baffinity%252Band%252Bapplication%252Bas%252Btag%252Bfurnishes%252Blong-acting%252Bpeptides%26aulast%3DZorzi%26aufirst%3DAlessandro%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca  Vitali</span>, <span class="hlFld-ContribAuthor ">Rudi  Fasan</span>. </span><span class="cited-content_cbyCitation_article-title">Biological and Hybrid Biological/Chemical Strategies in Diversity Generation of Peptidic Macrocycles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 155-184. <a href="https://doi.org/10.1002/9781119092599.ch7" title="DOI URL">https://doi.org/10.1002/9781119092599.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119092599.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119092599.ch7%26sid%3Dliteratum%253Aachs%26atitle%3DBiological%252Band%252BHybrid%252BBiological%25252FChemical%252BStrategies%252Bin%252BDiversity%252BGeneration%252Bof%252BPeptidic%252BMacrocycles%26aulast%3DVitali%26aufirst%3DFrancesca%26date%3D2017%26date%3D2017%26spage%3D155%26epage%3D184%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPractical%252BMedicinal%252BChemistry%252Bwith%252BMacrocycles%26aulast%3DMarsault%26aufirst%3DEric%26date%3D2017%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Teresa A. F.  Cardote</span>, <span class="hlFld-ContribAuthor ">Alessio  Ciulli</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclic and Macrocyclic Peptides as Chemical Tools To Recognise Protein Surfaces and Probe Protein-Protein Interactions. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (8)
                                     , 787-794. <a href="https://doi.org/10.1002/cmdc.201500450" title="DOI URL">https://doi.org/10.1002/cmdc.201500450</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500450%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DCyclic%252Band%252BMacrocyclic%252BPeptides%252Bas%252BChemical%252BTools%252BTo%252BRecognise%252BProtein%252BSurfaces%252Band%252BProbe%252BProtein-Protein%252BInteractions%26aulast%3DCardote%26aufirst%3DTeresa%2BA.%2BF.%26date%3D2016%26date%3D2015%26volume%3D11%26issue%3D8%26spage%3D787%26epage%3D794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ewa D.  Micewicz</span>, <span class="hlFld-ContribAuthor ">Shantanu  Sharma</span>, <span class="hlFld-ContribAuthor ">Alan J.  Waring</span>, <span class="hlFld-ContribAuthor ">Hai T.  Luong</span>, <span class="hlFld-ContribAuthor ">William H.  McBride</span>, <span class="hlFld-ContribAuthor ">Piotr  Ruchala</span>. </span><span class="cited-content_cbyCitation_article-title">Bridged Analogues for p53-Dependent Cancer Therapy Obtained by S-Alkylation. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Peptide Research and Therapeutics</span><span> <strong>2016,</strong> <em>22 </em>
                                    (1)
                                     , 67-81. <a href="https://doi.org/10.1007/s10989-015-9487-3" title="DOI URL">https://doi.org/10.1007/s10989-015-9487-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10989-015-9487-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10989-015-9487-3%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Peptide%2520Research%2520and%2520Therapeutics%26atitle%3DBridged%252BAnalogues%252Bfor%252Bp53-Dependent%252BCancer%252BTherapy%252BObtained%252Bby%252BS-Alkylation%26aulast%3DMicewicz%26aufirst%3DEwa%2BD.%26date%3D2016%26date%3D2015%26volume%3D22%26issue%3D1%26spage%3D67%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Smita B.  Gunnoo</span>, <span class="hlFld-ContribAuthor ">Annemieke  Madder</span>. </span><span class="cited-content_cbyCitation_article-title">Bioconjugation – using selective chemistry to enhance the properties of proteins and peptides as therapeutics and carriers. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (34)
                                     , 8002-8013. <a href="https://doi.org/10.1039/C6OB00808A" title="DOI URL">https://doi.org/10.1039/C6OB00808A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB00808A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB00808A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DBioconjugation%252B%2525E2%252580%252593%252Busing%252Bselective%252Bchemistry%252Bto%252Benhance%252Bthe%252Bproperties%252Bof%252Bproteins%252Band%252Bpeptides%252Bas%252Btherapeutics%252Band%252Bcarriers%26aulast%3DGunnoo%26aufirst%3DSmita%2BB.%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D34%26spage%3D8002%26epage%3D8013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kristine  Chua</span>, <span class="hlFld-ContribAuthor ">Eileen  Fung</span>, <span class="hlFld-ContribAuthor ">Ewa D.  Micewicz</span>, <span class="hlFld-ContribAuthor ">Tomas  Ganz</span>, <span class="hlFld-ContribAuthor ">Elizabeta  Nemeth</span>, <span class="hlFld-ContribAuthor ">Piotr  Ruchala</span>. </span><span class="cited-content_cbyCitation_article-title">Small cyclic agonists of iron regulatory hormone hepcidin. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (21)
                                     , 4961-4969. <a href="https://doi.org/10.1016/j.bmcl.2015.03.012" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.03.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.03.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSmall%252Bcyclic%252Bagonists%252Bof%252Biron%252Bregulatory%252Bhormone%252Bhepcidin%26aulast%3DChua%26aufirst%3DKristine%26date%3D2015%26volume%3D25%26issue%3D21%26spage%3D4961%26epage%3D4969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rodrigo  Vazquez-Lombardi</span>, <span class="hlFld-ContribAuthor ">Tri Giang  Phan</span>, <span class="hlFld-ContribAuthor ">Carsten  Zimmermann</span>, <span class="hlFld-ContribAuthor ">David  Lowe</span>, <span class="hlFld-ContribAuthor ">Lutz  Jermutus</span>, <span class="hlFld-ContribAuthor ">Daniel  Christ</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges and opportunities for non-antibody scaffold drugs. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2015,</strong> <em>20 </em>
                                    (10)
                                     , 1271-1283. <a href="https://doi.org/10.1016/j.drudis.2015.09.004" title="DOI URL">https://doi.org/10.1016/j.drudis.2015.09.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2015.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2015.09.004%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DChallenges%252Band%252Bopportunities%252Bfor%252Bnon-antibody%252Bscaffold%252Bdrugs%26aulast%3DVazquez-Lombardi%26aufirst%3DRodrigo%26date%3D2015%26volume%3D20%26issue%3D10%26spage%3D1271%26epage%3D1283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Heinis</span>, <span class="hlFld-ContribAuthor ">Greg  Winter</span>. </span><span class="cited-content_cbyCitation_article-title">Encoded libraries of chemically modified peptides. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2015,</strong> <em>26 </em>, 89-98. <a href="https://doi.org/10.1016/j.cbpa.2015.02.008" title="DOI URL">https://doi.org/10.1016/j.cbpa.2015.02.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2015.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2015.02.008%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DEncoded%252Blibraries%252Bof%252Bchemically%252Bmodified%252Bpeptides%26aulast%3DHeinis%26aufirst%3DChristian%26date%3D2015%26volume%3D26%26spage%3D89%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Darrell  Sleep</span>. </span><span class="cited-content_cbyCitation_article-title">Albumin and its application in drug delivery. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Delivery</span><span> <strong>2015,</strong> <em>12 </em>
                                    (5)
                                     , 793-812. <a href="https://doi.org/10.1517/17425247.2015.993313" title="DOI URL">https://doi.org/10.1517/17425247.2015.993313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17425247.2015.993313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17425247.2015.993313%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Delivery%26atitle%3DAlbumin%252Band%252Bits%252Bapplication%252Bin%252Bdrug%252Bdelivery%26aulast%3DSleep%26aufirst%3DDarrell%26date%3D2015%26date%3D2014%26volume%3D12%26issue%3D5%26spage%3D793%26epage%3D812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natia  Tsomaia</span>. </span><span class="cited-content_cbyCitation_article-title">Peptide therapeutics: Targeting the undruggable space. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>94 </em>, 459-470. <a href="https://doi.org/10.1016/j.ejmech.2015.01.014" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.01.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.01.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.01.014%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPeptide%252Btherapeutics%25253A%252BTargeting%252Bthe%252Bundruggable%252Bspace%26aulast%3DTsomaia%26aufirst%3DNatia%26date%3D2015%26volume%3D94%26spage%3D459%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisa  Pollaro</span>, <span class="hlFld-ContribAuthor ">Sandeep  Raghunathan</span>, <span class="hlFld-ContribAuthor ">Julia  Morales-Sanfrutos</span>, <span class="hlFld-ContribAuthor ">Alessandro  Angelini</span>, <span class="hlFld-ContribAuthor ">Stephan  Kontos</span>, <span class="hlFld-ContribAuthor ">Christian  Heinis</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic Peptides Conjugated to an Albumin-Binding Tag Diffuse Efficiently into Solid Tumors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2015,</strong> <em>14 </em>
                                    (1)
                                     , 151-161. <a href="https://doi.org/10.1158/1535-7163.MCT-14-0534" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-14-0534</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-14-0534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-14-0534%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DBicyclic%252BPeptides%252BConjugated%252Bto%252Ban%252BAlbumin-Binding%252BTag%252BDiffuse%252BEfficiently%252Binto%252BSolid%252BTumors%26aulast%3DPollaro%26aufirst%3DLisa%26date%3D2015%26date%3D2014%26volume%3D14%26issue%3D1%26spage%3D151%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Di</span>. </span><span class="cited-content_cbyCitation_article-title">Strategic Approaches to Optimizing Peptide ADME Properties. </span><span class="cited-content_cbyCitation_journal-name">The AAPS Journal</span><span> <strong>2015,</strong> <em>17 </em>
                                    (1)
                                     , 134-143. <a href="https://doi.org/10.1208/s12248-014-9687-3" title="DOI URL">https://doi.org/10.1208/s12248-014-9687-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1208/s12248-014-9687-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1208%2Fs12248-014-9687-3%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520AAPS%2520Journal%26atitle%3DStrategic%252BApproaches%252Bto%252BOptimizing%252BPeptide%252BADME%252BProperties%26aulast%3DDi%26aufirst%3DLi%26date%3D2015%26date%3D2014%26volume%3D17%26issue%3D1%26spage%3D134%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mochamad Zakki  Fahmi</span>, <span class="hlFld-ContribAuthor ">Keng-Liang  Ou</span>, <span class="hlFld-ContribAuthor ">Jem-Kun  Chen</span>, <span class="hlFld-ContribAuthor ">Ming-Hua  Ho</span>, <span class="hlFld-ContribAuthor ">Shin-Hwa  Tzing</span>, <span class="hlFld-ContribAuthor ">Jia-Yaw  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Development of bovine serum albumin-modified hybrid nanoclusters for magnetofluorescence imaging and drug delivery. </span><span class="cited-content_cbyCitation_journal-name">RSC Adv.</span><span> <strong>2014,</strong> <em>4 </em>
                                    (62)
                                     , 32762-32772. <a href="https://doi.org/10.1039/C4RA05785F" title="DOI URL">https://doi.org/10.1039/C4RA05785F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA05785F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA05785F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Adv.%26atitle%3DDevelopment%252Bof%252Bbovine%252Bserum%252Balbumin-modified%252Bhybrid%252Bnanoclusters%252Bfor%252Bmagnetofluorescence%252Bimaging%252Band%252Bdrug%252Bdelivery%26aulast%3DFahmi%26aufirst%3DMochamad%2BZakki%26date%3D2014%26date%3D2014%26volume%3D4%26issue%3D62%26spage%3D32762%26epage%3D32772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nir  London</span>, <span class="hlFld-ContribAuthor ">Barak  Raveh</span>, <span class="hlFld-ContribAuthor ">Ora  Schueler-Furman</span>. </span><span class="cited-content_cbyCitation_article-title">Druggable protein–protein interactions – from hot spots to hot segments. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2013,</strong> <em>17 </em>
                                    (6)
                                     , 952-959. <a href="https://doi.org/10.1016/j.cbpa.2013.10.011" title="DOI URL">https://doi.org/10.1016/j.cbpa.2013.10.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2013.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2013.10.011%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DDruggable%252Bprotein%2525E2%252580%252593protein%252Binteractions%252B%2525E2%252580%252593%252Bfrom%252Bhot%252Bspots%252Bto%252Bhot%252Bsegments%26aulast%3DLondon%26aufirst%3DNir%26date%3D2013%26volume%3D17%26issue%3D6%26spage%3D952%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Allan A.  Kaspar</span>, <span class="hlFld-ContribAuthor ">Janice M.  Reichert</span>. </span><span class="cited-content_cbyCitation_article-title">Future directions for peptide therapeutics development. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2013,</strong> <em>18 </em>
                                    (17-18)
                                     , 807-817. <a href="https://doi.org/10.1016/j.drudis.2013.05.011" title="DOI URL">https://doi.org/10.1016/j.drudis.2013.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2013.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2013.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DFuture%252Bdirections%252Bfor%252Bpeptide%252Btherapeutics%252Bdevelopment%26aulast%3DKaspar%26aufirst%3DAllan%2BA.%26date%3D2013%26volume%3D18%26issue%3D17-18%26spage%3D807%26epage%3D817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shiyu  Chen</span>, <span class="hlFld-ContribAuthor ">David  Gfeller</span>, <span class="hlFld-ContribAuthor ">Sergey A.  Buth</span>, <span class="hlFld-ContribAuthor ">Olivier  Michielin</span>, <span class="hlFld-ContribAuthor ">Petr G.  Leiman</span>, <span class="hlFld-ContribAuthor ">Christian  Heinis</span>. </span><span class="cited-content_cbyCitation_article-title">Improving Binding Affinity and Stability of Peptide Ligands by Substituting Glycines with
              D
              -Amino Acids. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2013,</strong> <em>14 </em>
                                    (11)
                                     , 1316-1322. <a href="https://doi.org/10.1002/cbic.201300228" title="DOI URL">https://doi.org/10.1002/cbic.201300228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.201300228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.201300228%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DImproving%252BBinding%252BAffinity%252Band%252BStability%252Bof%252BPeptide%252BLigands%252Bby%252BSubstituting%252BGlycines%252Bwith%252BD%252B-Amino%252BAcids%26aulast%3DChen%26aufirst%3DShiyu%26date%3D2013%26date%3D2013%26volume%3D14%26issue%3D11%26spage%3D1316%26epage%3D1322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vanessa  Baeriswyl</span>, <span class="hlFld-ContribAuthor ">Christian  Heinis</span>. </span><span class="cited-content_cbyCitation_article-title">Polycyclic Peptide Therapeutics. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2013,</strong> <em>8 </em>
                                    (3)
                                     , 377-384. <a href="https://doi.org/10.1002/cmdc.201200513" title="DOI URL">https://doi.org/10.1002/cmdc.201200513</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201200513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201200513%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DPolycyclic%252BPeptide%252BTherapeutics%26aulast%3DBaeriswyl%26aufirst%3DVanessa%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D3%26spage%3D377%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/medium/jm-2012-01276e_0002.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301276e&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/medium/jm-2012-01276e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Stability of different peptide formats. (A) Schematic drawing of bicyclic peptide <b>1</b>, monocylic peptide <b>2</b>, and linear peptide <b>3</b>. (B) Chromatographic analysis of peptides incubated in mouse plasma for 0, 24, and 48 h at a concentration of 50 μM and 37 °C. Samples were analyzed by reversed-phase chromatography (RP-HPLC) using a C8 column and absorption measured at a wavelength of 220 nm. (C) Masses of peptides detected by ESI mass spectrometry in the indicated peaks of the RP-HPLC chromatograms. The peptides and peptide fragments that potentially correspond to the masses are schematically depicted. (D) The relative amounts of peptide and peptide fragments were quantified by integrating the peak area in the RP-HPLC chromatograms and are represented in a bar diagram. The relative amount of intact or marginally modified peptide is shown in black, and that of massively degraded peptide is shown in white.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301276e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/medium/jm-2012-01276e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Stability of the two individual peptide rings of <b>1</b>. (A) Schematic drawing of the N- and C-terminal peptide rings <b>4</b> and <b>5</b>. (B) Chromatographic analysis of peptides incubated in mouse plasma for 0, 24, and 48 h at a concentration of 50 μM and 37 °C. Samples were analyzed by reversed-phase chromatography (RP-HPLC) using a C8 column and absorption measured at a wavelength of 220 nm. (C) Masses of peptides detected by ESI mass spectrometry in the indicated peaks of the RP-HPLC chromatograms. The peptides and peptide fragments that potentially correspond to the masses are schematically depicted. (D) The relative amounts of the intact monocyclic peptides and degradation products were quantified by integrating the peak area in the RP-HPLC chromatograms and are represented in a bar diagram. The relative amount of intact cyclic peptide is shown in black, and the different degradation products are shown in gray and white.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301276e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/medium/jm-2012-01276e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0007.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Schematic drawing of <b>8</b> (A) and <b>13</b> (B). Key chemical structures such as the mesitylene linker in the bicyclic peptide, the disulfide bridge in the albumin binding peptide <b>9</b>, the triazole linker, and the fluorescein (highlighted in green) are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301276e&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/medium/jm-2012-01276e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0006.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Pharmacokinetic parameters of <b>8</b> and <b>13</b> in mice. Compounds <b>8</b> and <b>13</b> were applied intravenously (200 μL of 50 μM; around 25 μg of <b>8</b> and 50 μg of <b>13</b>), blood samples were taken at the indicated time points, and the concentration of conjugate was measured by reversed-phase UFLC (A) and ELISA (B). The indicated values are averages of at least two mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301276e&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/medium/jm-2012-01276e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Binding and inhibitory activity of <b>13</b>. Binding of <b>13</b> to hSA (A), mSA (B), and human uPA (C) was determined by fluorescence polarization. (D) Inhibition of human uPA in the presence of casein only (0.1% w/v) or casein (0.1% w/v) and 1.5 μM hSA or 1.5 μM mSA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301276e&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/medium/jm-2012-01276e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Stability of bicyclic peptide ex vivo and in vivo. (A) Compound <b>13</b> incubated in mouse plasma ex vivo was analyzed by reversed-phase chromatography (RP-HPLC) using a C8 column, and absorption was measured at a wavelength of 220 nm. Compound <b>13</b> (indicated with “a”) eluted immediately prior to a broad peak of multiple plasma components (see also Figure S9 in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). (B) Compound <b>13</b> injected into the tail vein of mice, and blood samples were taken after the indicated time points and analyzed by reversed-phase UFLC using a C8 column and fluorescence detection (excitation at 490 nm and emission at 525 nm). Fluorescence monitoring required a buffer system with neutral pH resulting in a broad and asymmetric peak for <b>13</b>. Components of plasma did not show fluorescence (first chromatogram). (C) Mass spectra of peaks eluting at between 10 and 11 min in the UFLC chromatogram shown in B. The detected mass corresponded to intact <b>13</b> (<i>M</i><sub>r</sub> = 5097 Da).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-22/jm301276e/production/images/large/jm-2012-01276e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301276e&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24030" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24030" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 33 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Werle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernkop-Schnurch, A.</span><span> </span><span class="NLM_article-title">Strategies to improve plasma half life time of peptide and protein drugs</span> <span class="citation_source-journal">Amino Acids</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1007%2Fs00726-005-0289-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=16622600" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD28Xls1egsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2006&pages=351-367&author=M.+Werleauthor=A.+Bernkop-Schnurch&title=Strategies+to+improve+plasma+half+life+time+of+peptide+and+protein+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies to improve plasma half life time of peptide and protein drugs</span></div><div class="casAuthors">Werle, M.; Bernkop-Schnuerch, A.</div><div class="citationInfo"><span class="NLM_cas:title">Amino Acids</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">351-367</span>CODEN:
                <span class="NLM_cas:coden">AACIE6</span>;
        ISSN:<span class="NLM_cas:issn">0939-4451</span>.
    
            (<span class="NLM_cas:orgname">Springer Wien</span>)
        </div><div class="casAbstract">A review.  Due to the obvious advantages of long-acting peptide and protein drugs, strategies to prolong blood plasma half life time of such compds. are highly on demand.  Short plasma half life times are commonly due to fast renal clearance as well as to enzymic degrdn. occurring during systemic circulation.  Modifications of the peptide/protein can lead to prolonged plasma half life times.  By shortening the overall amino acid amt. of somatostatin and replacing L-analog amino acids with D-amino acids, plasma half life time of the derivate octreotide was 1.5 h in comparison to only few minutes of somatostatin.  A PEG2,40K conjugate of INF-α-2b exhibited a 330-fold prolonged plasma half life time compared to the native protein.  It was the aim of this review to provide an overview of possible strategies to prolong plasma half life time such as modification of N- and C-terminus or PEGylation as well as methods to evaluate the effectiveness of drug modifications.  Furthermore, fundamental data about most important proteolytic enzymes of human blood, liver, and kidney as well as their cleavage specificity and inhibitors for them are provided to predict enzymic cleavage of peptide and protein drugs during systemic circulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovVKc2VODC97Vg90H21EOLACvtfcHk0lh6aFPN730OTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xls1egsrw%253D&md5=2e286c53028f38cfe33deef26bb160d0</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs00726-005-0289-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-005-0289-3%26sid%3Dliteratum%253Aachs%26aulast%3DWerle%26aufirst%3DM.%26aulast%3DBernkop-Schnurch%26aufirst%3DA.%26atitle%3DStrategies%2520to%2520improve%2520plasma%2520half%2520life%2520time%2520of%2520peptide%2520and%2520protein%2520drugs%26jtitle%3DAmino%2520Acids%26date%3D2006%26volume%3D30%26spage%3D351%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Pollaro, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diderich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angelini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellotto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinis, C.</span><span> </span><span class="NLM_article-title">Measuring net protease activities in biological samples using selective peptidic inhibitors</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">427</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=427&publication_year=2012&pages=18-20&author=L.+Pollaroauthor=P.+Diderichauthor=A.+Angeliniauthor=S.+Bellottoauthor=H.+Wegnerauthor=C.+Heinis&title=Measuring+net+protease+activities+in+biological+samples+using+selective+peptidic+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPollaro%26aufirst%3DL.%26aulast%3DDiderich%26aufirst%3DP.%26aulast%3DAngelini%26aufirst%3DA.%26aulast%3DBellotto%26aufirst%3DS.%26aulast%3DWegner%26aufirst%3DH.%26aulast%3DHeinis%26aufirst%3DC.%26atitle%3DMeasuring%2520net%2520protease%2520activities%2520in%2520biological%2520samples%2520using%2520selective%2520peptidic%2520inhibitors%26jtitle%3DAnal.%2520Biochem.%26date%3D2012%26volume%3D427%26spage%3D18%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Kontermann, R. E.</span><span> </span><span class="NLM_article-title">Strategies for extended serum half-life of protein therapeutics</span> <span class="citation_source-journal">Curr. Opin. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">868</span><span class="NLM_x">–</span> <span class="NLM_lpage">876</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1016%2Fj.copbio.2011.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=21862310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOhtLfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=868-876&author=R.+E.+Kontermann&title=Strategies+for+extended+serum+half-life+of+protein+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for extended serum half-life of protein therapeutics</span></div><div class="casAuthors">Kontermann, Roland E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">868-876</span>CODEN:
                <span class="NLM_cas:coden">CUOBE3</span>;
        ISSN:<span class="NLM_cas:issn">0958-1669</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  With a growing no. of protein therapeutics being developed, many of them exhibiting a short plasma half-life, half-life extension strategies find increasing attention by the biotech and pharmaceutical industry.  Extension of the half-life can help to reduce the no. of applications and to lower doses, thus are beneficial for therapeutic but also economic reasons.  Here, a comprehensive overview of currently developed half-life extension strategies is provided including those aiming at increasing the hydrodynamic vol. of a protein drug but also those implementing recycling processes mediated by the neonatal Fc receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq31zlJXgPlCrVg90H21EOLACvtfcHk0liy0MA3IArxYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOhtLfK&md5=bfc4ed0a2ac98e447b1e7be799f02d32</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.copbio.2011.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.copbio.2011.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DKontermann%26aufirst%3DR.%2BE.%26atitle%3DStrategies%2520for%2520extended%2520serum%2520half-life%2520of%2520protein%2520therapeutics%26jtitle%3DCurr.%2520Opin.%2520Biotechnol.%26date%3D2011%26volume%3D22%26spage%3D868%26epage%3D876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Mezo, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reidy, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amari, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoehn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitonti, A. J.</span><span> </span><span class="NLM_article-title">Atrial natriuretic peptide-Fc, ANP-Fc, fusion proteins: semisynthesis, in vitro activity and pharmacokinetics in rats</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc200592c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVKrsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=518-526&author=A.+R.+Mezoauthor=K.+A.+McDonnellauthor=S.+C.+Lowauthor=J.+Songauthor=T.+J.+Reidyauthor=Q.+Luauthor=J.+V.+Amariauthor=T.+Hoehnauthor=R.+T.+Petersauthor=J.+Dumontauthor=A.+J.+Bitonti&title=Atrial+natriuretic+peptide-Fc%2C+ANP-Fc%2C+fusion+proteins%3A+semisynthesis%2C+in+vitro+activity+and+pharmacokinetics+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Atrial Natriuretic Peptide-Fc, ANP-Fc, Fusion Proteins: Semisynthesis, In Vitro Activity and Pharmacokinetics in Rats</span></div><div class="casAuthors">Mezo, Adam R.; McDonnell, Kevin A.; Low, Susan C.; Song, Jeff; Reidy, Tom J.; Lu, Qi; Amari, John V.; Hoehn, Todd; Peters, Robert T.; Dumont, Jennifer; Bitonti, Alan J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">518-526</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Atrial natriuretic peptide (ANP) may be a useful mol. for the treatment of cardiovascular diseases due to its potent natriuretic effects.  In an effort to prolong the short in vivo half-life of ANP, fusions of the peptide to the Fc domain of IgG were generated using a semisynthetic methodol.  Synthetic ANP peptides were synthesized with thioesters at either the N- or C-termini of the peptide and subsequently linked to the N-terminus of recombinantly expressed Fc using native chem. ligation.  The linker length between the ANP and Fc moieties was varied among 2, 11, or 16 amino acids.  In addn., either one ("monomeric") or two ("dimeric") ANP peptides were linked to Fc to study whether this modification had an effect on in vitro activity and/or in vivo half-life.  The various constructs were studied for in vitro activity using a cell-based cGMP assay.  The ANP-Fc fusion constructs were between 16- and ∼375-fold weaker than unconjugated ANP in this assay, and a trend was obsd. where the most potent conjugates were those with longer linkers and in the dimeric configuration.  The pharmacokinetics of several constructs were assessed in rats, and the half-life of the ANP-Fc's were found to be approx. 2 orders of magnitude longer than that of the unconjugated peptide.  There was no significant difference in terminal half-life between the monomeric and dimeric constructs (2.8-5.5 h), but a trend was obsd. where the Cmax of the monomeric constructs was approx. 3-fold higher than that of the dimeric constructs, although the origin of this effect is not understood.  These novel ANP-Fc fusion constructs hold promise for future therapeutic application in the treatment of cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokycZW1pNZmLVg90H21EOLACvtfcHk0liy0MA3IArxYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVKrsrs%253D&md5=dceffc220228072aab6469cc5a4bbaa2</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fbc200592c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc200592c%26sid%3Dliteratum%253Aachs%26aulast%3DMezo%26aufirst%3DA.%2BR.%26aulast%3DMcDonnell%26aufirst%3DK.%2BA.%26aulast%3DLow%26aufirst%3DS.%2BC.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DReidy%26aufirst%3DT.%2BJ.%26aulast%3DLu%26aufirst%3DQ.%26aulast%3DAmari%26aufirst%3DJ.%2BV.%26aulast%3DHoehn%26aufirst%3DT.%26aulast%3DPeters%26aufirst%3DR.%2BT.%26aulast%3DDumont%26aufirst%3DJ.%26aulast%3DBitonti%26aufirst%3DA.%2BJ.%26atitle%3DAtrial%2520natriuretic%2520peptide-Fc%252C%2520ANP-Fc%252C%2520fusion%2520proteins%253A%2520semisynthesis%252C%2520in%2520vitro%2520activity%2520and%2520pharmacokinetics%2520in%2520rats%26jtitle%3DBioconjugate%2520Chem.%26date%3D2012%26volume%3D23%26spage%3D518%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Tyndall, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, D. P.</span><span> </span><span class="NLM_article-title">Proteases universally recognize beta strands in their active sites</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">999</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr040669e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2005&pages=973-999&author=J.+D.+Tyndallauthor=T.+Nallauthor=D.+P.+Fairlie&title=Proteases+universally+recognize+beta+strands+in+their+active+sites"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Proteases universally recognize beta strands in their active sites</span></div><div class="casAuthors">Tyndall, Joel D. A.; Nall, Tessa; Fairlie, David P.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">973-999</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Proteases account for a significant proportion (∼2%) of the human genome with >550 defined members and a further ∼100 predicted human proteases.  Proteases also represent 1-5% of the genomes of infectious organisms such as bacteria, parasites, and viruses.  They are categorized by the nature of their active site catalytic residue(s) as metallo (34%), serine (30%), cysteine (26%), aspartic (4%), and the less characterized threonine (5%).  Mammalian proteases, of which ∼20% are membrane-bound, are aberrantly expressed or underregulated during many disease conditions, suggesting that inhibitors of specific proteases might be able to control irregular mammalian physiol.  Alternatively, since there are now >50 human proteases where one or more genetic mutations have been found to lead to hereditary diseases, gene therapy may be a useful approach when it eventually becomes technol. feasible.  The goal of protease inhibitor design is to develop potent inhibitors of the offending or mammalian protease but with accompanying selectivity to avoid inhibiting very similar host proteases required for normal host physiol.  This review summarizes an anal. of >1500 3-dimensional crystal (x-ray) and soln. (NMR) structures from the Protein Data Bank of substrates, products, and inhibitors bound in the active sites of all 5 protease classes.  Most of the active sites, with few exceptions, have been found to recognize peptidic and non-peptidic ligands in an extended β-strand conformation.  Such conformational selection of ligands explains the resistance of folded/structured regions of proteins to proteolytic degrdn., the susceptibility of denatured proteins to processing, and the higher affinity of conformationally constrained 'extended' inhibitors/substrates for proteases.  On the basis of the results presented by the authors, one would predict that the use of various approaches to fix an extended β-strand ligand conformation should produce high-affinity inhibitors even for proteases of unknown structure, provided that the substrate specificity and protease type is known.  This inference should be extremely valuable, particularly when the structure of a protease is not known and inhibitor design has to be based solely on substrate preferences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8uFIrmHewBrVg90H21EOLACvtfcHk0ljBR2lY66wSFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqtLo%253D&md5=67da540a9c260f7c80d9a2f7128dfc15</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fcr040669e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr040669e%26sid%3Dliteratum%253Aachs%26aulast%3DTyndall%26aufirst%3DJ.%2BD.%26aulast%3DNall%26aufirst%3DT.%26aulast%3DFairlie%26aufirst%3DD.%2BP.%26atitle%3DProteases%2520universally%2520recognize%2520beta%2520strands%2520in%2520their%2520active%2520sites%26jtitle%3DChem.%2520Rev.%26date%3D2005%26volume%3D105%26spage%3D973%26epage%3D999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Trabi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craik, D. J.</span><span> </span><span class="NLM_article-title">Circular proteins—No end in sight</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=132-138&author=M.+Trabiauthor=D.+J.+Craik&title=Circular+proteins%E2%80%94No+end+in+sight"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrabi%26aufirst%3DM.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26atitle%3DCircular%2520proteins%25E2%2580%2594No%2520end%2520in%2520sight%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2002%26volume%3D27%26spage%3D132%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Muttenthaler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Araujo, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dekan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alewood, P. F.</span><span> </span><span class="NLM_article-title">Modulating oxytocin activity and plasma stability by disulfide bond engineering</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8585</span><span class="NLM_x">–</span> <span class="NLM_lpage">8596</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100989w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8585-8596&author=M.+Muttenthalerauthor=A.+Anderssonauthor=A.+D.+de+Araujoauthor=Z.+Dekanauthor=R.+J.+Lewisauthor=P.+F.+Alewood&title=Modulating+oxytocin+activity+and+plasma+stability+by+disulfide+bond+engineering"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm100989w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100989w%26sid%3Dliteratum%253Aachs%26aulast%3DMuttenthaler%26aufirst%3DM.%26aulast%3DAndersson%26aufirst%3DA.%26aulast%3Dde%2BAraujo%26aufirst%3DA.%2BD.%26aulast%3DDekan%26aufirst%3DZ.%26aulast%3DLewis%26aufirst%3DR.%2BJ.%26aulast%3DAlewood%26aufirst%3DP.%2BF.%26atitle%3DModulating%2520oxytocin%2520activity%2520and%2520plasma%2520stability%2520by%2520disulfide%2520bond%2520engineering%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8585%26epage%3D8596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Reissmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imhof, D.</span><span> </span><span class="NLM_article-title">Development of conformationally restricted analogues of bradykinin and somatostatin using constrained amino acids and different types of cyclization</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2823</span><span class="NLM_x">–</span> <span class="NLM_lpage">2844</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.2174%2F0929867043364135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=15544478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosVynuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=2823-2844&author=S.+Reissmannauthor=D.+Imhof&title=Development+of+conformationally+restricted+analogues+of+bradykinin+and+somatostatin+using+constrained+amino+acids+and+different+types+of+cyclization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Development of conformationally restricted analogs of bradykinin and somatostatin using constrained amino acids and different types of cyclization</span></div><div class="casAuthors">Reissmann, Siegmund; Imhof, Diana</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2823-2844</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The structure-based design of peptide drugs requires the knowledge of the bioactive conformation.  Studies on this receptor-bound 3D structure require linear or cyclic analogs with strongly reduced flexibility, but high biol. activity, since only analogs with retained potency have preserved the bioactive conformation.  Constrained amino acids contg. double bonds or bulky substituents at the Nα-, Cα- and Cβ-atom as well as at the arom. ring atom were successfully applied to obtain potent and stable analogs of bradykinin and somatostatin, which due to their restricted conformation were suitable objects for conformational studies.  Besides the generation of constrained cyclic analogs with improved biol. and pharmacol. properties, cyclic peptides were used as convenient models for the study of turn formations.  Cyclization of the linear peptide bradykinin was performed by linking the N-terminus and the C-terminus, and in both bradykinin and somatostatin by cyclization using the amino acid side chains and by backbone cyclization.  The later requires the introduction of Nα-functionalized amino acids for ring closure which can be performed either through incorporation of Nα-functionalized amino acids or dipeptide building units.  Conformational anal. of a cyclic bradykinin analog by means of NMR-studies together with mol. dynamics simulation led to a quasicyclic 3D structure with two turns and together with other 3D structures provided a pharmacophore model of bradykinin antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov42oSt19vsbVg90H21EOLACvtfcHk0ljBR2lY66wSFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosVynuro%253D&md5=b662d8ac59b1ebf58b0b1ce6ab36461c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F0929867043364135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043364135%26sid%3Dliteratum%253Aachs%26aulast%3DReissmann%26aufirst%3DS.%26aulast%3DImhof%26aufirst%3DD.%26atitle%3DDevelopment%2520of%2520conformationally%2520restricted%2520analogues%2520of%2520bradykinin%2520and%2520somatostatin%2520using%2520constrained%2520amino%2520acids%2520and%2520different%2520types%2520of%2520cyclization%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D2823%26epage%3D2844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Bovy, P. R.</span><span> </span><span class="NLM_article-title">Structure activity in the atrial natriuretic peptide (ANP) family</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1002%2Fmed.2610100105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=2136927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADyaK3cXptFynsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1990&pages=115-142&author=P.+R.+Bovy&title=Structure+activity+in+the+atrial+natriuretic+peptide+%28ANP%29+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structure activity in the atrial natriuretic peptide (ANP) family</span></div><div class="casAuthors">Bovy, Philippe R.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">115-42</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    </div><div class="casAbstract">A review, with 121 refs., on the structure and synthesis of atriopeptin analogs with lengths ranging between 30 and <10 amino acid residues; the identification of the min. mol. size and bioactive conformation; and the contribution of each amino acid side chain to receptor recognition and activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJ48wu9_DHm7Vg90H21EOLACvtfcHk0ljBR2lY66wSFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXptFynsA%253D%253D&md5=a6a7ad279abe2aa7c31c43c8b286c330</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1002%2Fmed.2610100105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.2610100105%26sid%3Dliteratum%253Aachs%26aulast%3DBovy%26aufirst%3DP.%2BR.%26atitle%3DStructure%2520activity%2520in%2520the%2520atrial%2520natriuretic%2520peptide%2520%2528ANP%2529%2520family%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D1990%26volume%3D10%26spage%3D115%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Daly, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craik, D. J.</span><span> </span><span class="NLM_article-title">Bioactive cystine knot proteins</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">362</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1016%2Fj.cbpa.2011.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=21362584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXntV2luro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=362-368&author=N.+L.+Dalyauthor=D.+J.+Craik&title=Bioactive+cystine+knot+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Bioactive cystine knot proteins</span></div><div class="casAuthors">Daly, Norelle L.; Craik, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">362-368</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The cystine knot is a structural motif that confers exceptional stability on proteins.  Here we provide an update on the topol. of the cystine knot and the combinatorial diversity of proteins that contain it.  We describe recent chem. biol. studies that have utilized this structural motif for the development of potential therapeutic or diagnostic agents.  The cystine knot appears to have evolved in fungi, plants and animals as a stable and adaptable framework for the display of a wide variety of bioactive peptide sequences, but is amenable to chem. or recombinant synthesis and thus has a wide range of applications in chem., biol. and medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof-bZHYTT2rbVg90H21EOLACvtfcHk0li_UgAoSVmtEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXntV2luro%253D&md5=36ab9a8c7b875eccbb9f023b15139a1f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2011.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2011.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DN.%2BL.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26atitle%3DBioactive%2520cystine%2520knot%2520proteins%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D15%26spage%3D362%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Miljanich, G. P.</span><span> </span><span class="NLM_article-title">Ziconotide: Neuronal calcium channel blocker for treating severe chronic pain</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">3029</span><span class="NLM_x">–</span> <span class="NLM_lpage">3040</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.2174%2F0929867043363884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=15578997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpvV2is7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=3029-3040&author=G.+P.+Miljanich&title=Ziconotide%3A+Neuronal+calcium+channel+blocker+for+treating+severe+chronic+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Ziconotide: Neuronal calcium channel blocker for treating severe chronic pain</span></div><div class="casAuthors">Miljanich, G. P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3029-3040</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Ziconotide (PRIALT) is a neuroactive peptide in the final stages of clin. development as a novel non-opioid treatment for severe chronic pain.  It is the synthetic equiv. of ω-MVIIA, a component of the venom of the marine snail, Conus magus.  The mechanism of action underlying ziconotide's therapeutic profile derives from its potent and selective blockade of neuronal N-type voltage-sensitive calcium channels (N-VSCCs).  Direct blockade of N-VSCCs inhibits the activity of a subset of neurons, including pain-sensing primary nociceptors.  This mechanism of action distinguishes ziconotide from all other analgesics, including opioid analgesics.  In fact, ziconotide is potently anti-nociceptive in animal models of pain in which morphine exhibits poor anti-nociceptive activity.  Moreover, in contrast to opiates, tolerance to ziconotide is not obsd.  Clin. studies of ziconotide in more than 2,000 patients reveal important correlations to ziconotide's non-clin. pharmacol.  For example, ziconotide provides significant pain relief to severe chronic pain sufferers who have failed to obtain relief from opiate therapy and no evidence of tolerance to ziconotide is seen in these patients.  Contingent on regulatory approval, ziconotide will be the 1st in a new class of neurol. drugs: the N-type calcium channel blockers, or NCCBs.  Its novel mechanism of action as a non-opioid analgesic suggests ziconotide has the potential to play a valuable role in treatment regimens for severe chronic pain.  If approved for clin. use, ziconotide will further validate the neuroactive venom peptides as a source of new and useful medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobm9vmoUd5-7Vg90H21EOLACvtfcHk0li_UgAoSVmtEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpvV2is7c%253D&md5=d9fac93922cac758ea913b50da48a330</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F0929867043363884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043363884%26sid%3Dliteratum%253Aachs%26aulast%3DMiljanich%26aufirst%3DG.%2BP.%26atitle%3DZiconotide%253A%2520Neuronal%2520calcium%2520channel%2520blocker%2520for%2520treating%2520severe%2520chronic%2520pain%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D3029%26epage%3D3040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Colgrave, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craik, D. J.</span><span> </span><span class="NLM_article-title">Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: The importance of the cyclic cystine knot</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">5965</span><span class="NLM_x">–</span> <span class="NLM_lpage">5975</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi049711q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjsFGgsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=5965-5975&author=M.+L.+Colgraveauthor=D.+J.+Craik&title=Thermal%2C+chemical%2C+and+enzymatic+stability+of+the+cyclotide+kalata+B1%3A+The+importance+of+the+cyclic+cystine+knot"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Thermal, Chemical, and Enzymatic Stability of the Cyclotide Kalata B1: The Importance of the Cyclic Cystine Knot</span></div><div class="casAuthors">Colgrave, Michelle L.; Craik, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5965-5975</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cyclotides constitute a recently discovered family of plant-derived peptides that have the unusual features of a head-to-tail cyclized backbone and a cystine knot core.  These features are thought to contribute to their exceptional stability, as qual. obsd. during expts. aimed at sequencing and characterizing early members of the family.  However, to date there has been no quant. study of the thermal, chem., or enzymic stability of the cyclotides.  In this study, the authors demonstrate the stability of the prototypic cyclotide kalata B1 to the chaotropic agents 6 M guanidine hydrochloride (GdHCl) and 8 M urea, to temps. approaching boiling, to acid, and following incubation with a range of proteases, conditions under which most proteins readily unfold.  NMR spectroscopy was used to demonstrate the thermal stability, while fluorescence and CD were used to monitor the chem. stability.  Several variants of kalata B1 were also examd., including kalata B2, which has five amino acid substitutions from B1, two acyclic permutants in which the backbone was broken but the cystine knot was retained, and a two-disulfide bond mutant.  Together, these allowed detns. of the relative roles of the cystine knot and the circular backbone on the stability of the cyclotides.  Addn. of a denaturant to kalata B1 or an acyclic permutant did not cause unfolding, but the two-disulfide deriv. was less stable, despite having a similar three-dimensional structure.  It appears that the cystine knot is more important than the circular backbone in the chem. stability of the cyclotides.  Furthermore, the cystine knot of the cyclotides is more stable than those in similar-sized mols., judging by a comparison with the conotoxin PVIIA.  There was no evidence for enzymic digestion of native kalata B1 as monitored by LC-MS, but the reduced form was susceptible to proteolysis by trypsin, endoproteinase Glu-C, and thermolysin.  Fluorescence spectra of kalata B1 in the presence of dithiothreitol, a reducing agent, showed a marked increase in intensity thought to be due to removal of the quenching effect on the Trp residue by the neighboring Cys-5-Cys-17 disulfide bond.  In general, the reduced peptides were significantly more susceptible to chem. or enzymic breakdown than the oxidized species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI1We2BSc3QLVg90H21EOLACvtfcHk0li_UgAoSVmtEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjsFGgsL4%253D&md5=4d42bc872644a74d75610fe84846ece1</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fbi049711q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi049711q%26sid%3Dliteratum%253Aachs%26aulast%3DColgrave%26aufirst%3DM.%2BL.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26atitle%3DThermal%252C%2520chemical%252C%2520and%2520enzymatic%2520stability%2520of%2520the%2520cyclotide%2520kalata%2520B1%253A%2520The%2520importance%2520of%2520the%2520cyclic%2520cystine%2520knot%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D5965%26epage%3D5975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span>Melusine. <a href="http://www.melusine.com" class="extLink">www.melusine.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Melusine.+www.melusine.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Heinis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutherford, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, G.</span><span> </span><span class="NLM_article-title">Phage-encoded combinatorial chemical libraries based on bicyclic peptides</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">502</span><span class="NLM_x">–</span> <span class="NLM_lpage">507</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1038%2Fnchembio.184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=19483697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1altbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=502-507&author=C.+Heinisauthor=T.+Rutherfordauthor=S.+Freundauthor=G.+Winter&title=Phage-encoded+combinatorial+chemical+libraries+based+on+bicyclic+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Phage-encoded combinatorial chemical libraries based on bicyclic peptides</span></div><div class="casAuthors">Heinis, Christian; Rutherford, Trevor; Freund, Stephan; Winter, Greg</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">502-507</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Here we describe a phage strategy for the selection of ligands based on bicyclic or linear peptides attached covalently to an org. core.  We designed peptide repertoires with three reactive cysteine residues, each spaced apart by several random amino acid residues, and we fused the repertoires to the phage gene-3-protein.  Conjugation with tris-(bromomethyl)benzene via the reactive cysteines generated repertoires of peptide conjugates with two peptide loops anchored to a mesitylene core.  Iterative affinity selections yielded several enzyme inhibitors; after further mutagenesis and selection, we were able to chem. synthesize a lead inhibitor (PK15; Ki = 1.5 nM) specific to human plasma kallikrein that efficiently interrupted the intrinsic coagulation pathway in human plasma tested ex vivo.  This approach offers a powerful means of generating and selecting bicyclic macrocycles (or if cleaved, linear derivs. thereof) as ligands poised at the interface of small-mol. drugs and biologics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZhJRZyldisLVg90H21EOLACvtfcHk0li_UgAoSVmtEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1altbs%253D&md5=0634460f77b185fbcf85309c6dbf93e3</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.184%26sid%3Dliteratum%253Aachs%26aulast%3DHeinis%26aufirst%3DC.%26aulast%3DRutherford%26aufirst%3DT.%26aulast%3DFreund%26aufirst%3DS.%26aulast%3DWinter%26aufirst%3DG.%26atitle%3DPhage-encoded%2520combinatorial%2520chemical%2520libraries%2520based%2520on%2520bicyclic%2520peptides%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D5%26spage%3D502%26epage%3D507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Timmerman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beld, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puijk, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meloen, R. H.</span><span> </span><span class="NLM_article-title">Rapid and quantitative cyclization of multiple peptide loops onto synthetic scaffolds for structural mimicry of protein surfaces</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">824</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1002%2Fcbic.200400374" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=15812852" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksFajsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=821-824&author=P.+Timmermanauthor=J.+Beldauthor=W.+C.+Puijkauthor=R.+H.+Meloen&title=Rapid+and+quantitative+cyclization+of+multiple+peptide+loops+onto+synthetic+scaffolds+for+structural+mimicry+of+protein+surfaces"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid and quantitative cyclization of multiple peptide loops onto synthetic scaffolds for structural mimicry of protein surfaces</span></div><div class="casAuthors">Timmerman, Peter; Beld, Joris; Puijk, Wouter C.; Meloen, Rob H.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">821-824</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">This work describes cyclization reaction of cysteine-contg. linear peptides onto bromomethylated arom. scaffolds without requiring side-chain protections.  The reaction is extremely fast and clean and runs to completion in less than 15 min at room temp.  The cyclic peptides are good mimics of protein surfaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfSQnHmkXl_LVg90H21EOLACvtfcHk0lgkliibKCIUwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksFajsL0%253D&md5=52a1d3bb0bc8a483a683cdb900525c0f</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fcbic.200400374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.200400374%26sid%3Dliteratum%253Aachs%26aulast%3DTimmerman%26aufirst%3DP.%26aulast%3DBeld%26aufirst%3DJ.%26aulast%3DPuijk%26aufirst%3DW.%2BC.%26aulast%3DMeloen%26aufirst%3DR.%2BH.%26atitle%3DRapid%2520and%2520quantitative%2520cyclization%2520of%2520multiple%2520peptide%2520loops%2520onto%2520synthetic%2520scaffolds%2520for%2520structural%2520mimicry%2520of%2520protein%2520surfaces%26jtitle%3DChemBioChem%26date%3D2005%26volume%3D6%26spage%3D821%26epage%3D824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Angelini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cendron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Touati, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanotti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinis, C.</span><span> </span><span class="NLM_article-title">Bicyclic peptide inhibitor reveals large contact interface with a protease target</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb200478t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslGit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=817-821&author=A.+Angeliniauthor=L.+Cendronauthor=S.+Chenauthor=J.+Touatiauthor=G.+Winterauthor=G.+Zanottiauthor=C.+Heinis&title=Bicyclic+peptide+inhibitor+reveals+large+contact+interface+with+a+protease+target"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Bicyclic Peptide Inhibitor Reveals Large Contact Interface with a Protease Target</span></div><div class="casAuthors">Angelini, Alessandro; Cendron, Laura; Chen, Shiyu; Touati, Jeremy; Winter, Greg; Zanotti, Giuseppe; Heinis, Christian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">817-821</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">From a large combinatorial library of chem. constrained bicyclic peptides we isolated a selective and potent (Ki = 53 nM) inhibitor of human urokinase-type plasminogen activator (uPA) and crystd. the complex.  This revealed an extended structure of the peptide with both peptide loops engaging the target to form a large interaction surface of 701 Å2 with multiple hydrogen bonds and complementary charge interactions, explaining the high affinity and specificity of the inhibitor.  The interface resembles that between two proteins and suggests that these constrained peptides have the potential to act as small protein mimics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_mNSBCb03BLVg90H21EOLACvtfcHk0lgkliibKCIUwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslGit74%253D&md5=00ecceafcb4d3403d9c5c2a1c93032a5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fcb200478t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb200478t%26sid%3Dliteratum%253Aachs%26aulast%3DAngelini%26aufirst%3DA.%26aulast%3DCendron%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DTouati%26aufirst%3DJ.%26aulast%3DWinter%26aufirst%3DG.%26aulast%3DZanotti%26aufirst%3DG.%26aulast%3DHeinis%26aufirst%3DC.%26atitle%3DBicyclic%2520peptide%2520inhibitor%2520reveals%2520large%2520contact%2520interface%2520with%2520a%2520protease%2520target%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2012%26volume%3D7%26spage%3D817%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Andreasen, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egelund, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, H. H.</span><span> </span><span class="NLM_article-title">The plasminogen activation system in tumor growth, invasion, and metastasis</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">40</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1007%2Fs000180050497" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=10949579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhslOrsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2000&pages=25-40&author=P.+A.+Andreasenauthor=R.+Egelundauthor=H.+H.+Petersen&title=The+plasminogen+activation+system+in+tumor+growth%2C+invasion%2C+and+metastasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The plasminogen activation system in tumor growth, invasion, and metastasis</span></div><div class="casAuthors">Andreasen, P. A.; Egelund, R.; Petersen, H. H.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-40</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review with 197 refs.  Generation of the serine proteinase plasmin from the extracellular zymogen plasminogen can be catalyzed by either of two other serine proteinases, the tissue-type and tissue-type plasminogen activators (uPA and tPA).  The plasminogen activation system also includes the serpins PAI-1 and PAI-2, and the uPA receptor (uPAR).  Many findings, gathered over several decades, strongly suggest an important and causal role for uPA-catalyzed plasmin generation in cancer cell invasion through the extracellular matrix.  Recent evidence suggests that the uPA system is also involved in cancer cell-directed tissue remodeling.  Moreover, the system also supports cell migration and invasion by plasmin-independent mechanisms, including multiple interactions between uPA, uPAR, PAI-1, extracellular matrix proteins, integrins, endocytosis receptors, and growth factors.  These interactions seem to allow temporal and spatial reorganizations of the system during cell migration and a selective degrdn. of extracellular matrix proteins during invasion.  The increased knowledge about the plasminogen activation system may allow utilization of its components as targets for anti-invasive therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU5ANtYZtQgbVg90H21EOLACvtfcHk0lgkliibKCIUwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhslOrsrk%253D&md5=6760b4d8aabe089ac9a2fe4587b08103</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1007%2Fs000180050497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs000180050497%26sid%3Dliteratum%253Aachs%26aulast%3DAndreasen%26aufirst%3DP.%2BA.%26aulast%3DEgelund%26aufirst%3DR.%26aulast%3DPetersen%26aufirst%3DH.%2BH.%26atitle%3DThe%2520plasminogen%2520activation%2520system%2520in%2520tumor%2520growth%252C%2520invasion%252C%2520and%2520metastasis%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2000%26volume%3D57%26spage%3D25%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Dennis, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, Y. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadkhodayan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchhofer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Combs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damico, L. A.</span><span> </span><span class="NLM_article-title">Albumin binding as a general strategy for improving the pharmacokinetics of proteins</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">35035</span><span class="NLM_x">–</span> <span class="NLM_lpage">35043</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1074%2Fjbc.M205854200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=12119302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD38Xnt1Wgsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=35035-35043&author=M.+S.+Dennisauthor=M.+Zhangauthor=Y.+G.+Mengauthor=M.+Kadkhodayanauthor=D.+Kirchhoferauthor=D.+Combsauthor=L.+A.+Damico&title=Albumin+binding+as+a+general+strategy+for+improving+the+pharmacokinetics+of+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Albumin Binding as a General Strategy for Improving the Pharmacokinetics of Proteins</span></div><div class="casAuthors">Dennis, Mark S.; Zhang, Min; Meng, Y. Gloria; Kadkhodayan, Miryam; Kirchhofer, Daniel; Combs, Dan; Damico, Lisa A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">35035-35043</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Plasma protein binding can be an effective means of improving the pharmacokinetic properties of otherwise short lived mols.  Using peptide phage display, we identified a series of peptides having the core sequence DICLPRWGCLW that specifically bind serum albumin from multiple species with high affinity.  These peptides bind to albumin with 1:1 stoichiometry at a site distinct from known small mol. binding sites.  Using surface plasmon resonance, the dissocn. equil. const. of peptide SA21 (Ac-RLIEDICLPRWGCLWEDD-NH2) was detd. to be 266 ± 8, 320 ± 22, and 467 ± 47 nm for rat, rabbit, and human albumin, resp.  SA21 has an unusually long half-life of 2.3 h when injected by i.v. bolus into rabbits.  A related sequence, fused to the anti-tissue factor Fab of D3H44 (Presta, L., Sims, P., Meng, Y. G., Moran, P., Bullens, S., Bunting, S., Schoenfeld, J., Lowe, D., Lai, J., Rancatore, P., Iverson, M., Lim, A., Chisholm, V., Kelley, R. F., Riederer, M., and Kirchhofer, D. (2001) Thromb. Haemost. 85, 379-389), enabled the Fab to bind albumin with similar affinity to that of SA21 while retaining the ability of the Fab to bind tissue factor.  This interaction with albumin resulted in reduced in vivo clearance of 25- and 58-fold in mice and rabbits, resp., when compared with the wild-type D3H44 Fab.  The half-life was extended 37-fold to 32.4 h in rabbits and 26-fold to 10.4 h in mice, achieving 25-43% of the albumin half-life in these animals.  These half-lives exceed those of a Fab'2 and are comparable with those seen for polyethylene glycol-conjugated Fab mols., immunoadhesins, and albumin fusions, suggesting a novel and generic method for improving the pharmacokinetic properties of rapidly cleared proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLFW2XIwkgXbVg90H21EOLACvtfcHk0lgqe_ivsmSh4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xnt1Wgsbk%253D&md5=f026054505bc103514fca23f1070bd0d</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M205854200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M205854200%26sid%3Dliteratum%253Aachs%26aulast%3DDennis%26aufirst%3DM.%2BS.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DMeng%26aufirst%3DY.%2BG.%26aulast%3DKadkhodayan%26aufirst%3DM.%26aulast%3DKirchhofer%26aufirst%3DD.%26aulast%3DCombs%26aufirst%3DD.%26aulast%3DDamico%26aufirst%3DL.%2BA.%26atitle%3DAlbumin%2520binding%2520as%2520a%2520general%2520strategy%2520for%2520improving%2520the%2520pharmacokinetics%2520of%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D35035%26epage%3D35043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Nguyen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyes, A. E.,  2nd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damico, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, M. S.</span><span> </span><span class="NLM_article-title">The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin</span> <span class="citation_source-journal">Protein Eng., Des. Sel.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1093%2Fprotein%2Fgzl011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=16621915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmt1Wktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2006&pages=291-297&author=A.+Nguyenauthor=A.+E.+Reyesauthor=M.+Zhangauthor=P.+McDonaldauthor=W.+L.+Wongauthor=L.+A.+Damicoauthor=M.+S.+Dennis&title=The+pharmacokinetics+of+an+albumin-binding+Fab+%28AB.Fab%29+can+be+modulated+as+a+function+of+affinity+for+albumin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin</span></div><div class="casAuthors">Nguyen, Allen; Reyes, Arthur E., II; Zhang, Min; McDonald, Paul; Wong, Wai Lee T.; Damico, Lisa A.; Dennis, Mark S.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Engineering, Design & Selection</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">291-297</span>CODEN:
                <span class="NLM_cas:coden">PEDSBR</span>;
        ISSN:<span class="NLM_cas:issn">1741-0126</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">An AB.Fab (albumin-binding Fab) consists of a Fab and a phage-derived albumin-binding peptide.  This mol. is capable of binding both antigen and albumin simultaneously.  Using a Fab derived from Herceptin we generated a panel of AB.Fab variants with wide-ranging affinities for albumin.  An assay that measured AB.Fab binding to albumin in soln. was developed to most accurately reflect the binding affinity for albumin in vivo.  Affinity varied depending upon the species of albumin tested.  For rat and rabbit albumin, affinities ranged from 0.04 to 2.5 μM.  Reduced affinity for albumin correlated with a reduced half-life and higher clearance rates in both species; the beta half-life ranged 6-fold while clearance ranged over 50-fold in rats and 20-fold in rabbits.  To est. the pharmacokinetic properties of an AB.Fab in humans, AB.Fab variants with similar affinities for rat and rabbit albumin were selected.  Using their pharmacokinetic parameters and the principles of allometric scaling for albumin, we est. an approx. beta half-life for an AB.Fab with 0.5 μM affinity for albumin of up to 4 days in humans with a clearance of 76 mL/h.  These variants demonstrate the ability to modulate the clearance of a Fab fragment in vivo and help to establish guidelines for pharmacokinetic engineering of mols. through albumin binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9SJ16IWdf77Vg90H21EOLACvtfcHk0lgqe_ivsmSh4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmt1Wktb8%253D&md5=a783bc53292c684b3daefc72fd633734</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1093%2Fprotein%2Fgzl011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fprotein%252Fgzl011%26sid%3Dliteratum%253Aachs%26aulast%3DNguyen%26aufirst%3DA.%26aulast%3DReyes%26aufirst%3DA.%2BE.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DMcDonald%26aufirst%3DP.%26aulast%3DWong%26aufirst%3DW.%2BL.%26aulast%3DDamico%26aufirst%3DL.%2BA.%26aulast%3DDennis%26aufirst%3DM.%2BS.%26atitle%3DThe%2520pharmacokinetics%2520of%2520an%2520albumin-binding%2520Fab%2520%2528AB.Fab%2529%2520can%2520be%2520modulated%2520as%2520a%2520function%2520of%2520affinity%2520for%2520albumin%26jtitle%3DProtein%2520Eng.%252C%2520Des.%2520Sel.%26date%3D2006%26volume%3D19%26spage%3D291%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Langenheim, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, W. Y.</span><span> </span><span class="NLM_article-title">Improving the pharmacokinetics/pharmacodynamics of prolactin, GH, and their antagonists by fusion to a synthetic albumin-binding peptide</span> <span class="citation_source-journal">J. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">203</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1677%2FJOE-09-0211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=19770179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFWhurrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2009&pages=375-387&author=J.+F.+Langenheimauthor=W.+Y.+Chen&title=Improving+the+pharmacokinetics%2Fpharmacodynamics+of+prolactin%2C+GH%2C+and+their+antagonists+by+fusion+to+a+synthetic+albumin-binding+peptide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the pharmacokinetics/pharmacodynamics of prolactin, GH, and their antagonists by fusion to a synthetic albumin-binding peptide</span></div><div class="casAuthors">Langenheim, John F.; Chen, Wen Y.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endocrinology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">203</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">375-387</span>CODEN:
                <span class="NLM_cas:coden">JOENAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-0795</span>.
    
            (<span class="NLM_cas:orgname">Society for Endocrinology</span>)
        </div><div class="casAbstract">To prolong the circulation half-life of human prolactin (hPRL), human GH (hGH), and their competitive antagonists, hPRL-G129R and hGH-G120R, we examd. the effects of fusing a serum albumin-binding peptide (SA20) to their amino- or carboxyl-terminus.  Fusion of the SA20 peptide to the amino-terminus of the ligands was less detrimental upon their ability to induce or inhibit signal transduction and cell proliferation in vitro than fusion to the carboxyl-terminus.  Pharmacokinetic (PK) studies in mice revealed that the half-life of SA20-hPRL and SA20-hGH was prolonged and their clearance was reduced in comparison with hPRL and hGH.  Pharmacodynamic (PD) studies in 8-wk-old female mice revealed that lobuloalveolar development in mammary glands was greater in all three groups (daily, every 2 days, or every third day over a 12-day period) of mice treated with SA20-hPRL (4 mg/kg) compared with hPRL (3·59 mg/kg).  Similarly, daily administration (i.p.) of SA20-hGH (8 mg/kg) or hGH (7·15 mg/kg) to 23-day-old female mice over a 40-day period revealed the superiority of SA20-hGH over hGH as measured by wt. gain, body length, and lobuloalveolar development in the mammary glands.  These findings indicate that SA20 modification of hPRL, hGH, and their resp. antagonists improves their PK/PD properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3eGLuNdKoQ7Vg90H21EOLACvtfcHk0lgqe_ivsmSh4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFWhurrN&md5=371d7be39ed671d3ec7cd25d03ab62fc</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1677%2FJOE-09-0211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252FJOE-09-0211%26sid%3Dliteratum%253Aachs%26aulast%3DLangenheim%26aufirst%3DJ.%2BF.%26aulast%3DChen%26aufirst%3DW.%2BY.%26atitle%3DImproving%2520the%2520pharmacokinetics%252Fpharmacodynamics%2520of%2520prolactin%252C%2520GH%252C%2520and%2520their%2520antagonists%2520by%2520fusion%2520to%2520a%2520synthetic%2520albumin-binding%2520peptide%26jtitle%3DJ.%2520Endocrinol.%26date%3D2009%26volume%3D203%26spage%3D375%26epage%3D387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Korsinczky, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schirra, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craik, D. J.</span><span> </span><span class="NLM_article-title">Sunflower trypsin inhibitor-1</span> <span class="citation_source-journal">Curr. Protein Pept. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.2174%2F1389203043379594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=15544530" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFGjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=351-364&author=M.+L.+Korsinczkyauthor=H.+J.+Schirraauthor=D.+J.+Craik&title=Sunflower+trypsin+inhibitor-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Sunflower trypsin inhibitor-1</span></div><div class="casAuthors">Korsinczky, Michael L. J.; Schirra, Horst Joachim; Craik, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Protein and Peptide Science</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">351-364</span>CODEN:
                <span class="NLM_cas:coden">CPPSCM</span>;
        ISSN:<span class="NLM_cas:issn">1389-2037</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  SFTI-1 is a bicyclic 14 amino acid peptide that was originally isolated from the seeds of the sunflower Helianthus annuus.  It is a potent inhibitor of trypsin, with a sub-nanomolar Ki value and is homologous to the active site region of the well-known family of serine protease inhibitors known as the Bowman-Birk trypsin inhibitors.  It has a cyclic backbone that is cross-braced by a single disulfide bridge and a network of hydrogen bonds that result in a well-defined structure.  SFTI-1 is amenable to chem. synthesis, allowing for the creation of synthetic variants.  Alterations to the structure such as linearizing the backbone or removing the disulfide bridge do not reduce the potency of SFTI-1 significantly, and minimizing the peptide to as few as nine residues results in only a small decrease in reactivity.  The creation of linear variants of SFTI-1 also provides a tool for investigating putative linear precursor peptides.  The mechanism of biosynthesis of SFTI-1 is not yet known but it seems likely that it is a gene-coded product that has arisen from a precursor protein that may be evolutionarily related to classic Bowman-Birk inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPPRnSe76NqbVg90H21EOLACvtfcHk0lgqe_ivsmSh4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFGjtbc%253D&md5=b2344eaaa52a5ebb807593168a2737ac</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F1389203043379594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389203043379594%26sid%3Dliteratum%253Aachs%26aulast%3DKorsinczky%26aufirst%3DM.%2BL.%26aulast%3DSchirra%26aufirst%3DH.%2BJ.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26atitle%3DSunflower%2520trypsin%2520inhibitor-1%26jtitle%3DCurr.%2520Protein%2520Pept.%2520Sci.%26date%3D2004%26volume%3D5%26spage%3D351%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Luckett, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barker, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konarev, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewry, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brady, R. L.</span><span> </span><span class="NLM_article-title">High-resolution structure of a potent, cyclic proteinase inhibitor from sunflower seeds</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1006%2Fjmbi.1999.2891" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=10390350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADyaK1MXktFehsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=1999&pages=525-533&author=S.+Luckettauthor=R.+S.+Garciaauthor=J.+J.+Barkerauthor=A.+V.+Konarevauthor=P.+R.+Shewryauthor=A.+R.+Clarkeauthor=R.+L.+Brady&title=High-resolution+structure+of+a+potent%2C+cyclic+proteinase+inhibitor+from+sunflower+seeds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">High-Resolution Structure of a Potent, Cyclic Proteinase Inhibitor from Sunflower Seeds</span></div><div class="casAuthors">Luckett, S.; Garcia, R. Santiago; Barker, J. J.; Konarev, Al. V.; Shewry, P. R.; Clarke, A. R.; Brady, R. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">525-533</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Proteinaceous serine proteinase inhibitors are widespread throughout the plant kingdom where they play an important role in protection against pests and pathogens.  Here, we describe the isolation and characterization of a novel 14 amino acid residue cyclic peptide from sunflower seeds, which is a potent inhibitor of trypsin (Ki=100 pM).  The crystal structure of this peptide in complex with bovine β-trypsin shows both sequence and conformational similarity with the trypsin-reactive loop of the Bowman-Birk family of serine proteinase inhibitors.  This inhibitor, however, is unique in being monofunctional, cyclic and far shorter (14 amino acid residues) than inhibitors belonging to this family (typically 60-70 amino acid residues).  The high potency of this peptide is likely to arise from the considerable structural rigidity achieved through its cyclic nature which is further stabilized by a single internal disulfide bond.  This study helps delineate the minimal unit required for effective peptide inhibitors of serine proteinases, and will assist in the further design of inhibitors to this widespread class of enzymes.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqflG8_cLIMOLVg90H21EOLACvtfcHk0lj4OMKj7QTE9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktFehsb0%253D&md5=2f3b198effcf0085d4337c2a47a2826d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1999.2891&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1999.2891%26sid%3Dliteratum%253Aachs%26aulast%3DLuckett%26aufirst%3DS.%26aulast%3DGarcia%26aufirst%3DR.%2BS.%26aulast%3DBarker%26aufirst%3DJ.%2BJ.%26aulast%3DKonarev%26aufirst%3DA.%2BV.%26aulast%3DShewry%26aufirst%3DP.%2BR.%26aulast%3DClarke%26aufirst%3DA.%2BR.%26aulast%3DBrady%26aufirst%3DR.%2BL.%26atitle%3DHigh-resolution%2520structure%2520of%2520a%2520potent%252C%2520cyclic%2520proteinase%2520inhibitor%2520from%2520sunflower%2520seeds%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1999%26volume%3D290%26spage%3D525%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Colgrave, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korsinczky, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foley, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craik, D. J.</span><span> </span><span class="NLM_article-title">Sunflower trypsin inhibitor-1, proteolytic studies on a trypsin inhibitor peptide and its analogs</span> <span class="citation_source-journal">Biopolymers</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">672</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2010&pages=665-672&author=M.+L.+Colgraveauthor=M.+J.+Korsinczkyauthor=R.+J.+Clarkauthor=F.+Foleyauthor=D.+J.+Craik&title=Sunflower+trypsin+inhibitor-1%2C+proteolytic+studies+on+a+trypsin+inhibitor+peptide+and+its+analogs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColgrave%26aufirst%3DM.%2BL.%26aulast%3DKorsinczky%26aufirst%3DM.%2BJ.%26aulast%3DClark%26aufirst%3DR.%2BJ.%26aulast%3DFoley%26aufirst%3DF.%26aulast%3DCraik%26aufirst%3DD.%2BJ.%26atitle%3DSunflower%2520trypsin%2520inhibitor-1%252C%2520proteolytic%2520studies%2520on%2520a%2520trypsin%2520inhibitor%2520peptide%2520and%2520its%2520analogs%26jtitle%3DBiopolymers%26date%3D2010%26volume%3D94%26spage%3D665%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Ruiz-Rodriguez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spengler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albericio, F.</span><span> </span><span class="NLM_article-title">Siamese depsipeptides: constrained bicyclic architectures</span> <span class="citation_source-journal">Angew. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">8564</span><span class="NLM_x">–</span> <span class="NLM_lpage">8567</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=8564-8567&author=J.+Ruiz-Rodriguezauthor=J.+Spenglerauthor=F.+Albericio&title=Siamese+depsipeptides%3A+constrained+bicyclic+architectures"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuiz-Rodriguez%26aufirst%3DJ.%26aulast%3DSpengler%26aufirst%3DJ.%26aulast%3DAlbericio%26aufirst%3DF.%26atitle%3DSiamese%2520depsipeptides%253A%2520constrained%2520bicyclic%2520architectures%26jtitle%3DAngew.%2520Chem.%26date%3D2009%26volume%3D48%26spage%3D8564%26epage%3D8567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Harris, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chess, R. B.</span><span> </span><span class="NLM_article-title">Effect of pegylation on pharmaceuticals</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">214</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm301276e&amp;key=10.1038%2Fnrd1033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm301276e&amp;key=12612647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhsFKrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=214-221&author=J.+M.+Harrisauthor=R.+B.+Chess&title=Effect+of+pegylation+on+pharmaceuticals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of PEGylation on pharmaceuticals</span></div><div class="casAuthors">Harris, J. Milton; Chess, Robert B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">214-221</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein and peptide drugs hold great promise as therapeutic agents.  However, many are degraded by proteolytic enzymes, can be rapidly cleared by the kidneys, generate neutralizing antibodies and have a short circulating half-life.  PEGylation, the process by which polyethylene glycol chains are attached to protein and peptide drugs, can overcome these and other shortcomings.  By increasing the mol. mass of proteins and peptides and shielding them from proteolytic enzymes, PEGylation improves pharmacokinetics.  This article will review how PEGylation can result in drugs that are often more effective and safer, and which show improved patient convenience and compliance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLhPAuz8WjMLVg90H21EOLACvtfcHk0lj4OMKj7QTE9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhsFKrtLs%253D&md5=d6bb387e746740b10e088e1f55af37db</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrd1033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1033%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DJ.%2BM.%26aulast%3DChess%26aufirst%3DR.%2BB.%26atitle%3DEffect%2520of%2520pegylation%2520on%2520pharmaceuticals%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D214%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Dennis, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFarland, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogasawara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwall, R.</span><span> </span><span class="NLM_article-title">Imaging tumors with an albumin-binding Fab, a novel tumor-targeting agent</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">254</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=254-261&author=M.+S.+Dennisauthor=H.+Jinauthor=D.+Duggerauthor=R.+Yangauthor=L.+McFarlandauthor=A.+Ogasawaraauthor=S.+Williamsauthor=M.+J.+Coleauthor=S.+Rossauthor=R.+Schwall&title=Imaging+tumors+with+an+albumin-binding+Fab%2C+a+novel+tumor-targeting+agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDennis%26aufirst%3DM.%2BS.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DDugger%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DR.%26aulast%3DMcFarland%26aufirst%3DL.%26aulast%3DOgasawara%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DS.%26aulast%3DCole%26aufirst%3DM.%2BJ.%26aulast%3DRoss%26aufirst%3DS.%26aulast%3DSchwall%26aufirst%3DR.%26atitle%3DImaging%2520tumors%2520with%2520an%2520albumin-binding%2520Fab%252C%2520a%2520novel%2520tumor-targeting%2520agent%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D254%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Holmes, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibaudeau, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">L'Archeveque, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milner, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezrin, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridon, D. P.</span><span> </span><span class="NLM_article-title">Site specific 1:1 opioid:albumin conjugate with in vitro activity and long in vivo duration</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">444</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc0000233" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt1GktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2000&pages=439-444&author=D.+L.+Holmesauthor=K.+Thibaudeauauthor=B.+L%27Archevequeauthor=P.+G.+Milnerauthor=A.+M.+Ezrinauthor=D.+P.+Bridon&title=Site+specific+1%3A1+opioid%3Aalbumin+conjugate+with+in+vitro+activity+and+long+in+vivo+duration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Site specific 1:1 opioid:albumin conjugate with in vitro activity and long in vivo duration</span></div><div class="casAuthors">Holmes, Darren L.; Thibaudeau, Karen; L'Archeveque, Benoit; Milner, Peter G.; Ezrin, Alan M.; Bridon, Dominique P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">439-444</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A site-specific 1:1 dynorphin A-(1-13)-NH2 deriv. conjugated specifically to Cys 34 on human serum albumin (CCI-1035) was shown to be an opioid receptor agonist in vitro and to be a long lasting antinociceptive agent when administered i.v. to mice as assessed by an acetic acid writhing assay.  When 10 μmol/kg of CCI-1035 was administered to mice, rapid antinociception was obsd. within 5 min following i.v. bolus injection and was sustained beyond 8 h.  Antinociceptive activity was absent in a heat induced pain model using a mouse tail-flick assay.  This finding represents the first report of a 1:1 albumin opioid conjugate retaining potent in vivo activity equal to or greater than dynorphin A, accompanied by a dramatic extension in duration of action.  This novel site-specific bioconjugation technol. produces an agent that may be useful for peripheral pain therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIp8OKpfc78LVg90H21EOLACvtfcHk0lgka4YSBIJe5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt1GktLY%253D&md5=f5ca43125a08038376a65ace5c91e828</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fbc0000233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc0000233%26sid%3Dliteratum%253Aachs%26aulast%3DHolmes%26aufirst%3DD.%2BL.%26aulast%3DThibaudeau%26aufirst%3DK.%26aulast%3DL%2527Archeveque%26aufirst%3DB.%26aulast%3DMilner%26aufirst%3DP.%2BG.%26aulast%3DEzrin%26aufirst%3DA.%2BM.%26aulast%3DBridon%26aufirst%3DD.%2BP.%26atitle%3DSite%2520specific%25201%253A1%2520opioid%253Aalbumin%2520conjugate%2520with%2520in%2520vitro%2520activity%2520and%2520long%2520in%2520vivo%2520duration%26jtitle%3DBioconjugate%2520Chem.%26date%3D2000%26volume%3D11%26spage%3D439%26epage%3D444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Leger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benquet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quraishi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Wyk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridon, D.</span><span> </span><span class="NLM_article-title">Kringle 5 peptide-albumin conjugates with anti-migratory activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">845</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=841-845&author=R.+Legerauthor=C.+Benquetauthor=X.+Huangauthor=O.+Quraishiauthor=P.+van+Wykauthor=D.+Bridon&title=Kringle+5+peptide-albumin+conjugates+with+anti-migratory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeger%26aufirst%3DR.%26aulast%3DBenquet%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DQuraishi%26aufirst%3DO.%26aulast%3Dvan%2BWyk%26aufirst%3DP.%26aulast%3DBridon%26aufirst%3DD.%26atitle%3DKringle%25205%2520peptide-albumin%2520conjugates%2520with%2520anti-migratory%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D841%26epage%3D845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Leger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robitaille, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quraishi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denholm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benquet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Wyk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellerin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet-Gagnon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridon, D.</span><span> </span><span class="NLM_article-title">Synthesis and in vitro analysis of atrial natriuretic peptide-albumin conjugates</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3571</span><span class="NLM_x">–</span> <span class="NLM_lpage">3575</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3571-3575&author=R.+Legerauthor=M.+Robitailleauthor=O.+Quraishiauthor=E.+Denholmauthor=C.+Benquetauthor=J.+Caretteauthor=P.+van+Wykauthor=I.+Pellerinauthor=N.+Bousquet-Gagnonauthor=J.+P.+Castaigneauthor=D.+Bridon&title=Synthesis+and+in+vitro+analysis+of+atrial+natriuretic+peptide-albumin+conjugates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeger%26aufirst%3DR.%26aulast%3DRobitaille%26aufirst%3DM.%26aulast%3DQuraishi%26aufirst%3DO.%26aulast%3DDenholm%26aufirst%3DE.%26aulast%3DBenquet%26aufirst%3DC.%26aulast%3DCarette%26aufirst%3DJ.%26aulast%3Dvan%2BWyk%26aufirst%3DP.%26aulast%3DPellerin%26aufirst%3DI.%26aulast%3DBousquet-Gagnon%26aufirst%3DN.%26aulast%3DCastaigne%26aufirst%3DJ.%2BP.%26aulast%3DBridon%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520analysis%2520of%2520atrial%2520natriuretic%2520peptide-albumin%2520conjugates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3571%26epage%3D3575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Leger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibaudeau, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robitaille, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quraishi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Wyk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet-Gagnon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carette, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castaigne, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridon, D. P.</span><span> </span><span class="NLM_article-title">Identification of CJC-1131-albumin bioconjugate as a stable and bioactive GLP-1(7–36) analog</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4395</span><span class="NLM_x">–</span> <span class="NLM_lpage">4398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4395-4398&author=R.+Legerauthor=K.+Thibaudeauauthor=M.+Robitailleauthor=O.+Quraishiauthor=P.+van+Wykauthor=N.+Bousquet-Gagnonauthor=J.+Caretteauthor=J.+P.+Castaigneauthor=D.+P.+Bridon&title=Identification+of+CJC-1131-albumin+bioconjugate+as+a+stable+and+bioactive+GLP-1%287%E2%80%9336%29+analog"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeger%26aufirst%3DR.%26aulast%3DThibaudeau%26aufirst%3DK.%26aulast%3DRobitaille%26aufirst%3DM.%26aulast%3DQuraishi%26aufirst%3DO.%26aulast%3Dvan%2BWyk%26aufirst%3DP.%26aulast%3DBousquet-Gagnon%26aufirst%3DN.%26aulast%3DCarette%26aufirst%3DJ.%26aulast%3DCastaigne%26aufirst%3DJ.%2BP.%26aulast%3DBridon%26aufirst%3DD.%2BP.%26atitle%3DIdentification%2520of%2520CJC-1131-albumin%2520bioconjugate%2520as%2520a%2520stable%2520and%2520bioactive%2520GLP-1%25287%25E2%2580%259336%2529%2520analog%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4395%26epage%3D4398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Knudsen, L. B.</span><span> </span><span class="NLM_article-title">Glucagon-like peptide-1: the basis of a new class of treatment for type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4128</span><span class="NLM_x">–</span> <span class="NLM_lpage">4134</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030630m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4128-4134&author=L.+B.+Knudsen&title=Glucagon-like+peptide-1%3A+the+basis+of+a+new+class+of+treatment+for+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm030630m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030630m%26sid%3Dliteratum%253Aachs%26aulast%3DKnudsen%26aufirst%3DL.%2BB.%26atitle%3DGlucagon-like%2520peptide-1%253A%2520the%2520basis%2520of%2520a%2520new%2520class%2520of%2520treatment%2520for%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4128%26epage%3D4134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Knudsen, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huusfeldt, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansen, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, F. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thogersen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agerso, H.</span><span> </span><span class="NLM_article-title">Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1664</span><span class="NLM_x">–</span> <span class="NLM_lpage">1669</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9909645" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm301276e&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVKksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=1664-1669&author=L.+B.+Knudsenauthor=P.+F.+Nielsenauthor=P.+O.+Huusfeldtauthor=N.+L.+Johansenauthor=K.+Madsenauthor=F.+Z.+Pedersenauthor=H.+Thogersenauthor=M.+Wilkenauthor=H.+Agerso&title=Potent+derivatives+of+glucagon-like+peptide-1+with+pharmacokinetic+properties+suitable+for+once+daily+administration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration</span></div><div class="casAuthors">Knudsen, Lotte B.; Nielsen, Per F.; Huusfeldt, Per O.; Johansen, Nils L.; Madsen, Kjeld; Pedersen, Freddy Z.; Thogersen, Henning; Wilken, Michael; Agerso, Henrik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1664-1669</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of very potent derivs. of the 30-amino acid peptide hormone glucagon-like peptide-1 (GLP-1) is described.  The compds. were all derivatized with fatty acids in order to protract their action by facilitating binding to serum albumin. GLP-1 had a potency (EC50) of 55 pM for the cloned human GLP-1 receptor.  Many of the compds. had similar or even higher potencies, despite quite large substituents.  All compds. derivatized with fatty acids equal to or longer than 12 carbon atoms were very protracted compared to GLP-1 and thus seem suitable for once daily administration to type 2 diabetic patients.  A structure-activity relationship was obtained. GLP-1 could be derivatized with linear fatty acids up to the length of 16 carbon atoms, sometimes longer, almost anywhere in the C-terminal part without considerable loss of potency.  Derivatization with two fatty acid substituents led to a considerable loss of potency.  A structure-activity relationship on derivatization of specific amino acids generally was obtained.  It was found that the longer the fatty acid, the more potency was lost.  Simultaneous modification of the N-terminus (in order to obtain better metabolic stability) interfered with fatty acid derivatization and led to loss of potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_iyZt3E6tG7Vg90H21EOLACvtfcHk0lgka4YSBIJe5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVKksLg%253D&md5=d050c27dd6aea795191798254e2bf080</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm9909645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9909645%26sid%3Dliteratum%253Aachs%26aulast%3DKnudsen%26aufirst%3DL.%2BB.%26aulast%3DNielsen%26aufirst%3DP.%2BF.%26aulast%3DHuusfeldt%26aufirst%3DP.%2BO.%26aulast%3DJohansen%26aufirst%3DN.%2BL.%26aulast%3DMadsen%26aufirst%3DK.%26aulast%3DPedersen%26aufirst%3DF.%2BZ.%26aulast%3DThogersen%26aufirst%3DH.%26aulast%3DWilken%26aufirst%3DM.%26aulast%3DAgerso%26aufirst%3DH.%26atitle%3DPotent%2520derivatives%2520of%2520glucagon-like%2520peptide-1%2520with%2520pharmacokinetic%2520properties%2520suitable%2520for%2520once%2520daily%2520administration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D1664%26epage%3D1669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Roehrl, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, G.</span><span> </span><span class="NLM_article-title">A general framework for development and data analysis of competitive high-throughput screens for small-molecule inhibitors of protein-protein interactions by fluorescence polarization</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">16056</span><span class="NLM_x">–</span> <span class="NLM_lpage">16066</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi048233g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=16056-16066&author=M.+H.+Roehrlauthor=J.+Y.+Wangauthor=G.+Wagner&title=A+general+framework+for+development+and+data+analysis+of+competitive+high-throughput+screens+for+small-molecule+inhibitors+of+protein-protein+interactions+by+fluorescence+polarization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fbi048233g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi048233g%26sid%3Dliteratum%253Aachs%26aulast%3DRoehrl%26aufirst%3DM.%2BH.%26aulast%3DWang%26aufirst%3DJ.%2BY.%26aulast%3DWagner%26aufirst%3DG.%26atitle%3DA%2520general%2520framework%2520for%2520development%2520and%2520data%2520analysis%2520of%2520competitive%2520high-throughput%2520screens%2520for%2520small-molecule%2520inhibitors%2520of%2520protein-protein%2520interactions%2520by%2520fluorescence%2520polarization%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D16056%26epage%3D16066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i24"><a href="/doi/suppl/10.1021/jm301276e">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_53402"></div></div></div></div></div><hr /></hr><p class="last">Supplementary figures showing the synthesis strategies of the peptide conjugates and figures showing experimental data from the peptide binding, inhibition, and stability assays. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm301276e/suppl_file/jm301276e_si_001.pdf">jm301276e_si_001.pdf (2.26 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm301276e&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-22%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm301276e%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm301276e" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679956abaa843c94","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
